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ABSTRACT 
 
Dermal and transdermal delivery offers a number of potential advantages for drug 
delivery. However the skin provides an efficient barrier, preventing both excessive 
water loss from the body and the ingress of xenobiotics. Nevertheless, the vehicle 
used in the topical formulation can enhance the diffusion of a drug through 
membranes and reduce the barrier properties. It is hypothesized that oils and oil 
blends may interact with membranes to different extents depending on the 
physicochemical properties of the oil(s) and membrane. The aim of this study was 
to investigate the interaction of oily vehicles with different synthetic membranes 
(silicone, polyurethane (PU), high density polyethylene (HDPE) and cellulose 
acetate nitrate (CAN)) and human epidermis with a view to understanding the effect 
of the co-administration of oil blends on the permeation of model solutes (methyl 
parabens (MP), butyl parabens (BP) and caffeine (CF)). 
 
A gas chromatographic method was developed and validated to quantify the 
amounts of oil sorbed by silicone membrane (the principal membrane employed). 
High pressure liquid chromatography was used to quantify the amount of model 
solute that permeated the membranes contained within Franz diffusion cells. The 
uptake of different oils (isopropyl myristate (IPM), oleic acid (OA), hexadecane, 
isohexadecane (IHD) and light liquid paraffin) by the membranes was studied by 
monitoring the change in weight and thickness of the membranes after immersion in 
oil. Multivariate analysis (principal component analysis and quantitative structure-
property relationship) was used with a view to identifying the key molecular 
properties of vehicle components, permeants and the barrier membrane that 
influenced the permeation of the compounds through different membranes. These 
mathematical tools were also employed to understand and predict compound 
permeation across human epidermis from the oily vehicles. 
 
The permeation studies of model permeants through silicone membrane and CAN 
membrane were performed using systems having the same thermodynamic activity. 
The flux values achieved from different vehicles were different, which indicated 
vehicle sorption by the membrane potentially altering membrane properties. In 
solvent uptake studies the buffer showed a greater affinity for the more hydrophilic 
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CAN membrane but induced no swelling of the silicone membrane. The amounts of 
each oil sorbed by CAN were low; whereas oils were sorbed in different amounts 
by the hydrophobic membranes. Preferential uptake of one oil over the other 
component was observed for some blended oil mixtures (for example, this occurred 
for IHD from OA:IHD blends). Whereas using other blends (for example, those 
comprising IPM:IHD) both oils entered the membrane in a similar ratio to that 
applied to the surface. The diffusion of MP from buffer through silicone membrane 
pre-treated with different oils, showed that as the amount of oil sorbed into silicone 
membrane increased the diffusion of the subsequently applied MP also increased. 
Diffusion of the model permeants through different membranes from pure oils 
showed that oil uptake affected the amount of (model) compound permeated. The 
highest flux values through human epidermis for all three model permeants were 
obtained using IHD as a vehicle. Multivariate analysis confirmed that the nature of 
the vehicle, membrane and permeant affect the permeability of the latter; 
particularly highlighting the shape of the oil molecule with respect to its uptake into 
membranes. 
 
Oils added into formulations or mixtures are sorbed into the membranes in different 
amounts. Membrane properties are subsequently modified and the thermodynamic 
activity of permeant within the formulation is likely to be altered due to preferential 
oil sorption from the vehicle by the membrane. The flux of the permeants through 
the membranes was shown to be related to the extent of oil uptake and a complex 
interaction of physicochemical properties of vehicle, membrane and permeant. The 
novel approach of using multivariate analysis was found to be promising approach 
to disassociate the relative importance of the various factors that might influence 
the interaction and diffusion behaviour of vehicles and permeants with synthetic 
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The skin has many essential functions, the most important being to form a physical 
barrier to the environment, allowing and limiting the inward and outward passage of 
water, electrolytes and various substances. A good knowledge of the skin penetration of 
xenobiotics is essential for a number of different purposes, for example, drug delivery to 
skin (dermatological treatments) and through skin (transdermal patches), skin care and 
ultraviolet radiation protection (sunscreen). It is also relevant when seeking to 
understanding the potential toxicity of cosmetics, anti-infectives or insect repellents. Skin 
also has the ability to regulate body temperature by means of both its blood flow and the 
mechanism of perspiration, and also serves as a sensory organ. 
 
Topical and transdermal drug products are intended for external use. However dermal 
(topical) products are intended to be targeted to the pathological sites within the skin. The 
localized action on one or more layers of the skin is important in the treatment of 
dermatological conditions such as skin cancer, psoriasis, eczema, and microbial 
infections (Brown et al., 2006). However, although some active pharmaceutical 
ingredients from these topical products may also be absorbed beyond the dermal target 
site into the  systemic circulation; it is usually in sub-therapeutic concentrations. On the 
other hand, in transdermal drug delivery systems a drug has to diffuse through the various 
layers of the skin and into the systemic circulation for a therapeutic effect to be exerted, 
despite the skin not being the primary target organ; for example as in the use of 
therapeutic patches (e.g. scopolamine). Further examples of possible target sites for drug 
action in skin therapy are shown in Figure 1.1. 
 
Dermal and transdermal drug delivery provides a viable administration route for potent, 
low-molecular weight therapeutic agents which cannot withstand the hostile environment 
of the gastrointestinal tract and/or are subject to considerable first-pass metabolism by the 
liver. However, the barrier nature of human skin which confers its key protective function  
 




Figure 1.1 Anatomy and physiology of the skin, showing the potential targets or site of 
action for cosmetics and drugs (Brown et al., 2006). 
 
also imposes physicochemical limitations on the type of penetrants that can traverse the 
barrier.    
 
For a drug to be delivered passively via the skin it is generally accepted that it should 
have adequate lipophilicity and also a low molecular weight (Yano et al., 1986; Bos & 
Meinardi, 2000); and a molecular weight <500 Da is suggested to be preferable. These 
requirements have limited the number of commercially available products based on 
transdermal or dermal delivery. Thus, in order to exploit the potential advantages offered 
by this route of delivery, it would be desirable if the number of potential drug candidates 
could be increased. As such various strategies have begun to emerge over recent years to 
enhance the absorption of drugs that would otherwise not be absorbed in sufficient 
quantity to elicit a therapeutic response. A number of skin penetration enhancement 
techniques have been developed to improve bioavailability and increase the range of 
drugs for which topical and transdermal delivery is a viable option (Brown et al., 2006). 
 
The principal rationale for the inclusion of oils within topical vehicles has historically 
been driven primarily by cosmetic requirements, involving ‘consumer feel’, emollience, 
and acceptable product appearance. Nevertheless, some consideration has also been given 
to the ability of blended oils to solubilize any incorporated drug and affect the release and 
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partitioning of drugs into the skin (Kreilgaard, 2002; Saroj et al., 2012). However it has 
been shown that a number of oils can partition into the skin and integrate within the lipid 
bilayers after application to the skin surface. This might in turn be expected to modify the 
partition behaviour into the epidermal layers of any concomitantly administered drugs. In 
addition, the partition of certain oils such as isopropyl myristate and oleic acid have been 
reported to promote membrane lipid fluidity (Pillai et al., 2004; Lane, 2013), which may 
contribute to the increased disorder of stratum corneum and thus enhance permeability of 
bilayers within the stratum corneum. Any oil residue remaining in contact with the skin 
can also confer barrier function, reduce epidermal water loss and possibly further modify 
the permeation properties of the skin. 
 
However, the possible role of oils, which is incorporated and applied to the skin as 
supposedly inert vehicles/excipients in the modification of drug permeation, as a 
consequence of inducing an altered membrane structure has not been well-investigated. It 
is therefore the purpose of this study to study some of these factors. Accordingly it is 
appropriate to: review the structure of skin, consider the advantages; limitations and 
theoretical basis of transdermal delivery; and examine the vehicle effects on the skin, 
with an emphasis on the oils that have been previously incorporated in topically applied 
vehicles. It is also pertinent to assess the analytical and experimental techniques available 
for assessing permeation and appreciate the basis of techniques developed to predict 
permeability. 
 
1.1.2 Structure and barrier properties of the skin 
 
The skin is a very complex heterogeneous membrane and comprises the largest 
multifunctional organ of the body, accounting for more than 10% of the body mass. It is 
composed of tissue that grows, differentiates and renews itself constantly. The skin 
(Figure 1.1) consists of three anatomical layers: the epidermis, the dermis and a 
subcutaneous layer (hypodermis) (Schaefer et al., 1996; Williams, 2003; Cevec et al., 
2004). The barrier function of the skin is thus reflected in its multilayered structure.  
 
 





Epidermis is an epithelium divided into two distinct parts: the viable epidermis being a 
living hydrophilic layer (70% of water), and the stratum corneum, a hydrophobic layer 
(13% of water) made from dead cells which results in a horny texture. The epidermis is a 
thin, dry unvascularized and tough outer protective layer, consisting of cells which are 
differentiated from stem cells on the basal membrane at the interface between the 
epidermis and dermis. It has been reported that damage or removal of the epidermis 
allows diffusion of small water-soluble, non-electrolytes applied to skin surface to 
proceed approximately 1000 times faster than if applied to intact skin (Scheuplein & 
Blank, 1971). The epidermis, which is ~100 µm thick, is composed of four distinct 
regions, each representing a different phase of kertinocyte differentiation: the stratum 
basale, stratum spinosum, stratum ganulosum and stratum corneum (horny layer). Within 
the epidermis there are two distinct types of cells: the keratinocytes and the dendritic 
cells. The keratinocytes or keratin-forming cells are found in the basal layer. As 
keratinocytes divide and differentiate, they move from this deeper layer to the surface. 
There are three types of dendritic cells; melanocytes (melanin forming cells), Langerhans 
(immune) cells and Merkel (sensory) cells.   
 
Keratinocytes were shown to be the major site of drug metabolism in the skin (Baron et 
al., 2001; Swanson, 2004; Oesch et al., 2007). The topically applied dermatological drugs 
and xenobiotics, to which the skin is exposed, may be toxified or detoxified by skin 
enzymes, which may result in dermatological disorders including skin sensitization or 
even skin carcinogenesis. Cytochromes P450 enzymes are important enzymes available 
in the viable epidermis. Many chemical compounds to which the human skin is exposed, 
(such as ingredients in cosmetics, toiletries, health-care products, as well as many 
allergens, toxicants, and carcinogens) are substrates of cytochrome P450 enzymes. Also 
most drugs used in dermatology are either a substrate or an inducer or an inhibitor of 
cytochrome P450 enzymes. In addition, cytochrome P450 enzymes act on many 
endogenous substrates including vitamin A and vitamin D; both these are also widely 
used in dermatological practice (Oesch et al., 2007). Other enzymes available in the 
viable epidermis are flavin-dependent monooxygenases, alcohol dehydrogenases, 
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aldehyde dehydrogenases, esterases/amidases, and epoxide hydrolases. In addition 
glucuronosyl transferase, sulfo-transferase, acetyl-transferase and methyl-transferase are 
also present. However, the specific activities of these cutaneous enzymes possess less 
than 10% activity as compared with the liver enzymes (Smith & Hotchkiss, 2001; Oesch 
et al., 2007). 
 
Since there are no blood vessels in this layer of the skin, nutrients reach the epidermal 
cells by way of passive diffusion across the basement membrane at the dermal-epidermal 
border. The basement membrane physically separates the epidermis from the dermis. It 
acts as a permeability barrier, forming an adhesive interface between epithelial cells and 
the underlying matrix, and controlling cell organization and differentiation by mutual 
interactions between cell-surface receptors and molecules in the extracellular matrix, (the 
basement membrane is able to bind a variety of cytokines and growth factors, providing a 
reservoir for these compounds for subsequent controlled release during physiological 
remodeling or repair processes) (Iozzo, 2005; Masunaga, 2006; Breitkreutz et al., 2009). 
The passage of nutrients and other materials across the basement membrane is facilitated 
by the dermal papillae. The epidermal–dermal junction consists of papillae that project 
into the dermis. The papillae effectively increase the junctional surface area manifold in 
comparison to the area of the skin surface. Papillae at the dermal side are nearly 
completely filled with a cutaneous blood capillary plexus that is complemented with less 
abundant, small lymphatic vessels.  
 
1.1.2.2 Stratum corneum 
 
The final stage of keratinocyte differentiation is represented by the stratum corneum, the 
outermost layer of skin. Despite it being essentially dead tissue, diffusion through the 
stratum corneum is generally recognized as the rate limiting step to percutaneous 
absorption, although disruptions in the integrity of the other layers can also affect skin 
permeability (Schaefer & Redelmeier, 1996; Williams, 2003). 
 
The stratum corneum is a 10–20 μm thick membrane composed of dead, flattened, 
keratin-rich cells: the corneocytes (Figure 1.2). These dense cells are surrounded by a 
complex mixture of intercellular lipids (Elias, 1988; Wertz, 1992; Menon et al., 2012). 





Figure 1.2 Corneocyte lipid bilayers (Bensouilah & Buck, 2006). 
 
The most important feature of such lipids is that they are structured into ordered bilayer 
arrays and it is these that often provide the predominant diffusional path for a molecule 
crossing the stratum corneum (Albery & Hadgraft, 1979; Elias, 1983; Downing et al., 
1987; Grubauer et al., 1989). Water also diffuses along this tortuous route (Potts & 
Francoeur, 1991) and the overall topography can be stylized as having a “brick-and-
mortar” structure (Michaels et al., 1975; Elias, 1981; Shah, 1994). The corneocytes, (i.e. 
the “bricks”) are composed mainly of fibrous and water-insoluble keratin, which is about 
20% cross-linked and packed tightly. Such cells are almost impermeable to most solutes, 
in contrast to the intercellular area of the stratum corneum. The latter can be considered 
as the “mortar”, comprising a complex lipoidal mixture in a uniquely arranged matrix 
which forms lamellar phases responsible for the skin’s natural barrier. Compared with the 
corneocytes, the intercellular lipid matrix has a looser structure and is relatively more 
permeable to solutes (Venkatraman, 1998). The diffusant therefore tends to follow a 
tortuous route and has to cross sequentially and repeatedly, a number of hydrophilic and 
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lipophilic domains (Suhonen et al., 1999; Hadgraft, 2001a). The corneocyte size and 
number of cell layers is the predominant reason for the variation in drug permeation due 
to body site. In other words as cell size gets bigger and the number of cell layers increase 
the skin barrier function becomes larger (Hadgraft & Lane 2009).   
 
Corneocytes are linked together by protein structures termed corneodesmosomes, which 
continuing the ‘brick and mortar structure’ theme can be considered as being analogous 
to reinforcing ‘rivets’ within the mortar. Corneodesmosomes are important for the 
stratum corneum cohesion. When no longer functional, cells of the outer stratum corneum 
are shed in a process called desquamation. In desquamation, the desmosomes break down 
so the cells are no longer held together and can be shed from skin surface. Several 
enzymes degrade the desmosomes and allow non-functional cells to detach from each 
other and desquamate (shed). Alteration in the activity of these enzymes appears to be 
associated with skin barrier disturbances (Egelrud et al., 2005). This may partly be 
because of uncontrolled corneodesmolysis, which leads to weakening of the stratum 
corneum integrity and cohesion (Komatsu et al., 2005). Genetic differences in the amount 
or efficiency of these enzymes also determines the efficiency of this process. If the 
desmosomes are not degraded properly and the outer non-functional cells are held 
together longer than optimal, dry flaky sheets of skin develop in which the cells are still 
attached to one another. 
 
The water content of normal stratum corneum comprises 15-20% of its dry weight 
(Plewig et al., 1983; Schätzlein & Cevec, 1998; Warner et al., 1988) but when it becomes 
hydrated, the water content can increase to about 400% of its dry weight (Williams & 
Barry, 2004). The stratum corneum receives water from the dermis and some from the 
environment. The hydration of the stratum corneum is important from a pharmaceutical, 
dermatological, and cosmetic point of view. Dry skin is mostly associated with 
dermatological conditions (e.g. atopic dermatitis), whilst increasing the hydration of the 
skin has been reported to promote the percutaneous absorption of certain solutes 
(Bouwstra et al., 2003; Williams & Barry, 2004) and also enhance skin appearance by 
providing the latter with a soft and fresh look. Ceramides are mainly responsible for 
generating the stacked lipid structures that trap water molecules in their hydrophilic 
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region. These stacked lipids surround the corneocyte and incorporate water into the 
stratum corneum, they also provide an impermeable barrier by preventing the movement 
of water out of the surface layers of the skin. After the age of 40 there is a sharp decline 
in skin lipids thus increasing a person’s susceptibility to dry skin conditions (Bensouilah 
& Buck, 2006). Natural moisturizing factors present in the corneocytes in the stratum 
corneum are also responsible for keeping the skin moist and pliable by attracting and 
holding water, a property termed ‘hygroscopicity’. Natural moisturizing factors are free 
amino acids, along with other physiological chemicals such as lactic acid, urea and salts, 
including sodium pyrrolidone carboxylate. 
 
The major factor in the maintenance of a moist, pliable skin barrier is the presence of 
intercellular lipids (Figure 1.2). Generally all membrane lipids are amphiphilic i.e. they 
are constituted of a hydrophilic head group and a hydrophobic region. In human stratum 
corneum the major lipid classes are ceramides, cholesterol and saturated long chain free 
fatty acids. The ratio between these lipid classes is approximately equimolar (Weerheim 
& Ponec, 2001). Low levels of other lipid classes are also present, such as cholesterol 
sulphate, glucosylceramides and cholesterol esters. In human stratum corneum 11 
subclasses of ceramides have been identified. The ceramides head groups are very small 
and contain several functional groups that can form lateral hydrogen bonds with adjacent 
molecules. The ceramides have a range of different structures, varying in head-group 
architecture and fatty acid chain length (Bouwstra et al., 2008). 
 
The linear unsaturated nature of ceramides and free fatty acids in the stratum corneum are 
arranged in a bar-like form or a cylindrical form, which allow them to be tightly packed 
laterally and to form highly ordered gel phase domains. Apart from their lamellar 
organization, the lateral packing of lipids is of major importance for the barrier properties 
of skin. The lateral packing of lipids controls both the mobility within the lipid lamellae 
and the membrane. Cholesterol is an important membrane lipid. It can either increase the 
fluidity of membrane domains or make them more rigid, depending on the physical 
properties of the other lipids and on the relative proportion of cholesterol compared to the 
other components. A prime role of cholesterol in the epidermal barrier is to provide a 
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degree of fluidity to what would otherwise be a rigid, possibly brittle, membrane system. 
This may be necessary for the pliability of the skin (Wertz, 2000). 
 
Three different phases have been observed in samples reconstituted from extracted lipids 
(Bolzinger et al., 2012). These phases are orthorhombic, hexagonal and fluid lamellar 
(Figure. 1.3). The orthorhombic phase is very densely packed with a very low 
permeability. In this phase the hydrocarbon chains responsible for the crystalline state are 
not equally distributed in the lattice and the molecules are not able to rotate, even along 
their longest axes. In contrast, the crystalline hydrocarbon chains in the hexagonal phase 
are equally spaced, which provides a much denser structure than the liquid packing and 
confers a much reduced permeability, often this phase is also referred to as a gel-phase. 
The lipids are in a liquid (molten) state in the fluid lamellar phase and the membrane is 
highly permeability to most substances (Bouwstra et al., 2008; Bolzinger et al., 2012). 
 
 
Figure 1.3 Molecular organizations of stratum corneum lipids. Schemes of the chain 
conformation and lateral chain packing in orthorhombic, hexagonal and liquid-
crystalline phases of long-chain lipids (Bolzinger et al., 2012). 
 
The unsaturated nature of ceramides enables phase transitions to occur at temperatures as 
low as skin temperature (32°C). Since there is a slight temperature gradient across the 
skin, the internal temperature of the body is 37°C as against 32°C at the skin surface. 
Lipid phase transitions taking place in this temperature range will cause a gradient of 
properties across the stratum corneum (Pilgram et al., 1999). These latter workers studied 
the temperature dependence of the phases in relation to stratum corneum depth. At room 
temperature the lipid packing is predominantly orthorhombic while the presence of 
hexagonal packing is more pronounced at 32°C. The transition from orthorhombic to 
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hexagonal occurs between approximately 35-40°C (and a fluid lamellar phase forms upon 
heating above 70°C). The lipid organization in human stratum corneum invivo at 32°C is 
orthorhombic while in the inner layers of the stratum corneum the lipids are partly 
present in a hexagonal packing arrangement. However it has been shown that the lipid 
organization is non-homogeneous as a function of the stratum corneum depth, with 
results confirming the presence of predominantly orthorhombic phase at all depths 
(Damien & Bonchev, 2010). The presence of hexagonal and liquid phases was also 
detected, though only to a minor extent. The higher the extent of pure orthorhombic 
phase present, the lower the amount of water in the bilayers. The presence of the 
orthorhombic packing indicates that the lipids within the lamellae are very densely 




The dermis is a fibrous layer, which supports and strengthens the epidermis. The dermis 
is the thickest (1–3 mm) layer of the skin and comprises loose connective tissue 
consisting of fibrous proteins (collagen and elastin) embedded in an amorphous ground 
substance to form a matrix. The ground substance is composed primarily of water, ions, 
and complex carbohydrates such as glycosaminoglycans that are attached to proteins. The 
ground substance helps to hold the cells of the tissue together and allows oxygen and 
nutrients to diffuse through the tissue to cells. Elastin and collagen, present in this layer 
are responsible for the elasticity of the skin and the latter enables the skin to return to its 
original form after it has been stretched. Most of the appendages originate from the 
dermis, including the hair follicles, sebaceous glands, and sweat glands (Moser et al., 
2001). The dermis also contains nerves and blood vessels, which help maintain “sink” 
conditions within the skin by efficiently transporting permeated compounds to the 
systemic circulation (Bolzinger et al., 2012). In addition, the vascular network of the 
dermis is responsible for supplying nutrients and oxygen to the skin and also plays a role 
in regulating body temperature. A system of lymphatic vessels comprises an additional 
dermal circulatory system. These vessels are involved in removing cellular waste and 
help regulate the volume of the interstitial fluid in the dermis (Schaefer & Redelmeier, 
1996; Williams, 2003). Similar to the epidermis drug diffusion through the dermis is 
primarily a hindered diffusion through an aqueous-based medium. However, there are 
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important differences: the vascularization of the dermis contributes significantly to drug 
transport and distribution in the skin, as does the lymphatic system. Other functions of the 




The deepest layer of the skin, the hypodermis, is primarily composed of adipose tissue 
and as such, it functions as an energy depot, a layer of insulation, and as a shock absorber 
and it supplies nutrients to the other two upper layers. The hypodermis serves as the entry 
point for the cutaneous nerves and the blood and lymph networks that service the skin. 
The bases of the hair follicles are also present in this layer, as are the secretory portions 
of the sweat glands. Since the loose connective tissue of the hypodermis is interwoven 
with that of the dermis, there is no distinct boundary between these two layers (Schaefer 
& Redelmeier, 1996; Williams, 2003). 
` 
1.2 Routes of drug permeation across the skin 
 
Topically exposed drugs may permeate the skin via the intercellular, transcellular and 
appendageal (through either the eccrine (sweat) glands or hair follicles) routes (Barry, 
1987; Cullander & Guy, 1992: Roberts et al., 2002; Lane 2013) (Figure 1.4). The net 
diffusion of a drug through the skin is the sum of the fractional contributions of each of 
the separate routes of permeation. The transport of the drug is controlled by its diffusion 
coefficient inside the stratum corneum lipids, the retention by adsorption to keratin of 
corneocytes, and the partition coefficient between the drug, formulation and the stratum 
corneum lipids. 
 
The appendageal route is not considered to be a signiﬁcant pathway for drug permeation 
due to the fact that sweat glands and hair follicles occupy only 0.1% of the total surface 
area of human skin, therefore the amount of any compound diffusing via this route does 
not contribute appreciably to the steady state flux (Scheuplein, 1967; Singh & Singh, 
1993; Bolzinger et al., 2012; Lane, 2013). However it has been suggested  





Figure 1.4 Possible pathways through the stratum corneum (Lane, 2013). 
 
that this route may be important for the permeation of slowly diffusing compounds and 
very high molecular weight substances, such as nanoparticles (Lademann et al., 2011). It 
may also be important for ions and large polar molecules (Lauer et al., 1995), as well as 
contributing to the facilitated transport of charged molecules across the skin following 
application of a small electric current (iontophoresis) (Edwards et al., 1995).  
Additionally, the trans-appendageal route may be responsible for the rapid diffusion of 
compounds in the early stages of diffusion, before steady-state is achieved, and so might 
enable a loading dose to be delivered. Drug levels may then be subsequently sustained by 
slower diffusion of more of the compound through the epidermis (Scheuplein, 1967; Katz 
et al., 1971; Keister & Kasting, 1986; Meidan et al., 2005). 
 
The transcellular route (via the hydrophilic keratinised cells) is another possible route of 
penetration. However its contribution to overall flux is usually considered to be only 
minor, involving sequential partitioning of the permeant into and out of cells. Therefore 
the predominant route of penetration for all molecules appears to be through the 
intercellular spaces (via the lipid channels), despite it being a more tortuous path in which 
the molecule diffuses within the intercellular lipid phase only (Boddé et al., 1989; Sharata 
& Burnette, 1989; Potts & Guy, 1992; Hadgraft, 2001 a&b). As a result, the majority of 
techniques to optimise permeation of drugs across the skin are directed towards 
manipulation of solubility in the lipid domain or alteration of the ordered structure of this 
region. An important consequence of the existence of a continuous lipid pathway across 
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the stratum corneum is its implication for the use of simple lipid membranes as model 
skin barriers (Houk & Guy, 1988; Feldstein et al., 1998). 
 
1.3 Advantages and limitations of dermal and transdermal drug delivery 
 
The skin can serve as an alternative route of drug delivery and offers various advantages 
in comparison to conventional methods such as oral administration. These advantages can 
lead to an optimization in therapy compared to the use of the latter route. The potential 
advantages of transdermal drug delivery may include: avoidance of first-pass metabolism 
by the gastrointestinal tract and liver in the case of oral delivery (Cleary, 1993; Kormic et 
al., 2003) and ease of use and withdrawal of drug (Payne et al., 1998). It provides direct 
access to the target or diseased site e.g. treatment of skin disorders such as psoriasis, 
eczema and fungal infections (Colin Long, 2002). The direct administration of the drug to 
the pathological site enables any adverse effects associated with systemic toxicity to be 
minimised. It also provides convenient and painless administration (Cleary, 1993; Henzel 
& Loomba, 2003) as well as conferring improved patient acceptance and compliance 
compared with some other routes. The route also enables ease of dose termination in the 
event of any adverse reactions; whether the latter are either systemic or local (Payne et 
al., 1998; Jarupanich et al., 2003; Archer et al., 2004). In addition transdermal delivery 
usually provides a means of obtaining a sustained and controlled delivery over a 
prolonged period of time (Yang et al., 2004). This can improve the therapeutic effect and 
reduce side effects resulting from alternating high-to-low plasma drug concentrations, 
characteristic of non-controlled release oral and parenteral drug delivery systems (Cramer 
et al., 1994; Kormic et al., 2003). The route also provides an alternative in circumstances 
where oral dosing is not possible (in unconscious or nauseous patients) (Kormic et al., 
2003). 
 
However, as with all other routes of delivering drugs, using the skin as a portal also has 
its disadvantages. For instance, a molecular weight less than 500 Da is preferable to 
ensure ease of diffusion across the stratum corneum (Bos & Meinardi, 2000). It is usually 
necessary for the diffusing species to have sufficient aqueous and lipid solubility, 
equating to a Log P (octanol/water) value of between 1-3 such that it might successfully 
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traverse the stratum corneum (Yano et al., 1986). Pre-systemic metabolism due to the 
presence of enzymes in the skin such as peptidases, esterases, glucuronyl transferases and 
sulphotransferases, which are present at relatively high levels, can occur (Steinsträsser & 
Merkle, 1995). For example glucocorticoids for dermal and transdermal application are 
susceptible to esterase activity (Lombardi et al., 2008, Wohlrab et al., 2010). However 
metabolism can also enhance the penetration of some drugs; for instance testosterone is 
activated by 5-alpha-reductase to generate dihydrotestosterone, which has a higher 
androgenic potency than testosterone. A low permeability of the skin may result in a low 
bioavailability of drugs delivered by this route and the amounts of percutaneously 
absorbed drugs may not reach minimum therapeutic levels even for many potent drugs 
(Venkatraman, 1998). Skin irritation and sensitization might occur due to exposure of 
certain drugs, excipients, or components of delivery devices resulting in erythema, 
oedema, etc. (Hogan & Maibach, 1990; Carmichael, 1994;  Murphy & Carmichael, 2000; 
Toole et al., 2002; Hikima et al., 2005). 
 
With respect to the physico-chemical and physiological limitations outlined above, it is 
clear that only relatively few drugs can be considered for formulation via this route of 
delivery, under passive conditions. Accordingly, there has been a consistent demand for 
novel and effective methods to enhance drug permeation through the skin (Iervolino et 
al., 2000). 
 
1.4 Theoretical basis for passive absorption and its enhancement 
Permeation of drugs through the skin or other membranes, as indicated by Higuchi (1960) 
is a process of passive diffusion and can be described by Fick’s laws (Hadgraft, 2001a). 
In conditions of steady-state, the flux is given by: 
 J	 = 	D	K	Cv/L      (Equation 1.1) 
 
Where J is the flux of drug, D the diffusion coefficient of the drug in the membrane, K  
the partition coefficient of the drug in the membrane, L the length of the diffusion 
pathway, Cv the concentration of drug in the vehicle  
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In non-steady state or finite dosing models where the diffusion causes the concentration 
to change with time. The changes of the concentration profile are predicted by Fick’s 
second law: 
 
∂	C/ 	 ∂	t	 = 	−D	(∂2C/ ∂x2)     (Equation 1.2) 
Where, C is the concentration of the diffusing species in the membrane, D is the diffusion 
coefficient of the diffusing species, x is the diffusional pathlength, and t is time. 
 
According to Fick’s laws the most important factors that influence flux across the skin 
are the partition coefficient of the permeant, the diffusion coefficient, and the 
concentration gradient of the drug between the formulation and the skin, i.e. its 
thermodynamic activity in the formulation. Drug transport across a membrane can be 
considered to be a balance between driving forces and resistances. The diffusion 
coefficient D, directly correlates with the reciprocal of the viscosity of the barrier 
medium according to the Stokes-Einstein equation (Kokubo et al., 1991), and can be 
thought of as the kinetic resistance of the barrier to drug penetration.  
 
In Equation 1.1, the ratio Cv/Cs,v, the degree of saturation or saturation ratio, represents 
the relative chemical potential of the donor system. Under sink conditions, this value 
reflects the gross chemical potential gradient across a target membrane. Thus, it can be 
regarded as the thermodynamic driving force. Therefore, the passive transport rate of a 
molecule through a homogeneous barrier is proportionally related to its degree of 
saturation in the applied vehicle, providing no significant vehicle-drug or drug-membrane 
interactions occur (Benaouda et al., 2012 a&b; Davis & Hadgraft, 1991; Higuchi, 1960; 
Pellett et al., 1994). Therefore, inducing drug supersaturation in topical formulations is 
one way to increase the flux and this can be achieved by variations in the pH, temperature 
or formulation vehicle or by using volatile excipients (Hadgraft, 2004). 
 
Therefore, based on Equation 1.1, transdermal drug delivery is a thermodynamically 
favoured, but a kinetically suppressed process. To control the delivery of drugs into and 
across the skin the following strategies are possible: 
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1) Increase the drug diffusion coefficient, D, through reduction of barrier resistance by 
disordering the tightly packed lipid regions of stratum corneum, which consequently 
increases penetration through the intercellular lipid matrix (Barry, 1987; Moser et al., 
2001; Thomas & Panchagnula, 2003).  
 
2) Promote drug solubility, Cs,m, in the skin. This might be achieved by perhaps increasing 
the solubility of the drug in the skin caused by stratum corneum uptake of a cosolvent 
such as propylene glycol, 2-(2-ethoxyethoxy)ethanol (Transcutol), etc. (Moser et al., 2001; 
Thomas & Panchagnula, 2003). The increased solvent penetration may include increased 
drug solubility in the skin and increased skin penetration of the drug if the drug has a high 
affinity for the solvent (Yamada et al., 1987).  
 
3) Increase the driving force for penetration. This might be induced either by increasing 
drug concentration in the vehicle, Cv or by decreasing the drug solubility, Cs,v in the 
vehicle (Aungst et al., 1990, Moser et al., 2001).  
 
Most of the strategies for enhancing transdermal permeation of drug utilise one or a 
combination of these mechanisms.  
 
1.5 Factors affecting drug permeation through the skin 
 
Several biological and physicochemical parameters may influence drug permeation 
across the skin (Barry, 1983). The passive diffusion of a molecule from a vehicle into 
and across the skin is mainly affected by the physicochemical properties of the 
molecule, vehicle and nature of the skin. Influencing biological factors include skin 
age, body region, health status, race, metabolism and hydration. At different body 
sites, the composition and finally barrier properties of the stratum corneum may vary; 
these include differences in the thickness, number of cells or, the density of skin 
appendages in the stratum corneum (Scheuplein, 1978; Bensouilah & Buck, 2006). 
The viable epidermis contains several enzyme systems that may catalyze processes 
such as oxidation, reduction, hydrolysis or conjugation (Section 1.3). Therefore skin 
metabolism may have additional impact on transdermal delivery of drugs (Storm et 
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al., 1990; Zhang et al., 2009). The effect of age is mainly attributable to the smaller 
surface-to-volume ratio in case of newborn infants compared with adults rather than 
an effect of lower barrier function of younger skin (Scheuplein, 1978; Yosipovitch et 
al., 2000). Skin hydration is a crucial and possibly the most frequently investigated 
factor affecting drug permeation.  
 
1.6 Properties of drugs that affect diffusion 
 
The characteristics of a drug that influence transport rates and permeability include: 
lipophilicity, hydrogen bonding capability and size (Camenisch et al., 1996). For a 
drug to penetrate well, it should have a small molecular size, adequate solubility in an 
oil phase, and a moderately high partition coefficient. Most drugs currently available 
in a patch formulation share three features that enable administration through a 
convenient area of skin, namely: a molecular mass <500 Da, a moderate lipophilicity 
and a low required daily dose (<10 mg.day-1). 
 
The lipophilicity of a drug is the most informative and successful single 
physicochemical property to predict its permeation in biological systems (Testa et al., 
1996; Zhang et al., 2009). The lipophilicity of a drug is its tendency to prefer a lipidic 
or oil-like environment to an aqueous one. However, its magnitude depends on the 
summing of intermolecular interactions such as hydrogen bonding and dipole effects. 
Thus, although lipophilicity is a property ascribed to the drug compound, it is highly 
dependent on the choice of lipidic environment (Kaliszan, 1992). Drugs should 
possess a moderate lipophilicity if they are to diffuse through stratum corneum. 
Ideally, they should exhibit both lipoidal and aqueous solubilities: if too hydrophilic, 
the molecule will be unable to transfer into the stratum corneum; whereas if too 
lipophilic, the drug will tend to remain in the stratum corneum layer. Accordingly, an 
octanol water partition coefficient Log P 1-3 has been reported to be optimal (Yano et 
al., 1986; Naik et al., 2000).The lipophilicity of a compound dictates the partitioning 
behaviour into corneocytes and it has been postulated that hydrophilic compounds 
tend to partition into the corneocyte proteins, while the more lipophilic compounds 
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partition into the stratum corneum lipids (Raykar et al., 1988; Van der Merwe & 
Riviere, 2005). 
 
The ordered lipid layers provide a ﬁnite number of hydrogen bonding groups located 
in the polar head groups. Therefore during the diffusion process the drug should be 
sufficiently lipophilic to overcome the hydrogen bonding with polar head groups, with 
generally the hydrogen bonding capacity having a negative effect on permeation (Su 
et al., 2010). Octanol is the most commonly used lipophilic phase in two-phase 
partition experiments carried out in vitro, one reason being that it can provide a good 
hydrogen bonding environment for solutes. A solute, which makes strong hydrogen 
bonds with water, will be able to make similar bonds in octanol (Conradi et al., 1991). 
The hydrogen bonding capacity of a solute can be expressed as the difference between 
its partition coefficient into octanol and a solvent devoid of forming hydrogen bonds, 
typically an alkane (Young et al., 1988). It is reported that the presence of 2 or 3 
hydrogen bonding groups can successively reduce the diffusion coefficient, D, by an 
order of magnitude (Pugh et al., 1996). However in some cases where there is more 
than one hydrogen bond group, intramolecular hydrogen bonding between adjacent –
OH groups and adjacent hydrogen groups can also act to modify the permeant 
diffusion (Plessis et al., 2001). 
 
After the drug has partitioned into the membrane, it must be sufficiently ‘mobile’ to 
diffuse across it. The rate of diffusion is inversely proportional to the molecular 
volume (and hence molecular weight or size) of the ‘unit’ and the material through 
which it is diffusing; the smaller a molecule, the faster the rate of diffusion. This is 
due to larger molecules requiring more energy to diffuse. Various molecular dynamics 
simulations (Takeuchi, 1990; MűllerPlathe, 1991; Pant & Boyd, 1993) show that the 
mechanism of diffusion of permeants in polymers is a ‘hopping’ mechanism. In this 
mechanism, a permeant diffuses via ‘jumps’ between neighbouring free volume 
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1.7 Passive approaches to overcome the barrier nature of the skin  
 
The stratum corneum barrier can be altered passively to a degree using various 
strategies, some of which are outlined below: 
 
1.7.1 Vehicle / chemical enhancers  
 
As discussed in Section 1.2, the major route of drug penetration through the skin is 
through the intercellular channels (Albery, 1979), which contain a complex mixture of 
structured lipids (Elias, 1983). Generally the passage of compounds across the skin is 
divided into four steps: (1) the release of the penetrant from the vehicle then, (2) 
penetration, the entry of a substance into a particular skin layer, (3) permeation, the 
penetration through one layer into another, and finally (4) re-sorption, the uptake into 
the vascular system (Bolzinger et al., 2012). One of the major challenges for 
designing an effective (trans)dermal drug delivery system is the choice of vehicle in 
which the drug is entrapped in order to reach its target site i.e. the skin surface, the 
skin compartments or the systemic circulation. The partitioning behaviour of the drug 
from the vehicle into the lipid is therefore an important determinant in this first step of 
the absorption process. Also the solubility characteristics of the permeant in the lipids 
of the stratum corneum should be taken into account. This solubility could be 
influenced by components that diffuse out of the formulation into the skin. The 
diffusion of any applied potential permeant through the possibly modified structured 
lipids then follows. Therefore, the vehicle can have a significant impact on the rate at 
which a particular drug is delivered into and then through the skin i.e. the flux of the 
drug. This effect could occur as a consequence of changing the solubility of the 
penetrant in the skin, or by changing the thermodynamic activity of the formulation, 
or changing the resistance of the membrane for the penetration and diffusion. 
 
A good vehicle for the skin is likely to be a vehicle which will readily enter the skin, 
swell the overall matrix and increase the diffusion of the permeant. Also it might 
‘drag’ the permeant with it into the skin. The permeant molecules must dissolve in the 
vehicle in order to enable the former’s diffusion through the vehicle to the vehicle-
stratum corneum interface; therefore an appropriate vehicle should have the ability to 
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solubilize at least the minimum effective dose of the drug (Abbott, 2012). The 
diffusion through the skin depends on the concentration gradient and the diffusion 
coefficient. A high concentration in the vehicle on the stratum corneum sets the 
maximum possible concentration gradient across the stratum corneum; therefore the 
diffusion will be enhanced. Using supersaturated systems enhances drug flux (Section 
1.7.2). The diffusion coefficient of the vehicle depends on the molecular shape, size 
and molecular weight. The Hansen solubility parameters values and the Hildebrand 
solubility parameter also affect the permeation of the vehicles into the skin. The 
smaller the difference between these values of the vehicle and skin, then the higher 
the rate of permeation (Abbot, 2012). 
 
Vehicles or penetration enhancers have been suggested (Barry, 1988; Barry, 1991)  to 
act on the skin via either one or combination of the following mechanisms: (1) 
interaction with the intercellular lipids of the stratum corneum resulting in 
disorganization of the highly ordered structures and increasing the lipid fluidity thus 
enhancing the paracellular diffusivity through the stratum corneum  (Figure 1.5);(2) 
interaction with intracellular proteins of the corneocytes to increase transcellular 
permeation i.e. decreasing hydrogen–bonding between keratin and drug, increasing 
the porosity of the proteinaceous matrix via denaturation and formation of pores or 
vacuoles which serve as potential permeation pathways (Figure 1.6); and (3) 
increasing partitioning of the drug into the stratum corneum. 
 
The overwhelming majority of a topical formulation is comprised of its vehicle, 
which can be modified to enhance the driving force for diffusion and/or increase skin 
permeability; also it can have a direct impact upon the therapeutic efficacy and 
tolerability of the formulation. Therefore the amount of drug diffusing into the skin 
can differ several-fold as a result of the vehicle alone (Hadgraft, 1991). The 
synergistic effect associated with using a combination of vehicle enhancers has also 









Figure 1.5 Schematic representation of the mechanisms by which a chemical 
enhancer may interact with stratum corneum intercellular lipids (Menon & Lee, 
1998; Williams & Barry, 2004). 
 
 
Figure 1.6 Action of enhancers (particularly solvents) on the protein component of 
the stratum corneum, leading to fissuring of intercellular lipids, splitting of stratum 
corneumsquames, keratin denaturation and vacuole formation in corneocytes  
(Menon & Lee, 1998; Williams & Barry, 2004). 
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Although many chemicals have been evaluated as penetration enhancers none has 
proven to be ideal. Some of the more desirable properties for a penetration enhancer 
acting within skin have been given (Barry, 1983) as: 
 
 It should be non-toxic, non-irritating and non-allergenic. 
 It should have no pharmacological activity within the body. 
 It would ideally work rapidly, and the activity and duration of effect should be 
both predictable and reproducible. 
 It should have no pharmacological activity within the body - i.e. should not 
bind to receptor sites. 
 It should work uni-directionally, i.e. should allow therapeutic agents into the 
body whilst preventing the loss of endogenous material from the body. 
 When it is removed from the skin, barrier properties should return both rapidly 
and fully. 
 It should be appropriate for formulation into diverse topical preparations and 
thus should be compatible with both excipients and drugs. 
 It should be cosmetically acceptable with an appropriate skin ‘feel’. 
 
Permeation enhancers currently represent the most widely studied approach to 
transdermal drug permeation enhancement on account of the potential advantages 
they offer over other methods. Chemical permeation enhancers are relatively 
inexpensive and easy to formulate, they offer flexibility in their design, are simple in 
application and allow the freedom of self-administration to the patient. Finally, 
chemical enhancers can be formulated with the active therapeutic as a topical cream 
or gel, or an adhesive skin patch that can be applied anywhere on the body for 
prolonged systemic delivery of the drug. In general, permeation enhancers may 
contain a wide variety of different chemical functional groups and act by a variety of 
different mechanisms in enhancing drug transport (Karande & Mitragotri, 2009). 
Table 1.1 shows examples of penetration enhancers used in commercial transdermal 
and topical products 
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Table 1.1.Examples of penetration enhancers used in commercial transdermal and 
topical products (modified from Lane 2013). 
Active Trade name Enhancer 
Buprenorphine BuTrans Oleyloleate 
Estradiol Estraderm MX Isopropyl palmitate 
Estradiol  Progynova Ethyl oleate, Glycerol monolaurate, Isopropyl 
myristate 
Estradiol  Sandrena Ethanol, Propylene glycol 
Estradiol  Vivelle-Dot Dipropylene glycol, Oleyl alcohol 
Estradiol  Divigel Ethanol, Propylene glycol 




Evra Lauryl lactate 
Fentanyl  Fentalis Ethanol 
Oxybutynin  
 
Anturol Diethylene glycol monoethyl ether, Ethanol, Propylene 
glycol 
Testosterone  Androgel Isopropyl myristate 
Testosterone  Axiron Octyl salicylate, Ethanol, Isopropyl alcohol 
Testosterone  Fortesta Ethanol, Oleic acid,  
2-Propanol, Propylene glycol 
Testosterone  Testoderm Ethanol 
Testosterone  Testogel Ethanol, Isopropyl myristate 
Testosterone  Tostran Ethanol, Isopropyl alcohol 
Oleic acid, Propylene glycol 
Adapalene Differin Gel Propylene glycol 
Diclofenac  Mobigel Ethanol, Isopropyl alcohol 
Diclofenac  
 
VoltarolEmulgel Isopropyl alcohol, Propylene glycol 
Idoxuridine Herpid Dimethyl sulphoxide 
Ketoprofen Feldene Ethanol 
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1.7.1.1 Vehicle permeation enhancement by reducing the diffusional resistance of the 
skin 
 
As indicated in Section 1.4, an increase in the diffusion coefficient of the drug is one 
of the strategies to promote drug penetration through the skin. By disordering the lipid 
bilayers, many chemical enhancers can induce such an increase in the stratum 
corneum and thereby enhance penetration (Suhonen et al., 1999; Moser et al., 2001). 
The barrier function of intercellular lipids of the skin is attributed to several factors: a 
highly ordered multilamellar arrangement, a densely packed crystal-like structure, and 
solid phase at physiological temperature. Disturbances of these structures will result 
in a more disordered lipid matrix, thereby increasing the permeability of solutes. In 
general, the arrangement of a lipid bilayer can be affected at two locations, the polar 
head groups or the hydrophobic tails. 
 
A simple example of a substance employed to enhance permeation is water, which 
can interact with the polar head groups of the lipid bilayer and thereby interfere with 
the molecular packing of the lipids (Roberts & Walker, 1993). Water cannot easily be 
applied directly to skin in order to enhance membrane hydration and therefore indirect 
methods of enhancing skin hydration are used. These include the use of moisturising 
factors, occlusive materials (such as hydrophobic base and patches) (Nardello et al., 
2003), humectants, and hydrogels containing biopolymers such as hyaluronan 
(Neudecker et al., 2000). 
 
Occlusion hydrates the keratin in corneocytes and increases the water content between 
adjacent intercellular lipid lamellae. It has been found that the limited amount of 
water located in the polar regions can induce a phase transition of the solid lipids and 
thereby enhance the mobility of the lipid acyl chains (Knutson et al., 1985). This will 
induce a loosening of the lipid packing, gelation or fluidization of the solid lipid phase 
and result in faster diffusion of hydrophobic compounds (Behl et al., 1980; Williams 
& Barry, 2004). On the other hand, adsorbed water that forms a separate water phase 
will provide a transport route for hydrophilic solutes with less resistance to the latter’s 
penetration (as the partition coefficient between stratum corneum and the vehicle 
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increases towards unity) (Suhonen et al., 1999). Therefore, hydration of the stratum 
corneum enhances the penetration of both hydrophilic and hydrophobic compounds 
(Mak et al., 1991; Potts & Francoeur, 1991). Furthermore, skin temperature generally 
increases from 32°C to as much as 37°C under occlusive conditions (Hotchkiss et al., 
1992). Of the various approaches employed to enhance the percutaneous absorption of 
drugs, occlusion is the simplest and perhaps one of the most common methods in use. 
 
Hydrocarbons also have been used as vehicles or penetration enhancers to increase 
permeation of a variety of drugs across the skin. These permeation enhancers 
generally work by partitioning into the stratum corneum and disrupting the ordered 
lipid bilayer structure (Hori et al., 1991). Alkanes with 9–10 carbon atoms have been 
shown to induce the highest skin permeation enhancement of propranolol and 
diazepam, whilst shorter alkanes (5–6 carbon atoms) were most effective in enhancing 
the permeation of caffeine (Hori et al., 1991; Rahman et al., 1992). 
 
Fatty acids and fatty alcohols are another class of enhancer and they function by 
interfering with the packing of lipid bilayers by inserting themselves between the 
hydrophobic tails of the lipids. They act by forming pools between the lipids rather 
than being distributed homogeneously throughout the bilayer structure 
(Ongpipattanakul et al., 1991). This disorder may induce alteration of the arrangement 
of polar head regions as well, so that diffusion of both hydrophilic and hydrophobic 
molecules can be enhanced. An example of such an enhancer is oleic acid, which has 
been shown to increase molecular mobility by inducing a phase transition in the lipid 
matrix by interacting with the hydrophobic tails of the lipids making them more fluid 
(Golden et al., 1987; Ongpipattanakul et al., 1991). The permeation enhancement 
effects of this class of enhancer are related to the length and conformation of the 
hydrocarbon chain. The maximum effect was achieved with chain lengths of about 12 
carbon atoms (Aungst et al., 1986), and with the unsaturated double bonds in the 
middle of the chains with a cis conformation (Golden et al., 1987; Artusi et al., 2004). 
Since the lipids in the stratum corneum are primarily saturated (with the exception of 
small amounts of components such as linolenic acid) and therefore can form highly 
ordered structures, it is reasonable to assume that an unsaturated hydrophobic chain 
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inserted in the lipid bilayer may cause significant disruption to the bilayer structure 
(Golden et al., 1987; Harrison et al., 1996; Naik et al., 1995; Lane, 2013). 
 
Similarly, 1-dodecylazacycloheptan-2-one (azone) can intercalate with the 
hydrophobic chains of the lipid bilayers and disturb the packing of the lipids 
(Okamoto et al., 1991). Additionally, it was found that azone and its chemically-
related derivatives increased the diffusion coefficient of drug in the stratum corneum 
while the partition coefficient remained constant, showing that enhancement of 
diffusion accounted for the increased permeation (Schückler & Lee, 1992). 
 
Esters, as isopropyl myristate, are another example of a vehicle that can disrupt the 
order of the arrangements of the lipids. The later solvent is capable of integrating into 
the lipid bilayers, inducing an increased membrane fluidity which may contribute to 
increased disorder of the stratum corneum and thus enhance the permeability of the 
lipids in the stratum corneum (Pillai et al., 2004).  
 
Diffusion coefficients may be increased by mechanisms other than promoting disorder 
in the arrangement of lipids. Lipid extraction (delipidisation) may also provide an 
effective mechanism. For example, ethanol has been reported to selectively extract 
polar lipids from the lipid matrix, leading to a greater free volume in the lipid layer, 
thereby enhancing drug permeation (Bommannan et al., 1991). Further studies have 
also suggested that selective extraction of intercellular lipids may result in the 
formation of pores in the stratum corneum lipids (Peck et al., 1994). Ethanol has been 
used to enhance the skin permeation of solutes of differing physicochemical 
properties including: nitroglycerin (Berner et al., 1989) and estradiol (Megrab et al., 
1995). The ethanol enhanced effect has been reported to be concentration dependent 
with the maximum fluxes occurring at an ethanol: buffer ratio of approximately 0.6 
(Williams & Barry, 2004) beyond which a plateau or retardation in drug diffusivity 
across the epidermis might be expected to occur due to membrane dehydration. 
Dimethylsulphoxide and urea not only have an effect on the stratum corneum lipids, 
but also interact with keratin in the corneocytes (Benson, 2005). When a surfactant 
penetrates the stratum corneum, it interacts and binds with the keratin filaments and 
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can change keratin conformation, resulting in a disruption within the corneocyte. This 
in turn causes an increase in the diffusion coefficient and permeability of any applied 
drug (Anigbogu et al., 1995; Benson, 2005). 
 
1.7.1.2 Vehicle permeation enhancement by increasing solubility of drug in the skin 
 
Many solvents can penetrate into the intercellular lipid matrix and change the 
solubility of an applied drug by transiently changing the solubility parameter of the 
skin. In turn, this results in an increase in the partition coefficient of some drugs in the 
stratum corneum. Consequently, there may be an improvement in the flux of the drug 
through the skin (Hadgraft, 1999; Hadgraft, 2004; Watkinson et al., 2009; Lane, 
2013). For example the permeation of ibuprofen through skin from saturated 
propylene glycol–water mixtures increased with increasing volume fraction of 
propylene glycol. This was explained by an increase in the solubility of ibuprofen in 
the skin caused by the stratum corneum uptake of propylene glycol. However the 
solvent drag effect is also thought to participate in skin permeation enhancement of 
propylene glycol (Irwin et al., 1990; Bendas et al., 1995; Hadgraft & Pugh, 1998). 
Similarly, other solvents, such as ethanol, and N-methyl pyrrolidone, may also 
enhance drug permeation in a similar way (Hadgraft, 1999). Solvent drag can also 
account in part for the penetration enhancement effects of some solvents. For 
example, ethanol can pass rapidly through the stratum corneum and drag solute with it 
(Berner et al., 1989). However many chemical enhancers (e.g. propylene glycol and 
terpenes) act through a combination of several mechanisms, such as those which have 
been proposed for the effects of ethanol: causing alteration of the arrangement of the 
lipid polar head region (Granem et al., 1992), promoting extraction of polar lipids, 
enhancing drug solubility in the stratum corneum, and through exertion of the solvent 




Supersaturated systems can be used to increase the concentration gradient beyond its 
maximum saturation level. This results in an increase in thermodynamic activity 
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leading to an improvement in drug flux across the skin as can be inferred from Fick’s 
law of diffusion (Equation 1.1) (Hadgraft, 2001a). Supersaturated states can be 
prepared by loss of volatile solvent (Coldman et al., 1969), use of cosolvent mixtures 
(Davis & Hadgraft, 1991), temperature changes i.e. heating and cooling (Henmi et al., 
1994) and uptake of water into the formulation from the skin (Kemken et al., 1992). 
The utility of the approach has also been demonstrated; for example, supersaturated 
systems of hydrocortisone (Davis & Hadgraft, 1991), estradiol (Megrab et al., 1995), 
piroxicam (Pellet et al., 1997) and fentanyl (Santos et al., 2011) have been studied. A 
major limitation of this approach is the subsequent physicochemical instability of the 
drug in the vehicle, since the drug often rapidly crystallizes leading to a decrease in 
the initial high activity (Hadgraft, 1999). This problem has been reportedly overcome 
by the use of antinucleant polymers such as hydroxypropyl methylcellulose to 
stabilize such systems; although the success of this method is dependent on the nature 
of the drug. It is possible that there are molecular interactions between the polymer 
and the drug molecules that prevent subsequent drug molecules interacting with each 
other (Pellet et al., 1994; Iervolino et al., 2000; Raghavan et al., 2001 a&b; Santos et 
al., 2009). Preparing drug administration systems using volatile solvents that induce 
drug supersaturation in situ (that is, only after dose actuation), is another way to 
achieve supersaturation (Leichtnam et al., 2006; Reid et al., 2008, 2009; Jones et al., 
2009; Benaouda, 2012). The drug is prepared as a solution but, during dose actuation, 
it assembles into a micro fine occlusive film. In this technique a drug can be applied 
in a supersaturated form on the surface of human skin and stratum corneum transport 
will be enhanced without increasing the total loading of the compound in the topical 
product (Kondo et al., 1987). However, drug recrystallisation, remains a significant 
issue if solvents with low volatility are used to generate drug transient supersaturation 
(Santoset al., 2010). Low boiling point propellant, such as a hydrofluoroalkane, is 
employed to form a transiently supersaturated system and provides the opportunity of 
reducing the applied volume of the formulation. The hydrofluoroalkane facilitates the 
storage of the active agent in a thermodynamically stable premix, whilst retaining the 
ability to form high levels of drug supersaturation upon dose ejection (Jones et al., 
2009). Hydrofluoroalkane sprays have already been shown to be viable topical 
products, with MedSpray™ and Medtherm™ being examples of available products 
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utilizing this technology (Leichtnam et al., 2006; Brown & Jones, 2007; Evans et al., 
2010).  
 
1.7.3 Prodrugs or metabolic approach  
 
The permeability barrier properties of the skin are mediated by a series of lipid 
multilayers. Lipid synthesis is mediated by various enzymes (Steinsträsser & Merkle, 
1995) and any alteration in enzyme activity will affect the barrier properties of the 
skin. The use of enzyme-inhibitors to enhance the permeation of hydrophilic and 
lipophilic drugs permeation has been investigated (Tsai et al., 1996; Elias et al., 2002, 
2003; Babita & Tiwary, 2005). However another strategy to use a prodrug approach 
aimed at utilizing the enzyme function (Sloan & Wasdo, 2003). Such a prodrug 
approach depends on the ability of the available enzymes to metabolize the applied 
drug into its therapeutically active form. The prodrug design strategy generally 
involves addition of a promoiety to increase partition coefficient and hence solubility 
and transport of the parent drug across the stratum corneum. Upon reaching the viable 
epidermis, esterases (for example) can release the parent drug by hydrolysis thereby 
optimising solubility in the aqueous epidermis. The transdermal delivery of several 
compounds has been described in a number of studies, using such a prodrug approach 
for example oestradiol (Chien et al., 1985; Tojo et al, 1986 & 1991), indomethacin 
(Milosovich et al., 1989), theophylline, diclofenac (Bonina et al., 2001; Sloan et al., 
2000; Majumda et al., 2012), 5-fluorouracil (Taylor & Sloan, 1998; Sloan et al., 2003; 
Milosovich et al., 1989), levodopa (Kushnir et al., 2008), acetaminophen (Thomas et 
al., 2009), bupropion (Kiptoo et al., 2009), naltrexone (Strasinger  et al., 2008;Vaddi 
et al., 2009). 
 
1.7.4 Lipid vesicles 
 
Liposomes are colloidal particles formed as concentric biomolecular layers that are 
capable of encapsulating drugs. Vesicular carriers formed by the use of phospholipids 
have been shown to be very effective in enhancing the topical and transdermal 
delivery of solutes (Pierre, 2011). Phospholipids are amphiphilic molecules; having 
hydrophilic head groups and lipophilic tails. In aqueous solution the phospholipids are 
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arranged in bilayers, with the fatty acid tails being located on the interior of the 
vesicle, and the polar head groups pointed outwards. Phosphatidylcholine from 
soybean or egg yolk is the most common component (Touitou et al., 1994) and 
cholesterol is frequently added to the composition so as to stabilize the structure, 
thereby generating more rigid liposomes.  
 
Liposomes are characterised by both their size and lamellarity (number of concentric 
lipid bilayers). A single bilayer enclosing an aqueous compartment is referred to as a 
unilamellar lipid vesicle, and according to size this is also known as either a small 
unilamellar vesicle (30-100 nm) or large unilamellar vesicle (100-3000 nm). If more 
than one bilayer is present, the liposome is referred to as a multilamellar vesicle (> 
100 nm) (Gulati et al., 1998).The most effective liposomes employed to deliver drugs 
to the skin are claimed to be those composed of lipids similar to the stratum corneum 
lipids (Egbaria et al., 1990; Fresta & Puglisi, 1997; Sinico et al., 2005). This might be 
due to their ability to enter the stratum corneum lipid lamellae and fuse with 
endogenous lipids. Evidence suggests that liposomes do not enter the skin (Hope & 
Kitson, 1993; Moghimi& Patel, 1993; Schreier & Bouwstra, 1994; Badran et al., 
2012). Standard liposomes exert their topical delivery by fusing with stratum corneum 
surface lipids and as a result enhance the partitioning of encapsulated material into the 
stratum corneum (Zellmer et al., 1995; Kirjavainen et al., 1996). It has also been 
postulated that phospholipids can affect stratum corneum lipid bilayer fluidity and 
enhance drug partitioning into the bilayers (Kirjavainen et al., 1996; Elmoslemany et 
al., 2012). 
 
Another generation of vesicles has also been described and these have been termed 
‘ethosomes’ and ‘transferosomes’. These are claimed to be ultra-deformable 
liposomes, with an ability to penetrate into the skin i.e. squeeze themselves between 
the corneocytes in the stratum corneum to bypass the barrier (Cevc et al., 1993; 
Cevec, 1996; Godin & Touitou, 2003; Bragagni, 2012). Conventional liposomes 
remain near the skin surface, dehydrate and fuse with stratum corneum surface lipids 
and as a result can enhance the partitioning of encapsulated material into the stratum 
corneum (Zellmer et al., 1995; Kirjavainen et al., 1996, 1999 a&b). Transfersomes in 
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contrast are claimed to penetrate intact skin in vivo, carrying therapeutic 
concentrations of drugs (including macromolecules such as insulin (TransfersulinTM), 
with efficiency similar to subcutaneous administration, which only occurs when the 
elastic vesicles are topically applied in non-occlusive conditions (Cevc & Blume, 
2001; Cevc et al., 1998, 2002). Transfersomes can act as carrier systems because of 
their high deformability and adaptability, which allow them to squeeze through small 
pre-existing channels in the stratum corneum despite their larger size (Cevc et al., 
1998). The driving force for skin penetration of deformable vesicles is said to be the 
osmotic gradient across the skin. Topically applied Transfersomes become dehydrated 
on the skin surface by evaporation of the aqueous content and thus an osmotic 
pressure difference is created between the highly hydrated regions inside the skin and 
the dehydrated skin surface. This promotes the entrance of Transfersomes into the 
stratum corneum and they move into the deeper skin strata so as to avoid dehydration 
(Cevc & Blume, 2001; Cevc et al., 2002). Therefore, occlusive conditions are 
detrimental to the capability of Transfersomes to deliver drugs through the skin, as in 
this situation the osmotic effect would be removed. 
 
Ethosomes are liposomes with a high alcoholic content that have been reported to be 
capable of enhancing penetration to deep tissues and the systemic circulation (Dayan 
et al., 2000; Touitou et al., 2000; Touitou et al., 2001; Godin & Touitou, 2003; Mao  
et al., 2013; Celia et al., 2012; Park et al., 2014). It is proposed that the ethanol 
‘fluidises’ the ethosomal lipids and stratum corneum bilayer lipids and that this 
reduces the density of lipid multilayer and the barrier of the stratum corneum, 
allowing movement of the soft, malleable ethosomes into the skin. This process then 
results in fusion of the vesicles (ethosomes) with cell membranes in the deep layers of 
the skin allowing drug release and the subsequent absorption of the latter into the 
blood stream (Touitou et al., 2000; Godin &Touitou, 2003: Shi et al., 2012). 
 
1.8 Oils incorporated in topical formulations 
 
The topical application of oils and oil-based formulations in skin care and skin 
protection has been a common practice since ancient times. Such skin preparations 
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were originally comprised largely of animal fats and vegetable oils, especially 
sesame, olive and almond oils (Poucher, 1959). Oily vehicles are still currently widely 
used in cosmetics, for example in foundation creams, sun care creams, skin care 
creams, lip balms, deodorants, antiperspirant sticks, makeup removers and hair 
conditioners. Oils are also extensively used as moisturizers and emollients to improve 
skin quality and function in these formulations. A primary factor in selecting an oil 
for use on the skin is ‘the feel’ of the product on the skin.  In addition, other factors 
may play a substantial role. For example the relative occlusivity on the skin is 
important for achieving an effective moisturizing function (Agner & Serup, 1993; 
Friebe et al., 2003; Förster et al., 2009; Hafeez et al., 2013). The occlusive effect traps 
water in the stratum corneum (preventing transepidermal water loss by evaporation) 
and there by mimics the role of natural emollients such as sebum and natural 
moisturising factor. Such an emollient effect can aid in the treatment of atopic 
eczema, since the prevention of water loss leads to a swelling of the stratum corneum, 
the closing of any cracks, and in so doing restores the epidermal barrier (Cork, 1997). 
Furthermore, the compatibility and the ability to solubilize other materials need to be 
considered, as does the ability of the final formulation to form stable emulsions. 
Odour and stability to light and oxygen are also critical to cosmetic formulation 
(Berdick, 1972). The oils incorporated in such topical formulations include: 
petrolatum, hexacecane, isohexadecane, lanolin, mineral oil, vegetable oils, fruit oils, 
essential fatty acids, eucalyptus oil, black currant seed oil, hazelnut oil, wheat germ 
oil, almond oil, sesame oil, coconut oil, hemp oil, squalane and synthetic oils such as 
polysiloxane (Müller et al., 2007; Pardeike et al., 2009 Karpanen et al., 2010; Fox et 
al., 2011; Sherry et al., 2013). 
 
Oils also have been reported to enhance the percutaneous absorption of topically 
applied drugs (Dreher et al., 1997; Gallarate et al., 1999; Baroli et al., 2000; Alvarez-
Figueroa & Blanco-Mendez, 2001; Wang et al., 2003; Rastogi & Singh, 2004; Sintov 
& Shapiro 2004; Kogan & Garti, 2006; Karpanen et al., 2010; Fox et al., 2011). This 
enhancement may involve a combination of mechanisms including fluidization of 
stratum corneum lipids, changes in the mechanical properties of the skin by rendering 
it more supple, lipid extraction or other means of barrier perturbation and occlusion. 
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The latter mechanism is often a consequence of the capacity of oils to moisturize the 
tissue. Lipid formulations work to moisturise the skin by increasing the amount of 
water held in the stratum corneum (Cork, 1997, Loden, 2003). Specifically, depending 
on the constituents of the oils, they work either by occlusion, ‘trapping’ moisture 
within the skin, by supplementing the properties of native stratum corneum lipids to 
provide a better barrier function as a consequence of reduced epidermal water loss 
(which results in an increase in skin hydration) (Lodén & Lindberg, 1991; Olsen et 
al., 1993; Blanken et al., 1989; Stamatas et al., 2008) , or in an ‘active’ way by 
drawing moisture into the stratum corneum from the dermis (Flynn et al., 2001, 
Rawlings & Harding, 2004). Formulations which involve the active movement of 
water from the dermis to the epidermis contain substances known as humectants, e.g. 
glycerine. These have a low molecular weight and water-attracting properties (Loden, 
2003) and as they penetrate the epidermis they draw water from the dermis. Some 
cream and lotion emollients contain a mixture of occlusive and humectant substances; 
the humectant draws water into the epidermis while the occlusive element ensures that 
it is trapped there. The occlusive action of oils has been reported to increase the 
permeability and efficacy of drugs, due to the increasing presence of water, the 
swelling of corneocytes, possibly altering the intercellular lipid phase organization, as 
well as both increasing skin surface temperature and blood flow (Hotchkiss, 1992; 
Rawlings et al., 1994; Bucks & Maibach, 2005; Rawlings & Matts, 2005; Zhai & 
Maibach, 2005).  
 
Lipid-based drug delivery systems (formulations containing lipids such as oils) have 
been demonstrated to be useful in enhancing the bioavailability of highly lipophilic 
compounds because they can maintain the drug in the dissolved state until it is 
absorbed (Rane et al., 2008). A number of cosmetic products now contain either solid 
lipid nanoparticles or nanostructured lipid carriers (Dingler et al., 1998; Jenning et al., 
2000 a&b; Jenning & Gohla, 2001; Wissing & Müller, 2001 & 2002; Song & Liu, 
2005; Jee et al., 2006; Joshi & Patravale, 2006; Liu et al., 2007; Pardeike & Müller, 
2007; Shah et al., 2007; Pardeike et al., 2010). The cosmetic benefits of these lipid 
ingredients are reported to include an enhanced chemical stability and improved skin 
bioavailability of the active components, film-formation on the skin, skin hydration, 
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controlled occlusion, as well as an improved physical stability of the vehicle (Muller 
et al., 2007b; Barel et al., 2009). 
 
Other examples of oils commonly in skin formulations include:  isopropyl palmitate, 
octanol,triacetin, isostearylicisostearate, R(+)-limonene, and Mygliol 812® (medium 
chain length triglyceride), oleic acid, isopropyl myristate and Labrafil (Dreher et 
al.,1997; Gallarate et al., 1999; Rhee et al., 2001; Hiranita et al., 2003; Paolino et al., 
2002; Escribano et al., 2003; Sintov et al., 2004; Kogan et al., 2006). 
 
1.9 Assessment of in vitro permeation techniques 
 
The methods for measuring skin absorption and dermal delivery can be divided into 
two categories: in vivo and in vitro. Ideally novel formulations or devices should be 
tested on humans in order to gain knowledge of the permeation, absorption and 
potential damage of the drug to the membrane. Practically, in vivo skin absorption 
measurement studies are rare due to ethical, economical, and analytical concerns. A 
shift in focus has been made over more recent years so as to develop and validate 
alternative in vitro test methods. There may be sufficient evidence to suggest that in 
vitro data are predictive for in vivo percutaneous absorption in both animals and man 
(Scott et al., 1992; Howes et al., 1996; Van Ravenzwaay & Leibold 2004; Williams, 
2006; Lehman et al., 2011). Justification for the use of in vitro dermal absorption 
studies on isolated skin is based on the fact that the epidermis, in particular the 
stratum corneum, forms the principal in vivo barrier of the skin against penetration 
and uptake of xenobiotics in the body. In vitro methods measure the diffusion of 
chemicals into and across skin to a fluid reservoir and can utilise non-viable skin to 
measure diffusion only, or fresh, metabolically active skin to simultaneously measure 
diffusion and skin metabolism. Such methods have found particular use as a screen 
for comparing delivery of chemicals into and through skin from different formulations 
and can also provide useful models for the assessment of percutaneous absorption in 
humans (Howes et al., 1996; van de Sandt et al., 2004). 
 
Several in vitro methods using excised skin have been developed for the evaluation of 
drug permeation. The use of Franz-type diffusion cells (Franz, 1975), also known as 
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vertical diffusion cells, is by far the most commonly used in vitro model for the study 
of percutaneous absorption, providing key insights into the relationships between 
skin, drug and formulation. This method is popular due to its simplicity, cost 
effectiveness, and the fact that the experimental conditions can be easily controlled by 
the investigator according to the purpose of investigation. Factors that need to be 
considered, when diffusion cells are required for in vitro testing, include: diffusion 
cell, membrane type, temperature, receptor fluid, finite or infinite dose, open or 
occluded testing. 
 
1.9.1 Diffusion cell 
 
In vitro permeation studies usually involve the use of in vitro diffusion cells which are 
made from inert, non-reactive materials such as glass, stainless steel and teflon 
(Friend, 1992). Diffusion cells comprise donor and receptor chambers between which 
the membrane is positioned. There are two different types of cells i.e. flow through 
systems and static type (Franz cell) systems (Franz, 1975; Bronaugh & Stewart, 1985; 
Van der Sandt et al., 2004). 
 
1.9.2 Membrane type 
 
Human skin for in vitro studies can be obtained from cadavers, or following cosmetic 
or plastic surgical procedures, and is subject to variability in the age, race, anatomical 
site, general health of the donor (Feldstein et al., 1998). Extreme care is necessary in 
the preparation of human skin membrane. There is a great deal of variability in human 
skin from donor to donor and hence studies should incorporate control experiments 
for each piece of skin to normalize the results. Due to biological variability a large 
number of measurements should be performed to obtain representative data 
(Gabbanini et al., 2009). The length and method of skin storage may also introduce 
variability (Swarbrick et al., 1982; Feldstein et al., 1998). There can be a problem 
with ensuring the availability of suitable quantities of human skin, especially if 
extensive experimentation is required. Due to such difficulties in obtaining skin and 
associated ethical considerations, simpler, better-characterized, readily available, 
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homogeneous, chemically pure and easier to handle membrane systems have been 
proposed to act as a model to investigate transdermal absorption (Scott, 1986; 
Feldstein et al., 1998). These include the use of artificial membranes including: 
silicone membrane which is a non-porous, hydrophobic, relatively inert and 
reproducible barrier. Silicone membrane is particularly useful to apply as a barrier, 
when factors, such as the effects of drug concentration on permeation are evaluated 
(Zadeh et al., 2008). Cellulose acetate and regenerated cellulose membranes are also 
used (Shah et al., 1989; Babar et al., 1991; Megrab et al., 1995; Ng et al., 2012). 
 
Combining different polymers, such as silicone and cellulose acetate, has also been 
investigated as models to simulate the hydrophilic and lipophilic domains of the 
stratum corneum (Nastruzzi et al., 1993). Carbosil is a polydimethylsiloxane/ 
polycarbonate block copolymer membrane, acting as a skin-imitating, permeation 
barrier (Feldstein et al., 1998). Other hydrophobic membranes, such as polyethylene, 
have, under certain circumstances, also proven to act as suitable models of the stratum 
corneum barrier function. However, the partitioning characteristics of both silicone 
and Carbosil membranes, lead to a much lower diffusional barrier when compared to 
polyethylene (Feldstein et al. 1998). Animal skin has also been used extensively in 
place of human skin, sources include the: mouse, rat, pig and snake (Babar et al., 
1991; Dick & Scott, 1992; Schmook et al., 1993).  More recently, the use of living 
skin equivalents i.e. reconstructed human epidermis (GraftskinTM, SkinethicTM) has 
also been reported (Lotte, 1997; Lotte et al., 2002; Schmook et al., 2001). 
 
Synthetic membranes have been reported (Houk & Guy, 1988; Feldstein et al., 1998) 
to provide the most useful information about the in vivo process when: 
 
(1) The passive diffusional barrier imposed by the stratum corneum is the major 
resistance to transport. 
(2) The molecule of interest is known to be metabolically inert and not specifically 
bound in viable skin. 
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(3) There is information available (taking into consideration the penetrant’s 
physicochemical properties) concerning the probable importance of the possible 
penetration routes available in vivo. 
(4) In vivo experiments of similar design have been or can be performed and 
correlated with the in vitro results. 
 
However, the use of artificial membranes also has its problems. In most instances, the 
membrane acts merely to separate physically the formulation from the receptor phase 
with the release rate being determined by the formulation, not the membrane. 
Although this might be adequate for developing therapeutic drug delivery systems, 
such studies do not provide appropriate relevant data when the skin controls drug 
input into the body.   
Solute transport through a membrane that divides two compartments occurs either 
after the partitioning of the solute into, followed by diffusion through a distinct 
membrane phase (non-porous membrane), or by permeation through a continuous 
porous membrane. Cellulose acetate filtration and all dialysis membranes are 
examples of such porous barriers. Solutes (and some bulk solvent) may diffuse 
through the solution-filled pores, and the polymer and any immobilised solvent 
provides the only a physical barrier to free movement. 
Partitioning membranes require solutes to partition into and to diffuse through a phase 
distinct from that of the donor and receptor solutions. Hydrophobic membrane 
systems such as silicone membrane have been used to model drug transport through 
biological lipid barriers and to correlate the transport rates with the physicochemical 
properties of the drugs studied. Specific molecular structure, absolute aqueous 
solubility, and the relative affinity of the molecule for the membrane versus the 
aqueous phase have been shown to be important determinants of permeability. If skin 
transport is determined by the lipophilic diffusional barrier of the stratum corneum, 
partitioning-membrane systems can provide a good correlation with skin models 
(Houk & Guy, 1988; Ottaviani et al., 2006; Sinko et al., 2009 & 2012; Joshi et al., 
2012). 
 





The diffusion constant for diffusion processes across a homogenous membrane 
increases with increasing temperature (Clarys et al., 1998). Thus temperature should 
be maintained constant during permeation studies, at a temperature close to the 
normal topical skin temperature of 32°C. Any alteration in temperature will modify 
the flux of compounds across the membrane (Blank et al., 1967; Clarys et al., 1998; 
Akomeah et al., 2004). Increased xenobiotic penetration through the skin is associated 
with alterations in local blood flow (Sethna et al., 2005; Curry & Finkel, 2007; 
Sawyer et al., 2009). Four phase transitions in the structure of the stratum corneum, 
often defined as T1–T4, occur in the temperature ranges of 35–42, 65–75, 78–86 and 
90–115 °C respectively (Silva et al., 2006). When heat is applied to a mixture of 
ceramides, fatty acids, cholesterol, cholesterol sulphate and esters, which constitute 
the lipid bilayers within the stratum coeneum, they become disrupted (Harrison et al. 
1996). Wood et al. (2012) studied the effect of heat on the formulation release, drug 
partitioning and epidermal diffusion. Molecular mobility alterations in the vehicle, 
due to an increase in temperature to 45°C, led to higher drug release from the 
formulation. An increase in drug partitioning due to membrane mobility was also 
observed. A 5-fold increase in barrier diffusivity was attributed to lipidic bilayer 
structural rearrangement due to the fluidisation of the epidermis lipids in the 
temperature range of 37–45°C (Wood et al., 2012). 
 
1.9.4 Receptor fluid 
 
It is essential that during in vitro permeation studies, sink conditions are maintained to 
prevent significant back-diffusion of penetrant from the receptor phase into the donor 
chamber. Sink conditions may be defined as the provision of sufficient receptor phase 
to ensure that the thermodynamic activity in that compartment does not exceed 10% 
of the saturated solubility of penetrant in the receptor vehicle, in order to ensure an 
adequate driving force for diffusion is maintained (Higuchi, 1960 & 1961). Thus, the 
concentration of penetrant in the receptor should remain low throughout the diffusion 
study. The choice of a receptor fluid is influenced by the physicochemical properties 
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of the solute and the type of analytical method employed to determine the 
concentration. Also the receptor fluid should not alter the barrier properties of the 
membrane. Typically, aqueous solutions are used with polar solutes and ethanolic 
solutions with lipophilic solutes. The receptor fluid, preferably should be degassed in 
order to avoid formation of air bubbles during the experiment, and should be 
thoroughly stirred (static cells) or continuously replaced (flow through cells) during 
the entire experiment. 
With regards to measuring skin integrity, the use of model markers covering a wide 
range of physicochemical properties is recommended. Possible candidates that have 
been proposed to act in this function include: hydrocortisone, theophylline, benzoic 
acid, salicylic acid, caffeine, water, mannitol, sucrose and testosterone (Howes et al., 
1996). Increasing degree of skin damage causes an increase in the permeation of 
chemical markers. It is essential that the resulting permeability data recorded in the 
laboratory conducting the study agrees with that in the literature (performed under 
similar experimental conditions) to guarantee the fitness of the in vitro method 
employed. 
1.9.5 Finite or infinite dose 
The dose (finite or infinite) employed in permeation experiments should be 
considered depending on the type of information required. For in vitro studies 
requiring the determination of flux, or when investigating the effect of penetration 
enhanacers on drug permeation through the skin, and other skin permeation 
parameters, an infinite dose is employed (Selzer et al., 2013). In infinite dose studies, 
the applied dose is so large that depletion of the permeant in the donor chamber 
caused by evaporation or diffusion into and through the barrier is negligibly small. 
Consequently, the dose is considered to be thermodynamically stable. In contrast, in 
the finite dose regime, only a limited amount of the donor formulation is applied to 
the skin surface. The application of a finite dose supposedly best resembles the in vivo 
situation when applying e.g. an ointment. In addition, special effects like the influence 
of evaporation of excipients can be observed 
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The Organisation for Economic Co-Operation and Development (OECD) guideline 
428 (Howes, 1996), defines finite dose skin absorption experiments as those 
characterized by the application of ≤10 μl/cm² of a liquid formulation to the skin. For 
semisolid and solid substances, values range from 1 to 10 mg/cm2. The daily drug 
dose that can be systemically delivered through a reasonable ‘patch-sized’ area in 
contact with the skin is ≤ 10 mg/cm2. 
 
1.9.6 Open or occluded systems 
 
Occlusion or the covering of the donor compartment of invitro diffusion cells, where 
the test substance or formulation resides during diffusion studies has been shown to 
enhance percutaneous absorption (Treffel et al., 1992; Cross & Roberts, 2000). 
Occlusion of the skin has been reported to increase the percutaneous absorption of 
various topically applied compounds (Bucks & Maibach, 2005) as a result of increase 
in temperature and stratum corneum water content as discussed previously.  
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1.10 Aims and objectives 
 
In this study it is hypothesized that different oils interact with membranes depending 
on their inherent physicochemical properties. The aim of this study is to investigate 
the interaction of oily vehicles with synthetic membranes with a view to 
understanding the dermal delivery of concomitantly administered model permeant 
compounds. A further aim is to study the influence of mixed vehicle composition on 
the uptake of oil into silicone membrane and its influence on the diffusion of the 
model penetrants. Therefore the specific objectives were as follows: 
 
 To identify a suitable range of oils for use as drug delivery vehicles based on 
their structure, molecular and physicochemical characteristics. 
 
 To investigate the influence of blending different oil structures on the 
diffusion of model penetrants through silicone membrane. 
 
 To investigate the interaction of oily vehicle formulations with model 
membrane barrier systems in order to understand the effect of structure and 
function of oil on the interaction with membranes. 
 
 To study the influence of oil properties on the amount of oil that is sorbed by a 
membrane, from different oil blends applied to the membrane surface. 
 
 To determine the flux of model compounds across a number of artificial 
membranes. 
 
 To determine the flux of model penetrants across human epidermis from 
different oily vehicles. 
 
 To model and identify the molecular properties that influence the permeation 
of different model compounds through different membranes and human 
epidermis by multivariate analysis of the data.  
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1.11 Model oily vehicles 
 
In order to elucidate the factors affecting the amount of oils absorbed by membranes, 
five structurally unrelated oils with different solubility parameters, shape and size 
were required. The oils identified as suitable were isopropylmyristate (IPM) as an 
example of an ester oil, oleic acid (OA) as an example of cis fatty acid, isohexadecane 
(IHD) as a branched oil, hexadecane (HD) as an example of a linear oil and liquid 
paraffin (LP), which is comprised of mixed linear and branched oil molecules. All 
oils used are GRAS (Generally recognized as safe)  
 
IPM is the ester of isopropyl alcohol and myristic acid. This oil is used in cosmetic 
and topical medicinal preparations where a high absorption through the skin is 
desired. IPM has been used extensively and over a prolonged time in commercial 
products including cosmetics and creams (Holzner, 1963; Campbell & Bruce, 1981). 
It has also been used in several ex vivo and in vitro drug permeation studies 
previously (Hadgraft et al., 1990; Alberti et al., 2001, Brinkmann & Müller-
Goymann, 2003, Fang et al., 2002, Harada et al., 2005). IPM in combination with 
other solvents such as isopropyl alcohol, ethanol and triethanol amine has been shown 
to increase the drug permeation rate and bioavailability of these drugs (Alberti et al., 
2001, Brinkmann & Müller-Goymann, 2003, Fang et al., 2002). It is suggested that 
IPM is capable of integrating into the lipid bilayers to promote membrane fluidity, 
which may contribute to an increased disorder of stratum corneum and thus enhance 
permeability of lipids within the stratum corneum (Pillai et al., 2004; Brinkmann & 
Muller-Goymann, 2005). 
 
IHD is a light isoparaffin. It comprises a mixture of highly branched aliphatic 
hydrocarbon C16 isoparaffins with a small proportion of C12 and C20 paraffins of 
similar structure (Nardello et al., 2003). The high degree of branching of IHD 
considerably shortens the overall molecular length, and this can enhance its 
interaction with other molecules (Nardello et al., 2003). It is widely used in cosmetics 
and personal care products since the sensory perception of the residue on the skin is 
‘non-greasy’ in nature, but IHD has not been investigated as a vehicle in transdermal 
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delivery systems. It is a clear, colourless, slightly volatile, non-polar and hydrophobic 
liquid, which has very low toxicity and skin irritation. IHD forms particularly ‘robust’ 
emulsions (creams), which is an important feature for the product formulator. 
Foundation creams, sun-care creams, lip creams, deodorants and antiperspirant sticks, 
make up removers and hair conditioners are amongst the products that have been 
formulated with IHD. 
 
OA is a monounsaturatedomega-9-fatty acid and is present in various animal and 
vegetable sources; being the most abundant fatty acid in human adipose tissue. OA is a 
yellowish to pale brown, oily liquid with a characteristic lard-like odour and taste, 
comprised chiefly of (Z)-9-octadecenoic acid together with varying amounts of 
saturated and other unsaturated acids. Triglyceride esters of OA comprise the majority 
of olive oil, though there may be less than 2.0% as actual free acid in the virgin olive 
oil. Fatty acids promote skin permeation of various drugs (Cooper, 1984; Barry & 
Bennett, 1987; Larrucea et al., 2001; Nanayakkara et al., 2005). They interact with 
intercellular lipid domains and when intercalated in layers, they act to reduce the 
diffusional resistance to permeation and aid drug transport (Green & Hadgraft, 1987). 
The efficacy of fatty acids is related to their structures; there being differences 
between the efficacy of saturated and unsaturated forms and those of different 
hydrocarbon chain length (Tanojo et al., 1997; Kandimalla et al., 1999). The 
unsaturated fatty acids with cis conformation and C18 chain length, have been shown 
to be more effective enhancers than their saturated counterparts, promoting the 
permeation of different drugs (Aungst et al., 1986; Chi et al., 1995). It is reported that 
oleic acid exists as a separate phase within the lipid domains of porcine stratum 
corneum and suggested that the mechanism of enhancement of OA is mediated by the 
formation of permeable defects within the stratum corneum lipids (Naik et al., 1995). 
This is a consequence of the conformation of the cis double bond, which favours the 
condensation of OA with other molecules of OA rather than distribute homogeneously 
within the skin lipid bilayers (Ongpipattanakulet al., 1991). 
 
LP comprises a purified mixture of saturated hydrocarbons having the general formula 
CnH2n+2, with carbon chains generally greater than C20, obtained from petroleum 
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(Rowe et al., 2006). It is employed as a topical vehicle, having no colour and only the 
faintest odour. LP is used is cosmetics due to its occlusive and moisturizing properties. 
Paraffin oil and vegetable oils (sweet almond oil, jojoba oil) have been reported to 
penetrate only the outermost layers of the stratum corneum (Stamatas, 2008). In vivo 
confocal Raman micro-spectroscopy was used to test the penetration and occlusion 
potential of the oils. The amount of petrolatum penetrated was 3-4 times more than 
vegetable oils and it penetrated deeper than the vegetable oils. There was no 
significant difference between the amounts of the three vegetable oils that penetrated. 
Paraffin oil and vegetable oils have the same occlusive potential, which is lower than 
petrolatum (Agero & Verallo-Rowell 2004; Stamatas, 2008). 
 
 
HD is an alkane hydrocarbon. It is a colourless liquid, which does not mix with water. 
It is widely used in make-up, personal and skin care products due to its moisturizing 
and occlusive properties and non-greasy texture, although it is also reported to 
permeate well into the skin (Rossmiller & Hoekstra, 1966; Blank & McAuliffe, 1985; 
Singh et al., 2002).  
 
























2.1.1 Model permeants 
 
Permeants of different octanol/water partition coefficients and varying 
physicochemical properties, which are postulated to transverse the human skin 
through different routes, have been employed as suitable model permeants for 
transdermal research. For example, such permeants have been utilised for in vitro 
percutaneous absorption studies to: (i) determine the effect of possible penetration 
enhancement methods on the stratum corneum barrier (Ghanem et al., 1992) (ii) 
study the relationship between the physicochemical properties of the permeants and 
variability in their flux (Rougier et al., 1987; Williams et al., 1992; Liu et al., 1993) 
(iii) investigate any relationship between solvent and solute penetration (Cross et 
al., 2001) and (iv) validate in vitro skin permeation methods (Howes et al., 1996). 
In the current study, the model permeants: methyl paraben (MP), butyl paraben 
(BP) and caffeine (CF) were selected on the basis of their having a differing 
lipophilicity but similarity in molecular weight. Such a range of properties would 
enable some of the effects of partition on percutaneous absorption to be investigated 
discretely. These three compounds possess suitable stability over a range of pH and 
are reported to penetrate the skin via different routes (Akomeh et al., 2004) and 
have been employed by a number of formulation scientists to study transdermal 
penetration previously (Dias et al., 1999; Bock et al., 2002; Akomeah et al., 2004; 
Lopez et al., 2004; Akomeh et al., 2004; Nanayakkara et al., 2005; Oliveira et al., 
2010; Oliveira et al., 2011). The chemical structure and some of the 
physicochemical properties the chosen permeants are shown in Figure 2.1 and 










Figure 2.1 Structure of (a) methyl paraben (b) caffeine (c) butyl paraben. 
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Table 2.1 Physicochemical parameters of model permeants 









Molecular formula C8H8O3 C8H10N4O2 C11H14O3 
Molecular weight  152.15 194.2 194.227 
Log P(o/w) 1.96 -0.07 3.57 
δD
a 17.9 19.5 17.3 
δP
b 5.9 10.1 4.9 
δH
c 13.5 13 10.4 
Solubility parameter 
(MPa) 1/2 
24.13 28.83 22.29 
*data determined by Hansen Solubility Parameters in Practice (HSPiP) software version 
4.0.04 Copyright 2013 www.Hansen-Solubility.com 
adispersion component.  
bpolar component. 
chydrogen bonding component. 
 
BP and MP are the butyl and methyl esters of p-hydroxybenzoic acid (termed 
parabens), respectively and they are frequently used in foodstuff, pharmaceuticals, 
cosmetic, toiletries and other personal care products; including shampoos, 
moisturizers, etc. They are considered good preservatives since they possess broad 
antimicrobial properties, relatively low toxicity, low volatility and high stability 
(Kang et al., 1997). However, studies suggest parabens may be carcinogenic and 
possess estrogenic disrupting activity, thereby disputing the notion of low toxicity 
for these compounds (Darbre et al., 2004; Harvey & Everett, 2004; Khanna et al., 
2013). For example, it has been reported that the recommended intake of butyl and 
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propyl paraben (10 mg kg-1 body weight) was sufficient to cause adverse effects in 
male reproductive functions such as sperm production (Osihi, 2001 & 2002). In 
addition, both of these compounds have been reported to have the capacity to 
induce allergic contact dermatitis on topical exposure (Soni, 2002). Also the 
parabens have been reported to be implicated as a causative factor breast cancer 
(Khanna et al., 2013). However; such toxicological effects are of little relevance to 
the purpose of this study. Physically, MP and BP are white, crystalline powders, 
with a slight solubility in water but with a high solubility in ethanol (96%) and in 
methanol. 
 
CF, a white crystalline powder is an alkaloid of the methylxanthine family, which 
also includes the similar compounds theophylline and theobromine. It occurs 
naturally in tea and coffee, but is prepared synthetically for commercial purposes. It 
sublimes readily and, in contrast to the parabens, is sparingly soluble in water and 
dehydrated alcohol. CF has been reported to be used as an anti-viral (Hamuy et al., 
1998) and anti-cellulite (Bertin et al., 2001) and is claimed to be a mental stimulant 
(Benowitz, 1990; Kolega, 1993). The potential anticancer effects of CF upon oral 
administration have been reported (Sarkaria et al., 1999; Michal & Andrzej, 2008; 
Tomita & Tsuchiya, 2008). Orally administered and transdermally applied CF could 
protect the skin from ultraviolet light induced skin cancer (Huanget al., 1997; Lu et 
al., 2001; Lu et al., 2008; Shakeel & Ramadan 2010). 
 
2.1.2 Reverse phase high performance liquid chromatography (HPLC) for 
quantification of model permeants 
 
In order to monitor and quantify the amount of permeant traversing the membranes 
during diffusion studies, high performance liquid chromatography (HPLC) was 
used as the analytical method of choice. Model permeants used in this study could 
be analysed using several methods of analysis, for instance ultraviolet (UV) 
spectrometry, gas chromatography (GC) analysis, gas chromatography with  mass 
spectrometry, liquid chromatography with mass spectrometry, ultra-high pressure 
liquid chromatography with mass spectrometry and HPLC analysis. HPLC 
separates various components in mixtures and can quantify them in a precise and 
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accurate way in short time with high sensitivity and specificity. These advantages in 
combination with the ease of operation and effectiveness of the method make it a 
popular analytical tool. HPLC affords simple preparation of many samples, 
avoiding extensive extractions usually necessary for ultraviolet or colorimetric 
assays. It avoids problems associated with thermal instability in gas 
chromatography and the occasional need for preparing volatile derivatives prior to 
analysis; and it overcomes the time factor and manipulative problems of 
quantitative thin-layer chromatography (Fitzpatrick et al., 1975). Separation in 
reverse phase HPLC chromatography depends on the reversible 
adsorption/desorption of solute molecules with varying degrees of hydrophobicity 
onto a hydrophobic stationary phase. It involves the partitioning of a solute 
molecule between mobile phase (e.g. acetonitrile, methanol, aqueous buffers or a 
mixture) and stationary phase filled with a solid adsorbent material (often 
octadecylsilane which is bonded to a silica support). The distribution of the solute 
between the two phases depends upon: the degree of interaction between the solute 
and adsorbent material in the column, the adsorption properties of the medium, the 
hydrophobicity of the solute and the composition of the mobile phase. The 
compounds can be detected most conveniently by monitoring the absorbance of 
ultraviolet (UV) radiation; assuming there is an appropriate chromophore in the 
molecule. UV detectors function by monitoring light absorbed by the solute 
molecules, each solute or, more specifically, its chromophore(s) may absorb light 
maximally at a characteristic wavelength, which allows identification of the solute. 
On the other hand if two or more solutes absorb light at the same wavelength, 
HPLC has the potential to separate them and quantify such analytes. 
 
The HPLC method of analysis of all three permeants was adapted from the method 
described by Akomeah et al. (2004). HPLC was widely used previously to quantify 
the model permeants in transdermal studies (Twist & Zatz, 1986; Twist & Zatz, 
1988 a&b; Bonina, 1993; Dias et al., 1999; Akomeah et al., 2004; Nanayakkara et 
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2.1.3 Gas chromatography 
 
During diffusion studies permeants are expected to pass through the membranes, 
however the vehicle components may also enter the membrane. Since this thesis 
investigates oily vehicles, an appropriate analytical tool to quantify the amount of 
oil in the membrane is required. Oils are characterized by having non-polar and 
hydrophobic molecular skeletons. They are predominantly hydrocarbon-chain-
containing organic compounds, having a wide range of structures. Oils can be 
analyzed using thin layer chromatography or HPLC with a refractive index detector.  
However gas chromatography (GC) is the primary and certainly one of the most 
suitable tools to analyze lipids (Mondello et al 2004; Brufau et al., 2006; Clement et 
al., 2010; Forchielli et al., 2010; Amusquivar et al., 2011).  
 
GC comprises two phases: a stationary bed with a large surface area, and the other 
being a gas that passes through the stationary bed. The sample is vaporised and 
carried by the mobile gas (the carrier gas) through the column. Samples will 
partition into the stationary phase according to their solubility at a given 
temperature. The components of the sample separate from one another on the basis 
of their relative vapour pressure and affinity to the stationary bed. Classically, 
qualitative analysis with gas chromatography involves the comparison of retention 
data (retention time) of an unknown sample with that of a known one. Retention 
time is the time from the injection of the sample component until the recording of 
the peak maximum. The column temperature should be high enough for the sample 
components to pass through it at a reasonable speed. It needs to be higher than the 
boiling point of the sample, with higher temperature leading to decreased retention 
time and hence shorter analysis times. 
 
GC analysis was chosen in order to separate and determine the amount of oils 
sorbed by the silicone membrane, since it provides a precise, accurate, sensitive, 
easy to operate and effective technique. Gas chromatography has several 
advantages as a physical method of separating gas mixtures (Matei et al., 2012) 
including: (1) resolution, the technique is applicable to systems containing 
components with very similar boiling points,(2) sensitivity, the detector based on 
Chapter 2.  Validation of analytical methods 76 
 
thermal conductivity of the component can detect picograms of sample, (3) 
convenience, it does not require highly qualified personnel to perform routine 
separation (4) low cost, (5) high separation power, (6) ease of recording data and 
(7) ready automation.  
 
However GC has some disadvantages since it only detects volatile organic 
compounds; therefore it cannot be used for detecting semi-volatile compounds or 
thermally labile samples. The analytes should have a boiling point below 500°C 
(McNair & Miller, 1998). Operating under more extreme conditions may lead to 
short analysis intervals and incomplete use of the chromatographic column; for 
instance, many stationary phases undergo degradation or decomposition at 
operating temperatures above 250°C, resulting in a shorter operating life (Matei et 
al., 2012). 
 
GC has been used previously to quantify lipids of different classes for instance free 
fatty acids, citrus oils, essential oils, olive oil, IPM, free sterols, squalene, palm oil,  
steryl esters, cholesterol, waxes, hydrocarbons (Bogusz et al., 2004; Fagan & 
Wijesundera, 2004 ; Mondello et al.,2004; Nang Lau et al., 2005; Brufau et al., 
2006; Cardoso et al., 2006; Mondello et al., 2006; Isidorov, 2009 ; Liu et al., 2009; 
Clement et al., 2010; Forchielli et al., 2010; Amusquivar et al., 2011). Any GC 
method, in this case for the analysis for the oils, requires development and 
validation. 
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2.2 Aims & Objectives 
 
The aim of the work described in this chapter was to develop suitable analytical 
methods to examine the influence of oily vehicles on barrier membranes and model 
permeant flux. In order to achieve this aim, the following were the objectives of this 
chapter: 
 
1. Validate appropriate HPLC assay methods which would allow the precise 
quantification of the permeants being studied, in the presence of model membranes 
and human epidermis used in Franz cell diffusion studies. 
 
2. Develop and validate appropriate GC assay methods which would allow the precise 
quantification of the oils being absorbed into silicone membrane. 
 
3. Design a UV method which would allow the precise measurement of the solubility 
of model permeants in different oils. 
 
During in vitro permeation methods, it was planned to conduct Franz cell diffusion 
studies. Franz diffusion experiments have evolved into one of the most important 
methods for investigating transdermal drug administration (Ng et al., 2010). The 
method requires the capability of monitoring the permeation of model diffusants 
through both synthetic membranes and human epidermis. Therefore a further 
objective of this chapter was to ensure lack of leaching of the membrane 
components (due to the interaction with the oils) which might interfere with the 
analysis. Another objective was to prepare human epidermal sheets such that they 
could be accommodated within Franz cells and to confirm that any leachable 
material from epidermis and the associated filter paper did not interfere with the 
utilised method. 
  





The materials employed in the assay of the pentrants and oils are listed in Table 2.2. 
 
Table 2.2 Materials used 
 
Materials Supplier 
Methanol (HPLC grade) 
Acetonitrile (HPLC grade) 
Heptane (HPLC grade) 
Hexadecane 
 
Merck Chemicals, Germany 
Orthophosphoric acid Riedel-de-Haen Chemical, Germany 
Potassium hydroxide Scharlau  Chemical, Spain 
Methyl paraben  








Isopropanol BDH Laboratory Supplies,UK 
Deionised water  
 
 
Merck chemicals, Germany, and  IPRC 
water treatment 0.22μm Millipak, 
Millipore, USA 
Isopropyl myristate Uniema, Malaysia 
Isohexadecane Uniema, UK 
Whatman no. 1 filter paper Whatman International Ltd, UK 
Silicone membrane Samco Ltd.,  UK 
High density poly ethylene membrane  Pharmaceutical grade package material, 
donated from TQ Pharma, Jordan 
Poly urethane membrane Exopack, UK 
Cellulose acetate nitrate membrane Millipore, UK 
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2.3.2 HPLC assay method validation 
 
2.3.2.1 HPLC chromatographic conditions for model permeants 
 
A Class VP 2010 LC Pump with Auto sampler connected to a UV Absorbance 
Detector were employed (Shimadzu Japan). The column used for all permeants was 
a Symmetry 5 BDS (C18), 150 x 4.6 mm (5 m) (Waters, USA). The mobile 
phase for MP consisted of 35% v/v acetonitrile/65% phosphate buffer (50 mM 
KH2PO4 containing 1% w/v triethylamine, then adjusted to pH 3.5 with 
orthophosphoric acid). The mobile phase for the assay of BP was 50% 
acetonitrile/50% phosphate buffer (50 mM KH2PO4 adjusted to pH 3.0 with 
orthophosphoric acid) and for CF was 15% v/v acetonitrile/85% phosphate buffer 
(50 mM KH2PO4 adjusted to pH 3.0 with orthophosphoric acid). The flow rate and 
injection volume were maintained at 1 mL min-1 and 50 µL respectively, for all 
permeants. Samples were scanned using different wavelengths and the wavelength 
of detection (nm) was 254, 256 and 270 for MP, BP and CF respectively. 
 
2.3.2.2 Calibration curve (linearity and range) 
 
A stock solution (1.0 mg mL-1) was prepared by dissolving 100 mg of the required 
solute (MP, BP or CF) to 100 mL volume in 50:50 v/v methanol:de-ionized water. 
A series of standard solutions with varying concentrations of each permeant was 
prepared by serial dilution using phosphate buffer (50 mM KH2PO4 adjusted to pH 
7.0 with potassium hydroxide). Calibration curves were constructed by plotting the 
response (peak area) against concentration of the standards (0.2, 1.0, 5, 10, 15, 20 
g mL). 
 
2.3.2.3 Repeatability (intra-day variation) and intermediate precision 
 
Three replicate series of the standard solutions were made from three stock 
solutions and then analysed on the day of preparation (day 1). 
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In order to determine the precision of the assay, the standards were stored at room 
temperature (25-27 C) and analysed for the active content at different time 
intervals on three different days.   
 
Accuracy was determined using the low (0.2 µgmL-1), mid (10 µg mL-1) and high 
(20 µg mL-1) concentrations with three standard solutions of each concentration 
being employed for each point. The percent recovery and relative standard 
deviation (RSD) of the results were calculated. 
 
2.3.2.4 Limit of detection and quantification 
 
Calibration curves were constructed from the HPLC assay of the standard solutions, 
from which the limit of quantification (LOQ) and limit of detection (LOD) were 
calculated using equations 2.1 and 2.2, in accordance with ICH guidelines (2005). 
 
LOQ = 10/ S                          (2.1) 
 
LOD = 3.3/ S                          (2.2) 
Where,  is the standard deviation of the y-intercept and S the slope of the 
calibration curve. 
 
2.3.3 UV assay method 
 
The UV analytical method was carried out using Thermo electron vision pro 
software V4.20 (Thermo, Germany). A stock solution (1.0 mg mL-1) was prepared 
by dissolving 100 mg of the required solute (MP, BP or CF) to 100 mL volume in 
isopropanol. A series of standard solutions with varying concentrations of each 
permeant was prepared by serial dilution using isopropanol. Using a 1mL volume 
quartz cell, calibration curves were constructed by plotting the response 
(absorbance) as a function of concentration of standards. The concentrations for the 
calibration curves were 1,2,4,6 and 10 (µgmL-1) for BP, 1,2,4,5 and 8 (µgmL-1) for 
MP and 1, 2,5,10 and 20 (µgmL-1) for CF. 
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Samples were scanned spectrophotometrically at wavelengths between 200 and 400 
nm to detect an appropriate wavelength for the assay of each permeant. The 
wavelengths of detection (nm) were: 254, 256 and 270 for MP, BP and CF 
respectively. Blank samples of isopropanol, and oils were scanned to determine 
whether there was any interference in the absorption of light at the wavelengths of 
assay. 
 
2.3.4 GC assay method validation 
 
The analytical method development and validation for the IPM/IHD and IHD/HD 
vehicles was carried out using a gas chromotograph model Varian CTC Analytic, 
(Varian,USA). A 0.53mm × 30m fused silica capillary column bonded with a 
1.0µm film of phase (G42) (Quadrex, USA) was employed with helium as the 
carrier gas and flame ionization detection. 
 
For HD/IPM the analysis and validation were carried out using a Focus gas 
chromatograph (Thermo,Germany) with an auto sampler (Triplus, Germany) and 
the column was 0.53mm × 30m fused silica capillary column bonded with a 1.0µm 
film (InertCap, Japan). The analytical parameters used to carry out the GC 
quantification of the oil mixtures are shown in Table 2.3. 
 
2.3.4.1 Calibration curve (linearity and range) 
 
A stock solution (100 mg mL-1) was prepared by dissolving 2.50 g of the oil to 25 
mL volume in heptane. A series of oil standard solutions containing varying 
concentrations of each were prepared by serial dilution using heptane. Calibration 
curves were constructed by plotting the response (peak area) against concentration 
of the standards (0.1-20 mg mL-1) for the HD/IHD (0.1, 0.5, 1, 5, 20 mg mL-1), 
IPM/IHD (0.1, 1, 5, 10, 20 mg mL-1) and IPM/HD (0.1, 1, 5, 10, 20 mg mL-1) 
blends of oils. Unknown concentrations of oils were then determined by reference 
to the appropriate calibration curves. 
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Table 2.3 Analytical parameters for the GC quantification of IPM/IHD, IHD/HD and IPM/HD mixtures 
 
 IPM/IHD IHD/HD IPM/HD 
Instrument temperature program    
Initial temperature (°C) 70 70 70 
Initial time (min) 2 2 2 
Rate (°C/ min) 7 8 7 
final temperature (°C) 260 295 260 
final time (min) 5 2 5 
Injector temperature (°C) 220 220 220 
Total time (min) 34.14 32.12 34.14 
 
Inlet settings 
   
Mode split Split Split Split 
Split ratio 1:1 1:1 1:3 
Injection volume (µL) 9.0 9.0 3 
Flow rate (mLmin-1) 6 6 6 
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2.3.4.2 Repeatability (intra-day variation) and intermediate precision and accuracy 
 
Three replicate series of the standard solutions were made from three stock solutions 
and then analysed on the day of preparation (day 1). In order to determine the precision 
of the assay, the standards were stored at room temperature (25-27C) and analysed for 
the active content at different time intervals on three different days. The mean and RSD 
was calculated for each calibration point. Accuracy was determined using the low, mid 
and high concentrations with three standard solutions of each concentration being 
employed for each point. The percent recovery and RSD values were calculated. 
 
2.3.4.3 Limit of detection and quantification 
 
The LOD and LOQ were calculated as in section 2.3.2.4 
 
2.3.5 In vitro permeation method validation 
 
2.3.5.1 Membrane vehicle interference study 
 
In order to determine the effect of synthetic membranes on the assay method employed 
in this study, ‘simulated Franz cell’ diffusion experiments were carried out. A piece of 
membrane was cut (the diameter being approximately 2 cm) and sandwiched between 
the donor and receptor chamber of the Franz cell (Figure 2.2).  The receptor chamber 
was then filled with ~ 2 mL of phosphate buffer and 200 L of oily vehicle introduced 
into the donor chamber. The assembled cell was then immersed into a water bath 
maintained at 37oC. Samples (200 L) were only removed from the receptor 
compartment after 6 h and analysed via HPLC, the analysis was performed using the 
method described in section 2.3.2. 
 
2.3.5.2 Preparation of human epidermal sheets 
 
Fresh, surgically excised samples of human skin were obtained directly after abdomino 
plastic surgery with informed consent, from the patient attending a private clinic in 
Amman, Jordan. The board of directors and the ethics committee of the clinic reviewed 
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and approved the informed consent. Subcutaneous fat was carefully removed from the 
skin sample using forceps and a scalpel. Following removal of the fat, individual 
portions of skin were immersed in water at 60C for 45 seconds (Kligman & 
Christophers, 1963; Nanayakkara, 2005).  The skin was then pinned; dermis side down, 
on a corkboard and the epidermis (comprising stratum corneum and epidermal layer) 
gently removed from the underlying dermis by rolling the membrane using forceps. 
The dermis was then discarded and the epidermal membrane floated onto the surface of 
water and taken up onto a Whatman no.1 filter paper, the resultant epidermal sheets 
were blotted dry with tissue paper and stored flat, wrapped in aluminium foil and stored 
at -70 C until use.  
 
Figure 2.2 Schematic representation of Franz diffusion cell used for in vitro 
Permeation studies. 
 
2.3.5.3 Determination of permeant binding to filter paper 
 
During in vitro permeation studies (Figure 2.2), filter paper was used to support the 
epidermal membrane. However, a potential for some permeants to bind to the filter 
paper on which the epidermis is laid has been reported previously (Akomeah et al., 
2004; Nanayakkara et al., 2005). This possibility was investigated by immersing 
circular pieces of filter paper, into a vial containing 5 mL of a standard solution (10 g 
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mL-1) of each permeant in phosphate buffer. Samples (200 l) were removed from the 
vial after 0.5,4,6 and 8 h and assayed using the HPLC methods described in section 
2.3.2. 
 
2.3.5.4 Effect of skin-filter paper composite 
 
In order to determine the effect of skin and filter paper on the assay method employed 
in this study, ‘simulated Franz cell’ diffusion experiments were carried out. A piece of 
human epidermal sheet (approximately 2 cm) was laid onto a filter paper and 
sandwiched between the donor and receptor chamber of the Franz cell (Figure 2.2).  
The receptor chamber was then filled with ~ 2 mL of a standard solution of the 
permeant in phosphate buffer. 
 
100 L of the same standard was also introduced into the donor chamber to ensure that 
no diffusional gradient was established. The assembled cell was then immersed into a 
water bath maintained at 37oC.  Samples (200 L) were removed from the receptor 
after 8 h only and analysed via HPLC. This experiment was performed using standard 
concentrations (g mL-1) of 0.5, 5, and 20 of each model permeant. Controls were also 
performed using phosphate buffer alone. 
 
2.4. Results  
2.4.1 HPLC method validation 
2.4.1.1 Calibration curve (linearity and range)  
 
A typical example of a standard HPLC/UV chromatograph (peak area against time 
(min)) generated in response to the injection of one of the model permeant is shown in 
Figure 2.3. The retention times were around 3.71 ± 0.07 min, 5.47± 0.08 min and 3.10 
± 0.07 min for MP, BP and CF respectively. Injections of phosphate buffer produced a 
steady baseline and no peaks were apparent which might coincide with the elution of 
any of the analytes (permeants) at the stated retention times.  The data in Figure 2.4 
show the linearity of the plots (between 0.2-20 µg mL-1) of peak area as a function of 
concentration.  
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Figure 2.3 HPLC Chromatogram of a standard comprising 20 µgmL-1CF in 15% v/v 





Figure 2.4 Linearity of HPLC calibration curves showing mean peak areas (absorbance 
units x10-4) as a function of concentration of methyl paraben ( ), butyl paraben ( ) 
and caffeine ( ) in phosphate buffer. The wavelength of detection (nm) was 254, 256 
and 270 for MP, BP and CF respectively. Data represent meansd (n=6). Error bars lie 
within the symbols. 
 
 
CF: y = 13.88x + 0.651
R² = 0.999
BP:  y = 21.98x + 6.773
R² = 1
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2.4.1.2 Precision (intra-and inter-day), accuracy, limit of detection and quantification 
 
The relative standard deviation (% RSD) gives a measure of the precision of the 
analytical method (Table 2.4). The accuracy of the method was 95-105%. The 
repeatability (intra-assay variation) of the analytical method was found to be ≤ 5% 
RSD on all occasions. 
 
Table 2.4 Intra- and inter-day repeatability and precision (%RSD) obtained from 
HPLC chromatograms for MP, BP and CF standards of different concentration 
prepared in phosphate buffer 
 
There were no differences in the inter-day measurement of the slopes of the calibration 
curves for any of the model permeants employed (Table 2.5). These data also indicated 
the stability of the permeants in phosphate buffer at room temperature (25-27oC) over 
the duration of the experiment. The consistency observed in the measurement of both 
inter- and intra-day parameters implied that the employed HPLC conditions in the 
analytical determination of the permeants under investigation were “fit for purpose”. 
The assays were considered to have sufficient sensitivity to measure the likely levels of 
Concentration 
µg.mL-1 
% RSD intra-day (n=12) % RSD inter-day (n=18) 
 MP BP CF MP BP CF 
       
0.2 1.43 1.3 1.67 1.87 1.71 1.94 
1 0.71 1.28 1.63 1.93 1.64 1.86 
5 0.33 1.13 0.43 0.92 1.17 1.72 
10 0.11 1.04 1.00 1.03 1.38 1.56 
15 0.21 0.45 1.82 1.23 1.13 1.12 
20 0.13 1.35 0.48 0.54 1.23 1.05 
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each model permeant traversing the different membranes into the diffusion cell 
receptor. 
 
Table 2.5 Linear regression analysis for calibration curves of MP, BP and CF on three 
different days, for peak area response (*104) plotted as a function of concetration 
 
Compound Day Intercept 
Standard 








       
MP 1 4.17 0.56 28.10 0.16 >0.999 
 2 4.54 0.56 28.07 0.34 0.999 
 3 4.14 0.43 28.05 0.25 >0.999 
       
BP 1 6.61 0.44 22.17 0.12 >0.999 
 2 7.00 0.40 21.99 0.18 >0.999 
 3 7.30 0.38 21.95 0.19 >0.999 
       
CF 1 0.62 0.30 13.87 0.22 >0.999 
 2 0.83 0.25 13.78 0.23 >0.999 
 3 0.79 0.25 13.81 0.14 0.999 
 
2.4.2 UV method validation 
Spectrophotometric scanning of the blank (control) samples of different oils and 
isopropanol did not yield any interference at the wavelengths selected to assay the 
permeants. Linear calibration curves comprising plots of absorbance as a function of 
concentration were obtained in all cases (Figure 2.5). The % RSD of the repeatability 
and reproducibility between all calibration points was ≤ 2 on different days. The LOD 
values obtained were 0.07, 0.04, 0.02 µgmL-1 for MP, BP and CF, respectively. 
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Figure 2.5 Calibration curves for UV method showing absorbance as versus 
concentration for methyl paraben ( ) butyl paraben ( ) and caffeine ( ). The 
wavelength of detection (nm) was 254, 256 and 270 for MP, BP and CF 
respectively. Data represent mean±sd (n=6). Error bars lie within the symbols. 
 
2.4.3 GC Analytical methods  
 
Three different methods were developed and validated for IHD/IPM, IHD/HD and 
IPM/HD. 
 
2.4.3.1 Calibration curve (linearity and range)  
 
When the mixtures of oils comprising IHD/IPM, IHD/HD and IPM/HD were 
injected onto the GC column, distinct separate and uniform peaks corresponding to 
the separate oils were obtained with retention times of IHD, IPM and HD at 12.48 ± 
0.33, 21.91 ± 0.35 and 16.61 ±0.27 min, respectively. No other peaks were apparent 
which might coincide with the elution of the oils appeared when heptane was 
injected. Examples of chromatograms (peak height (arbitrary units) against time 
(min)) corresponding to the output obtained when standard solutions of IHD/IPM 
and IHD/HD were injected onto the GC column are shown in Figure 2.6 and 2.7. 
CF: y = 0.049x + 0.043
R² = 0.999
BP: y = 0.101x - 0.018
R² = 0.999













Chapter 2.  Validation of analytical methods 90 
 
 
Figure 2.6 GC Chromatogram generated after injecting a heptane solution 
containing 0.1 mgmL-1 IHD and 0.1 mgmL-1IPM. 
 
 
Figure 2.7 GC Chromatogram generated after injecting a heptane solution 
containing 1 mgmL-1IHD and 1 mgmL-1 HD. 
 
Intra-day analysis (day1) of the standards prepared in heptane for the three different 
methods yielded correlation coefficient (R2) values exceeding 0.99 for IHD, IPM 
and HD (Figures 2.8, 2.9 and 2.10). The plots in Figure 2.8 show the linearity of the 
IHD/IPM method. Figure 2.9 shows the linearity of the IHD/HD method, and 
Figure 2.10 shows the linearity of HD/IPM method. The calibration curves were 
constructed (between 0.1-20 mg mL-1) of oil. 




Figure 2.8 GC calibration curves showing mean peak areas (arbitrary units) as a 
function of concentration (mgmL-1) of IHD ( ) and IPM ( ). Data represent 






Figure 2.9 GC calibration curves showing mean peak areas (arbitrary units) as a 
function of concentration (mg mL-1) of IHD ( ) and HD ( ). Data represent mean 
 sd (n=6). Error bars lie within the symbols. 
 
IHD: y = 5.562x - 0.330
R² = 0.999


















IHD: y = 13.53x - 0.320
R² = 0.999
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Figure 2.10 GC calibration curves showing mean peak areas (arbitrary units) as a 
function of concentration (mg mL-1) of IPM ( ) and HD ( ). Data represent 
meansd (n=6). Error bars lie within the symbols. 
 
2.4.3.2 Precision (intra- and inter-day), accuracy, limit of detection and 
quantification 
 
The % RSD provides a measure of the precision of the analytical methods for 
IPM/IHD (Table 2.6), IHD/HD (Table 2.7) and IPM/IHD (Table 2.8). The 
repeatability (intra-assay variation) of the analytical method was found to be ≤ 5% 
RSD on all occasions. The accuracy of the methods was 95-105%.  
 
Table 2.6 Intra- and inter-day repeatability and precision (%RSD) obtained from 
GC chromatograms for IHD and HD standards of different concentrations 
prepared in heptane 
HD: y = 5.932x + 1.738
R² = 0.997






















% RSD intra-day (n=12) % RSD inter-day (n=18)  
 IHD IPM  IHD IPM 
0.1 1.96 1.95  2.40 2.47 
1 1.5 1.46  2.04 2.41 
5 0.99 1.79  1.32 1.11 
10 1.24 0.94  2.37 2.27 
20 1.25 1.07  2.92 2.86 
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Table 2.7 Intra-and inter-day repeatability and precision (%RSD) obtained from 
GC chromatograms for IHD and HD standards of different concentrations 




% RSD intra-day (n=12) % RSD inter-day (n=18)  
 IHD HD  IHD HD 
0.1 2.52 1.63  2.66 2.50 
0.5 1.83 1.10  1.70 1.73 
1 1.25 1.62  1.60 2.35 
5 1.04 1.89  1.92 1.75 
20 1.79 2.11  1.80 2.70 
 
 
Table 2.8 Intra- and inter-day repeatability and precision (%RSD) obtained from 
GC chromatograms for IPM and HD standards of different concentrations 




% RSD intra-day (n=12) % RSD inter-day (n=18)  
 IPM HD  IPM HD 
0.1 2.55 2.36  2.75 2.90 
0.5 1.76 1.78  2.02 2.12 
1 1.88 2.70  1.95 1.96 
5 1.54 1.55  1.98 2.01 
10 1.11 1.06  2.50 2.12 
20 2.14 2.02  2.78 2.58 
 
There were also no differences in the inter-day measurement of the slopes of the 
calibration curves for any of the oils employed (Tables 2.9, 2.10 and 2.11). The 
assay was considered to have sufficient sensitivity for its application in this 
investigation.   
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Table 2.9 Linear regression analysis for calibration curves of IHD and IPM on 
three different days, for peak area response (*107) plotted as a function of 
concetration 
 




deviation of the 
intercept 
slope Standard 




       
IHD 1 -0.69 0.12 5.76 0.55 0.999 
 2 -0.50 0.09 5.49 0.29 0.999 
 3 -0.71 0.12 5.48 0.17 0.999 
       
IPM 1 -0.55 0.12 5.55 0.08 0.999 
 2 -0.39 0.15 5.43 0.27 0.999 




Table 2.10 Linear regression analysis for calibration curves of IHD and HD on 
three different days, for peak area response (*106) plotted as a function of 
concetration 
 
Compound  Day Intercept Standard 
deviation of the 
intercept 
slope Standard 




       
IHD 1 -0.59 0.68 13.13 1.02 >0.999 
 2 -0.86 0.68 13.88 1.14 >0.999 
 3 -1.23 0.61 13.49 1.02 0.999 
       
HD 1 0.29 0.43 14.35 0.90 >0.999 
 2 0.07 0.39 14.38 0.60 >0.999 
 3 0.12 0.50 14.22 1.01 0.999 
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Table 2.11 Linear regression analysis for calibration curves of IPM and HD on 
three different days, for peak area response (*107) plotted as a function of 
concetration 
 
Compound  Day Intercept Standard 
deviation of the 
intercept 
slope Standard 




       
IPM 1 0.90 0.04 4.84 0.73 0.998 
 2 1.17 0.11 4.75 0.66 0.998 
 3 1.25 0.10 4.56 0.59 0.999 
       
HD 1 1.20 0.14 6.09 0.78 0.998 
 2 1.77 0.19 5.96 0.33 0.998 
 3 1.49 0.10 6.01 0.82 0.999 
 
2.4.4 In vitro permeation method validation 
2.4.4.1 Membrane vehicle interference study 
 
No additional peaks were detected in the chromatograms of any of the oil samples 
analysed after 6 h incubation with any of the membranes. Therefore it appears that 
none of the oily vehicles leeched assay-interfering components in detectable 
amounts from the membranes. Accordingly, the analytical method appears to be ‘fit 
for purpose’ in assaying the proposed model permeants. 
 
2.4.4.2 Permeant-filter paper binding study 
 
Data from the permeant–filter paper binding experiments showed that 97.9-102% of 
each permeant could be recovered after 8 h incubation of any of the permeants with 
filter paper. These results are within acceptable range for this study, and the filter 
paper can be used as a support in the diffusion studies. 
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2.4.4.3 Skin-permeant assay interference 
 
HPLC analysis of the permeant after 8 h at 37oC showed that there was no 
disappearance of model permeants from the receptor chamber when incubated with 
the filter paper and human epidermis composite in the Franz cell using low, 
medium and high concentrations of each permeant (Table 2.12). These results 
confirmed that there is no loss of the permeants when incubated with the skin and 
filter paper. In the control experiments using oily vehicles and phosphate buffer, no 
interfering peaks were noted at any of the retention times corresponding to the 
model permeants.  
 
Table 2.12 The amount of MP, BP and CF expressed as a percentage (%) of the 
original standard concentration of model permeant recovered from receptor 




MP BP CF 
0.5 102.7 ± 4.2 97.2 ± 6.7 102.9 ± 4.7 
2 101.8 ± 10.3 97.9 ± 8.9 101.2 ± 7.6 




The HPLC experimental results for assay validation of the model permeants 
demonstrated linearity, specificity, accuracy, repeatability and precision values, 
which were considered satisfactory and fit for the purpose of carrying out the 
proposed studies i.e. to quantify the model solutes involved in the in vitro 
permeation studies. The method was validated in the concentration range from 0.2 
to 20 µgmL−1, the correlation coefficients were r2≥ 0.999. The estimated lower 
detection limits were 0.05, 0.05 and 0.06 µgmL−1 for MP, BP and CF respectively. 
The precision of an analytical procedure is an important parameter, and it is 
determined by the relative standard deviation (RSD). The experimental results 
indicate good repeatability and all the RSD values were no more than 2.00%. The 
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heat separation method used in this investigation to isolate the epidermis from the 
remaining skin tissues has been shown to result in the elimination of most of the 
skin’s enzymatic activity (Wester et al., 1998). Accordingly, as expected the HPLC 
method, employed in this study did not identify or quantify p-hydroxybenzoic acid, 
which is the major metabolite when the parabens undergo hydrolysis due to the 
enzymes present in the skin.  
 
Oils belong to a class of substance called lipids, and oils are usually liquid at room 
temperature. Gas chromatography is one of the most powerful analytical procedures 
for separating and analyzing the properties of lipids. It separates complex mixtures 
of different molecules based on their physical properties, such as polarity and 
boiling point. Gas chromatography in combination with flame ionization detection 
is the most commonly employed technique in the petrochemical and pharmaceutical 
industries for the assay of oils (Zeng et al., 2012). The operation of flame ionization 
detectors is based on the detection of ions formed during combustion of organic 
compounds in a hydrogen flame. The sample is passed into a hydrogen flame to 
oxidise (burn) organic molecules which produce electrically charged particles 
(ions). A polarizing voltage attracts these ions to a collector located near the flame 
producing an electrical signal, which is sensed by an electrometer. The generation 
of these ions is proportional to the concentration of organic species in the sample 
gas stream. The flame ionization detector is the most sensitive gas chromatographic 
detector for hydrocarbons (Yang et al., 2008; Matei et al., 2012).  
 
Typically gas chromatography analysis is suitable for organic and inorganic 
compounds that are vaporized at 400°C or less. Due to the high boiling points of 
oils the injector, column and detector temperatures must be kept high. Most 
available GC methods allow for high detector and injector temperatures, but a 
limitation is likely to be conferred by the nature of the capillary column available. 
Most available columns have a maximum temperature limit of 320°C or less, and 
since oleic acid has a boiling point of 370°C, the available columns were unsuitable 
for the detection of this oil. Liquid paraffin is a mixture of hydrocarbons oils from 
C10 to C25, and therefore it is not easily quantifiable by gas chromatography with a 
flame ionization detector. It is not a selective technique for the LP components, and 
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the mixtures of hydrocarbons produce a broad hump of unresolved components. 
However, it can be it can be used semi-quantitatively to determine the sum of the 
saturated hydrocarbons or aromatic hydrocarbon, with specified molecular mass 
ranges available in a sample (Biedermann et al., 2009). 
 
The boiling points of IHD, HD and IPM are below 300°C and methods for mixtures 
of IPM/IHD, IHD/HD, and IPM/HD were designed, developed and validated. The 
chromatographic conditions (temperature programming) were optimized to achieve 
sufficient resolution of the analytes while maintaining the run-time as short as 
possible. To achieve full evaporation of the sample, the detector temperature was 
chosen to be higher than the boiling point of the two oils. Heptane was chosen as a 
solvent since it has the ability to dissolve the oils but is thermally stable and also 
volatile. Samples were found to be stable in heptane for one week (although, no 
further stability time points were completed after one week, since all analytical 
testing of samples was conducted within one week of sample preparation). Since the 
oils used were all hydrophobic the column employed was non polar silica, in order 
to achieve adequate separation. In GC analysis, in order to obtain the best peak 
shape and maximum resolution, a small sample size should be used; therefore a 
split mode was used to dilute the concentration of the sample. When a sample is 
introduced into the heated small chamber via a syringe through a septum, the heat 
facilitates volatilization of the sample. The carrier gas then either sweeps the 
entirety (splitless mode) or a portion (split mode) of the sample into the column. In 
split mode, a part of the sample/carrier gas mixture in the injection chamber is 
exhausted through the split vent. Split injection is preferred when working with 
samples with high analyte concentrations (>0.1%) whereas splitless injection is best 
suited for trace analysis with low amounts of analytes (<0.01%).  
 
The complete separation of the compounds of interest is always the primary goal in 
any chromatographic separation method. The methods were validated in the 
concentration range from 0.1 to 20 mgmL−1, with high correlation coefficients (r2≥ 
0.99), and estimated lower detection limits of 0.05 and 0.05 mgmL−1 for IHD and 
IPM respectively; 0.03 and 0.03mgmL−1 for IHD and HD respectively; and 0.08 and 
0.06 mgmL−1 for HD and IPM respectively. The experimental results indicate good 
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repeatability and all the RSD values were not more than 5.00%. Generally branched 
alkanes elute first, followed by the normal alkanes (Zeng et al., 2012), which was 
demonstrated by the IHD having a shorter elution time than HD. The degree of 
resolution, between two peaks, appears to be a good measure of the separating 
power of capillary columns (Szopa et al., 2000). All the methods achieved high 
resolution between the two peaks. The retention times for the three different oils 
that formed components of binary mixtures being approximately 12.28 ± 0.33 16.61 
± 0.27 and 21.91 ± 0.35 min for IHD, HD and IPM, respectively. Therefore, 
analytical conditions such as column type, column temperature and carrier gas flow 
rate etc. allowed a baseline separation to be achieved. IPM was assayed using GC 
analysis in previous studies however different analysis conditions were used in this 
investigation (Klaffenbach & Kronenfeld, 1997; Liu et al., 2009). The designed GC 
method experimental results, for the validation of the assay of IHD, HD and IPM 
mixtures, were considered satisfactory to quantify the amount of oils sorbed by the 
silicone membrane. 
 
It was planned to employ a series of synthetic and epidermal membranes to study 
the diffusion of model permeants from different oily vehicles; therefore it was 
necessary to check that there was no interference from the oily vehicles and 
membranes in the assay of model permeants. A simulated diffusion experiment was 
carried out, where an oily vehicle introduced to the donor compartment and the 
receptor solution was assayed after 6 h. It was shown that there is no interference 
due to components being solubilised from the membranes. No peaks appeared in the 
chromatograms. 
 
During the skin permeation studies, filter paper was placed underneath the 
epidermis in order to facilitate handling. However there is the potential for 
permeants to be sordebd by the paper or for the epidermis to introduce components 
into the solution leading to interference with the assay. Such phenomena, if they 
occurred, would adversely affect the estimation of the in vitro skin permeation 
parameters. The potential for assay interference and sorption was investigated by 
incorporating a skin-filter paper composite in a Franz cell. Solution containing the 
same active concentration of each permeant was introduced into both the donor and 
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receptor compartments in order to simulate potentially the experimental design but 
also ensure that there was no diffusional gradient. Analysis of the permeant 
concentration after 8 h showed that there was no sorption of the permeants by the 
epidermis or the filter, and the loss of the permeants was negligible (recovery ≥ 
97%). Other authors have reported the lack of interference for the model permeants 
used with filter paper and human epidermis (Akomeah et al., 2004; Nanayakkara et 
al., 2005). The model permeants used in this study have been frequently used in 
skin permeation studies investigating the influence of permeant lipophilicity (Twist 
and Zatz, 1988 a&b; Kitagawa et al., 1997; Godwin & Michniak, 1999; Akomeah et 
al., 2004; Nanayakkara et al., 2005; Dias et al., 2007; Oliveira, 2010).  
 
In conclusion, the Franz cell method appeared to provide a viable mean of assessing 
the in vitro diffusion of the selected model permeants. The assay methods would 
allow an adequate quantification of the diffusion of permeants from different 
vehicles through various membranes. The HPLC assay was found to be “fit for 
purpose”, and the GC method can be used to quantify the amount of oils sorbed by 
silicone membranes. 
 
















DIFFUSION OF MODEL PERMEANTS 













3.1.1 Partition diffusion process 
 
In order for a topically applied drug to cross a membrane, the drug must first be 
dissolved in the vehicle/formulation; it then diffuses to a region where it can 
partition into the membrane from the vehicle, diffuses through the membrane and 
then partitions into the receiver fluid in vitro or in vivo, to lower dermal layers or 
the circulation. The physicochemical properties of the permeation barriers (i.e. the 
membranes) are one of the major rate determinants for transport (Higuchi et al., 
1981; Martin, 1981). It includes the lipophilic character of the membrane, the 
presence of water pores and the membrane surface area available for absorption 
(Levine, 1970; Higuchi et al., 1981; Siepmann & Peppas, 2011). As discussed 
previously (Section 1.9.2) there is a requirement in certain studies to employ non-
biological membranes. These are categorized generally into two classes: barrier 
membranes and porous membranes. As suggested by the name, barrier 
membranes have no pores and the drug will diffuse by "molecular permeation”. 
Drug partitions into the membrane because it has some affinity for the membrane, 
then it will move from an area of high chemical potential to one with lower 
potential, and this ultimately leads to an equalisation of the chemical potential of 
the molecules throughout the membrane. Passive diffusion of a molecule through 
a membrane is controlled by several factors, including the solubility of the 
molecule, lipophilicity, molecular size and the concentration on either side of the 
membrane. A porous membrane allows small molecules to diffuse through the 
aqueous-filled pores, although the properties of the diffusing molecule, such as its 
size, shape, charge and aqueous solubility are critical determinants of the rate. 
 
3.1.2 Formulation components affecting flux across membrane 
 
The rate of transport of drugs from simple vehicles across the stratum corneum 
will often be insufficient to achieve therapeutic drug concentrations at the site of 
action. Simple vehicles are defined as those in which the drug is at or close to 
saturation solubility, and neither the vehicle nor the drug has any interaction with 
Chapter 3.  Diffusion of model permeants from oil blends 103 
 
the stratum corneum which might reduce the barrier function of the latter (Davis 
et al., 2002). In simple vehicle systems, a large difference in the rate of skin 
penetration can occur between two vehicles that contain a fixed drug 
concentration. Depending on the saturated solubility of the drug in each vehicle, 
vehicles in which the drug is at or near saturation will show enhanced drug 
penetration, compared with those in which the drug is sub-saturated (Ostrenga et 
al., 1971; Lippold, 1984). However, in many cases certain formulation 
components might also interact with the membrane, changing its physicochemical 
properties and consequently modulating solute transport. Hence, passive 
permeation enhancement can be achieved either by increasing the thermodynamic 
activity of the drug, or by using vehicles that could interact with membranes. A 
possible approach to increasing the thermodynamic activity of a drug is through 
the use of supersaturated systems, discussed in detail in Section 1.7.2, which was 
first proposed by Higuchi (1960). Supersaturated systems that are stabilized have 
been shown in a number of studies to enhance drug thermodynamic activity 
(Coldman et al., 1969; Davis & Hadgraft, 1991; Henmi et al., 1994; Pellett et al., 
1994 & 1997; Raghavan et al., 2001 a&b; Santos et al., 2009). 
 
A number of surfactants or solvents have been incorporated into transdermal 
delivery systems to act as permeation enhancers; for example low molecular 
weight alcohols, polysorbates, OA, azone, IPM, non-ionic surfactants, isopropyl 
palmitate, propylene glycol, hydrocarbon esters and urea (Embery & Dugard, 
1971; Barry & Bennet, 1987; Hadgraft, 1993; Abraham, 1997; Paudel et al., 2010; 
Lane, 2013). Vehicles can therefore either promote an increase in diffusivity 
within the barrier membrane and/or enhance the partitioning properties into the 
membrane. Diffusion enhancement is mediated by vehicles that could intercalate 
with the lipid bilayers and disrupt their packing or fluidize them. Some of these 
penetration enhancers have also been employed as vehicles, they have been 
reported to exist as discrete phases in the intercellular lipid domains, these include 
for example OA, IPM, azone and alcohols (Wiechers et al., 1987; Hirvonen et al., 
1994; Leopold & Lippold, 1995; Harrison et al., 1996; Clarys et al., 1998; 
Engblom et al., 1998; Degim et al., 1999; Ongpipattanakul et al., 1999; Lane, 
2013).  
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Partition of permeants from vehicles will be dictated by the creation of a more 
favourable environment for increased solubility of the drug. The latter will be 
mediated by those solvents which are well taken up into the skin and/or which are 
also good solvents for the molecule of interest, for example propylene glycol 
(Lane, 2013). Synergy between these prime mechanisms has been demonstrated 
using a number of different systems including, for example, propylene glycol and 
terpenes, OA and propylene glycol and azone plus propylene glycol (Wotton et 
al., 1985; Davis et al., 2002; Rosado et al., 2003). The drug in the formulation can 
interact with the skin layers during percutaneous penetration, which might result 
in a slowed or more limited absorption. This interaction might be reversible or 
irreversible. However when the drug binds to a speciﬁc site in the skin, this might 
produce a physiological response, which can be either a therapeutic or non-
therapeutic (i.e. unwanted or toxic) reaction. Also drugs might accumulate or be 
retained in the skin or membranes since this can occur as a result of relatively high 
drug partition, associated with slow drug diffusivity or drug crystallisation (Lane, 
2013). These processes might contribute to the reservoir capacity of the skin for 
certain compounds. Lower layers of the skin comprise a metabolically active 
region and therefore some drugs may undergo metabolism during the process of 
permeation (Sections 1.1.2.1 and 1.7.3).  
Chapter 3.  Diffusion of model permeants from oil blends 105 
 
3.2 Aims and Objectives 
 
Oils are generally assumed to be inert and not to interact with non-biological 
membranes. The aim of this study was to evaluate and compare the effect of oils 
and different oil blends on the solubility and diffusion of three model permeants 
of differing lipophilicity but similar molecular weight through a synthetic 
membrane. The diffusion of the respective compounds would be correlated with 
their physiochemical properties. In order to fulfil these aims the following 
objectives were developed: 
 
1. To determine the solubility of model permeants in the receiver phase, oils and 
oil mixtures. 
 
2. To study permeant release from oily vehicles using cellulose acetate nitrate 
(non-rate limiting) membranes. 
 






The materials used in these studies are listed in Table 2.2 
 
3.3.2 Solubility studies  
 
Solubility studies were conducted by adding an excess amount of each model 
permeant separately to deionized water, phosphate buffer pH 7.0, IPM, IHD, LP, 
HD, OA and to different blends of oils. The suspensions were vortexed briefly 
and further agitated at 32ºC in a shaking water bath at 110 rpm for around 48 h. 
After equilibration, the suspensions were filtered through 0.25 µm pore-size 
Teflon membrane filters (chosen to achieve minimal permeant adsorption) and the 
resultant solutions diluted. IPM, OA and IHD were diluted with isopropanol, HD 
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was diluted with n-hexane:isopropanol (50:50). LP was diluted with 
IHD:isopropanol co-solvent. This was because LP was not dissolved in 
isopropanol alone therefore IHD was added as a co-solvent (1500 mL isopropanol 
mixed with 300 mL IHD). The concentration of the permeant in each sample was 
determined using UV spectrophotometry (Section 2.3.3). Experimental data 
presented represent the mean (±SD) value (n = 4). 
 
3.3.3 Franz cell studies  
3.3.3.1 Cellulose acetate nitrate membrane  
 
The release rate of MP, BP and CF through cellulose acetate nitrate membranes 
from the saturated suspensions was determined using individually (volume) 
calibrated Franz cells. The donor compartments were prepared by adding excess 
drug to 10 g of oil. The flask containing the suspension was placed in a shaker 
water bath overnight at 32˚C. Diffusion experiments were carried out using 
(volume) calibrated Franz cells with a receptor phase of 20 mL and a diffusional 
area of 3.8 cm2. Before the experiment the membrane was immersed and soaked in 
the receptor medium overnight. The membrane was cut into circular discs and 
placed between the donor and the receptor compartments of the Franz cell. The 
receptor compartment was carefully filled with phosphate buffer pH 7.0, after 
which the receptor temperature was maintained at 32C by immersion in a 
temperature-controlled water bath. A small Teflon-coated magnetic bar 
(approximate length 5 mm) was included in the receptor compartment such that 
stirring occurred throughout the duration of the experiment. After allowing the 
membrane to equilibrate with the receptor fluid, 2 mL of the oily suspension (the 
sample contained undissolved/suspended solids of permeants at 32oC) of model 
permeant was then introduced into the donor. The experiments were conducted 
under occlusion (covering the donor compartment with parafilm) for 6 h using 
suspensions of MP, BP and CF respectively. At appropriate time intervals, 200 μL 
samples were withdrawn from the receptor compartment and immediately replaced 
with an equal volume of fresh phosphate buffer, (pH 7.0). Each sample was 
analysed for drug by HPLC (Section 2.3.2). The concentration of the permeant in 
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the receptor solution at any time point was corrected for previous sample removal. 
Each experiment was conducted three times. 
 
Fick’s law of passive diffusion cannot be directly employed in porous membranes 
therefore, Hatanaka et al., (1990) modified Fick’s Law to allow the fact that drug 
transport across a porous membrane was via the pores, thus the tortuosity and 
porosity factor of a membrane were included in a modified equation  
 J	 = 	Dv. K′. ε. Cv	/τ. h      Equation 3.1 
 
Where J is flux, Dv is the diffusion coefficient of the permeant into the vehicle that 
fills in the membrane pore. K' is the partition coefficient of the permeant between 
the solvent in the membrane pore and the vehicle, ε is membrane porosity, τ is 
tortuosity, Cv is permeant concentration in vehicle and h is membrane thickness. 
 Cv = av/ɣv       Equation 3.2 
 
Where αv is the thermodynamic activity of the drug in the vehicle and ɣv the 
activity coefficient of the drug in the vehicle. 
 
The cumulative amounts (per unit surface area of membrane) of permeant which 
diffused across cellulose acetate nitrate membrane were plotted against time (h). 
The slope of the linear plot was taken as the rate of permeation. 
 
3.3.3.2. Silicone membrane  
 
The diffusion of the model permeants from suspension was examined using 
silicone membrane. The permeation experiments were conducted as described 
previously (Section 3.3.3.1). However, calibrated Franz cells with a receptor phase 
of 2 mL and a diffusional area of 0.65 cm2 were also used in some diffusion 
studies. The suspension volume applied in the small cells was 200 µL. 
 
The cumulative amounts (per unit surface area of membrane) of permeant which 
diffused across silicone membrane were plotted against time (h). The slope of the 
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linear plot was taken as the flux of permeant permeation. The permeability 
coefficient (KP, cm h-1) for each solute was calculated as follows: 
 Kp	=	Js	/	Cv       Equation 3.3 
Cv is concentration of the penetrant in donor solution (saturated solubility of the 
penetrant in oil). 
 
3.4 Results 
3.4.1 Solubility studies of model permeants in donor/receptor fluid and deionised 
water 
 
The solubility data of the model permeants in different oils, deionised water and 
buffer are shown in Table 3.1. The solubility of model permeants in different oil 
blends of IHD and HD are shown in Figure 3.1. The solubility of permeants in the 
aqueous vehicles was in the order of CF>MP>BP (mole.mL-1), which is in 
accordance with the relative hydrophilicity of the permeants. While in oily 
vehicles the solubility of all permeants in OA and IPM was shown to be higher 
than in IHD, LP and HD. There was no significant difference in the solubility of 
each permeant, considered individually in HD, IHD or LP. Blending HD, LP or 
IHD with either OA or IPM increased the solubility of the permeants compared 
with IHD, HD and LP. 
 
Table 3.1 Solubility (mg mL-1) of the model permeants in IPM, OA, IHD, HD, LP, 
deionised water and phosphate buffer at 32°C 
Vehicle BP MP CF 
IPM 120.80 ± 2.60 35.04 ± 1.15 0.83 ± 0.02 
OA 60.58 ± 1.16 6.58 ± 0.11 5.08 ± 0.20 
IHD 1.32 ± 0.01 0.09 ± 0.01 0.07 ± 0.00* 
HD 1.23 ± 0.01 0.08 ± 0.01 0.07 ± 0.00* 
LP 1.21 ± 0.02 0.07± 0.01 0.08 ± 0.00* 
buffer 0.25 ± 0.01 2.39 ± 0.07 25.72± 0.63 
DIW 0.26 ± 0.01 2.01 ± 0.04 26.40 ± 0.32 
Data are expressed as mean ± sd (n≥ 4), * sd ≤ 0.009  
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(a)  (b) 
 
(c)      (d) 
 
(e)      (f) 
 
Figure 3.1 Solubility (mg mL-1) in 100 % IHD, OA(), IPM(), LP(), HD(x) and 
different oil blends containing IHD or HD at 32°C (a) MP solubility in IHD 
blends (b) MP solubility in HD blends (c) BP solubility in IHD blends (d) BP 
solubility in HD blends (e) CF solubility in IHD blends (f) CF solubility in HD 
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3.4.2 Franz cell studies 
3.4.2.1 Cellulose acetate nitrate membrane diffusion studies from oils and oil 
combinations 
The diffusion through the cellulose acetate nitrate membrane is predominantly 
through phosphate buffer filled pores. Therefore such diffusion depends on the 
relative affinity of the penetrant for the oily phase and phosphate buffer. The 
cumulative amounts of MP were higher than BP due to the higher affinity of MP 
into the buffer. Figures 3.2 and 3.3 show the cumulative amount of MP and BP 
permeated through cellulose acetate nitrate from pure oils. The cumulative amount 
of CF permeated through cellulose acetate nitrate membrane from different oils is 
shown in Figure 3.4, with the rate of permeation appearing to decrease after 3 h. 
 
 
Figure 3.2 The cumulative amount of MP diffusing through cellulose acetate 
nitrate membrane into the receptor compartment from the different vehicles as 
a function of time () HD () IHD (x) LP (*) OA and () IPM. Data 
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Figure 3.3 The cumulative amount of BP diffusing through cellulose acetate 
nitrate membrane into the receptor compartment from the different vehicles as 
a function of time () HD () IHD (x) LP (*) OA and () IPM. Data 
represent mean ± sd (n≥3). Error bars lie within the symbols. 
 
Figure 3.4 The cumulative amount of CF diffusing through cellulose acetate 
nitrate membrane into the receptor compartment from the different vehicles as 
a function of time () HD () IHD (x) LP (*) OA and () IPM. Data 
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The derived permeation rates of MP and BP through cellulose acetate nitrate 
membrane from different oil blends are shown in Figures 3.5, 3.6 and 3.7. The data 
show that the highest amount of MP that permeated was from IPM/IHD blends, 
while the highest amount of BP was from LP/IHD blends. For both MP and BP, the 





Figure 3.5 Rates of permeation obtained for MP diffusion through cellulose 
acetate nitrate membrane from different oil combinations comprising IHD with 
() LP () IPM (x) HD and () OA. Data represent mean ± sd (n≥3). Error 



































Figure 3.6 Rates of permeation obtained for BP diffusion through cellulose 
acetate nitrate membrane from different oil combinations comprising IHD with 
() LP () IPM (x) HD and () OA. Data represent mean ± sd (n≥3). Error 
bars lie within the symbols. 
 
Figure 3.7 Rates of permeation obtained for () MP and () BP diffusion 
through cellulose acetate nitrate membrane from different oil combinations 
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3.4.2.2 Silicone membrane diffusion studies from oils and oil combinations 
The results obtained from the diffusion studies from different oil blends indicated 
that after a lag time, a linear correlation existed between the amount of penetrant 
and time. The linear portion of the curve was used to calculate a flux. The 
correlation coefficients (R2), expressing the linearity of the plots were found to be 
≥ 0.98 for the diffusion of permeants from all of the vehicles. The permeation 
profile of the model penetrants from the different vehicles across silicone 
membrane is depicted in Figures 3.8-3.10. The highest amounts of MP and CF 
that diffused through silicone membrane were from IPM, while the highest 
amount of BP was from IHD. The lowest amount of BP and CF were attained 
when OA was used as a vehicle, while the lowest amount of MP that diffused 




Figure 3.8 The cumulative amount of MP diffused across silicone membrane into 
the receptor compartment from the different vehicles as a function of time () HD 
() IHD (x) LP (*) OA and () IPM. Data represent mean ± sd (n≥3). Error bars 































Figure 3.9 The cumulative amount of BP diffused across silicone membrane into 
the receptor compartment from the different vehicles as a function of time () HD 
() IHD (x) LP (*) OA and () IPM. Data represent mean ± sd (n≥3).Error bars 





Figure 3.10 The cumulative amount of CF diffused across silicone membrane into 
the receptor compartment from the different vehicles as a function of time () HD 
() IHD (x) LP (*) OA and () IPM. Data represent mean ± sd (n≥3). Error bars 
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Table 3.2 shows the calculated flux values and permeability coefficient (Kp) for the 
model permeants through silicone from different oils. 
 
Table 3.2 Silicone membrane permeation parameters permeability coefficients and 
























The influence of IHD content when present in binary mixtures of oil on the flux 
of MP, BP and CF is shown in Figure 3.11, Figure 3.13 and Figure 3.15 
respectively. Corresponding flux data for MP, BP and CF from HD binary blends 
Permeant Vehicle Js(g cm-2 h-1) KP (10-2 cm h-1) 
MP IHD 135.5  3.3 139.7  3.4 
 IPM 560.5  7.3 1.6  0.02 
 OA 56.7 0.9 0.86  0.01 
 HD 68.4 1.4 86.4  1.8 
 LP 39.1 4.2 55.9  6.01 
    
BP IHD 246.8  9.1 18.70  0.7 
 IPM 161.6  1.4 0.13  0.002 
 OA 65.8  1.3 0.11  0.003 
 HD 89.8  1.5 7.30  0.12 
 LP 66.7  0.3 5.51  0.02 
    
CF IHD 48.2  1.7 65.1 2.3 
 IPM 69.3  5.1 8.3  0.4 
 OA 7.9  0.5 0.16  0.01 
 HD 25.3  1.7 34.2  2.3 
 LP 13.8  0.6 17.9  0.8 
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are shown in Figure 3.12, Figure 3.14 and Figure 3.16 respectively. The highest 
fluxes were attained by blending IPM with IHD. The highest flux of MP and CF 
was from 100% IPM and the flux decreased as IHD or HD was added. However 
the highest flux of BP was obtained when it was applied as a suspension in a 75% 
IHD/25% IPM mixture. The diffusion of MP from OA/IHD blends was at a 
maximum when suspended in a blend containing between 50 – 75% IHD (i.e.50 – 
25% OA) content (Figure 3.11). With CF the maximum flux was attained from a 
vehicle containing a blend of 75% IHD (25% OA) (Figure 3.15). The flux from 
all oils was higher than from the aqueous buffer for all model permeants through 
silicone membrane; the fluxes from phosphate buffer being 41.71  1.01, 27.88  






Figure 3.11 Flux values obtained for MP diffusion through silicone membrane 
from different oil combinations comprising IHD with () LP () IPM (x) HD 























% IHD in different oils
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Figure 3.12 Flux values obtained for MP diffusion through silicone membrane 
from different oil combinations comprising HD with () LP () IPM. Data 




Figure 3.13 Flux values obtained for BP diffusion through silicone membrane 
from different oil combinations comprising IHD with () LP () IPM (x) HD 
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Figure 3.14 Flux values obtained for BP diffusion through silicone membrane 
from different oil combinations comprising HD with () LP () IPM. Data 





Figure 3.15 Flux values obtained for CF diffusion through silicone membrane 
from different oil combinations comprising IHD with () LP () IPM (x) HD 
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Figure 3.16 Flux values obtained for CF diffusion through silicone membrane 
from different oil combinations comprising HD with () LP () IPM. Data 
represent mean ± sd (n≥3). Error bars lie within the symbols. 
 
3.5 Discussion  
 
The measurement of the solubility of the permeants in phosphate buffer (pH 7.0) 
was essential in determining whether that medium could be used as receptor fluid, 
so as to ensure the maintenance of sink conditions during diffusion studies. Sink 
conditions should prevail throughout the Franz cell experiments, in order to 
maintain the concentration gradient as constant as possible without back-diffusion 
occurring (Higuchi, 1960). Thus, the concentration of permeant in the receptor 
fluid should remain low throughout the course of the diffusion study. Sink 
conditions have been defined practically as a situation when the thermodynamic 
activity in the receptor does not exceed 10% of the saturated solubility of 
permeant in the vehicle (Higuchi, 1960; Siepmann & Peppas, 2011). Accordingly, 
adequate solubility of the permeant in the receptor solution is essential so that its 
partition into the receptor fluid does not become dissolution- and diffusion-rate 
limiting. Earlier studies (Kitagawa et al., 1997; Dias et al., 1999; Akomeah et al., 























% HD in different oils
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suitability of using phosphate buffer as a receptor fluid in Franz cell studies in 
order to maintain sink conditions for the three model permeants.  
 
Measurement of the solubility of drug in the vehicle is an important parameter for 
both the drug permeation studies and in determination of the degree of saturation. 
CF, a relatively hydrophilic molecule was shown to be more soluble in an 
aqueous solvent than in the oily vehicles; with CF solubility being in the order 
OA>IPM>LP, IHD and HD. Since MP has moderate lipophilicity compared to BP 
and CF it was found to have intermediate solubility in both the aqueous and oily 
vehicles. The order of solubility for MP and BP in oily vehicles was 
IPM>OA>IHD, HD and LP.  
 
The solubility of each of the three permeants in LP, HD and IHD were not 
significantly different. Also no significant difference was found between their 
solubilities in oil combinations of IHD, HD and LP and the pure oil. These latter 
three oils are hydrocarbons and having similar chemical basis to their chemical 
structure and all form only either weak van der Waals forces or dispersion 
interactions with the model permeants. IPM is an ester with a long hydrophobic 
tail, and OA contains a cis unsaturated double bond and a carboxylic group within 
its structure (Figure 2.1). Therefore, IPM and OA have the ability of forming 
polar interactions as well as van der Waals interactions with the permeant. All 
permeants were found to have a higher solubility in IPM and OA compared with 
HD, IHD and LP. When OA and IPM were blended with any of the other oils the 
solubility of the model permeants generally were increased. The results are in 
general agreement with published results, for example the solubility of CF in IPM 
and OA has been reported previously as 0.93 ± 0.08 and 5.27 ± 0.06 mg/mL 
respectively at 32◦C (Dias et al., 2007a). MP was found to have a solubility of 
39.00 mg/mL in IPM at 32◦C (Oliveira et al., 2008) and MP, BP and CF solubility 
in de-ionized water had reported values of 2.16, 0.22, 21.88 mg/mL in DIW at 
25◦C (Akomeah et al., 2004). 
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Artificial membranes may be used during the development of a formulation to aid 
in the process of selecting a vehicle and excipients or alternatively as a quality 
control tool (Flynn et al., 1999). There are potentially a large number of bi-
component mixtures that can be generated from the oils used in the current study, 
and indeed the oils are frequently present as mixed blends in pharmaceutical and 
cosmetic products. Since the potential array of oil blend (and oil blend-permeant) 
combinations available to choose for study, the effects of selecting a few random, 
representative combinations on permeation of incorporated diffusants were 
examined. The use of cellulose acetate nitrate membrane allows the permeation 
through buffer-filled pores to be monitored, in the absence of a rate limiting 
continuous membrane. The permeants were all released readily from the vehicles 
and permeated the porous membrane relatively quickly.  
 
The permeabilities of MP and BP through cellulose acetate nitrate membrane 
from different oil blends are shown in Figures 3.5, 3.6 and 3.7. According to 
Equation 3.1 and 3.2 the release of a permeant through a porous membrane 
depends on the partition coefficient, diffusion coefficient, the thickness of the 
membrane, membrane porosity and tortuosity and also on the thermodynamic 
activity of the permeant in the vehicle which in turn are determined by the 
concentration and activity coefficient of the drug in the vehicle. It might be 
assumed that the properties of the cellulose acetate nitrate membrane are affected 
primarily by the buffer rather than the oily vehicles. Since buffer was present in 
all permeation experiments then it is possible that the membrane thickness, 
porosity and tortuosity will remain reasonably constant between experiments. 
However this would not be the case if the vehicle does interact with the 
membrane matrix. Another factor which affects the diffusion through the pores of 
the membrane is the activity coefficient of the drug in the vehicle, which also 
might result in the differences in the partitioning of the drugs into the buffer.  
 
Differences between the diffusion of MP (Figure 3.2) and BP (Figure 3.3) through 
cellulose acetate nitrate membrane, are partly attributable to the differences in the 
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partitioning of the drug from the oil into the buffer which fills the membrane 
pores (since the membranes were soaked in the buffer before initiating the 
experiment). The difference in the amounts of penetrant diffusing was therefore 
related to magnitude of its aqueous solubility, its partitioning properties between 
the vehicle and buffer, and the activity coefficient of the drug in the vehicle. Also 
an interaction between the vehicle and membrane matrix has to be considered. In 
addition oils may perhaps displace the bound water within the pores of the 
cellulose acetate nitrate membrane, or interact with the unbound water in the 
pores (OA and IPM) which in turn would affect the pore structure and shape, or 
the matrix of the membrane (Kamo et al., 1992; Barbe et al., 2000; Wang et al., 
2004). Any of these effects might influence the permeation of the penetrant 
through a ‘modified’ membrane. 
 
The important factors influencing the release of permeants from a vehicle into the 
receptor phase are the solubility in the vehicle and the partition coefficient 
between the vehicle and the receptor phase (Coldman et al., 1969). Higuchi 
(1960) predicted that the drug solubilising capacity of the vehicle in excess of that 
needed to dissolve the desired dose of drug can lead to a decrease in the rate of 
the drug delivery from that vehicle, i.e. as the solubility of the drug in the vehicle 
increases, the partition coefficient into a receptor phase decreases; the two effects 
tending to cancel each other (Poulsen et al., 1968). The higher release rate of MP 
compared with BP and CF is due to the mid-range partition coefficient of MP that 
will aid in its partition into the buffer. The partition coefficient of BP between oil 
and buffer was predicted to be lower than MP, due to its lower solubility in the 
buffer. The low partition coefficient. reflects the higher tendency BP to remain in 
the vehicle, such that the flux values of BP were lower than those of MP. 
 
The amount of CF released was in the order of OA>IPM>LP>IHD, HD. The 
highest amount of CF that permeated through the porous membrane was from 
OA. This might be attributed to the higher ability of OA to dissolve CF compared 
with other oils; therefore more drug is likely to be solubilised by OA entrapped 
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within the pores, such that CF from OA might have a shorter diffusion path to the 
receptor phase compared with other oils. There were no significant differences in 
either the solubility of CF in HD and IHD or its partitioning properties between 
the oil and the buffer. This is likely to account for the finding that there was no 
difference in the release of CF from the two oils.  
 
The results of CF permeation (Figure 3.4) through cellulose acetate nitrate 
membrane correlated well with the solubility of CF in the oil. When the CF 
molecules partition from the donor to the receptor through the membrane pores, 
the amount lost should be compensated by the dissolution of un-dissolved drug 
from the excess particles suspended in the donor compartment. The viscosity of 
the oil may influence the dissolution rate of the drug, its diffusion through the 
donor vehicle, and its diffusion through the oil-filled regions of the membrane 
pores. However due to the high solubility of CF in the buffer and low solubility in 
the oils, the amount released may not have been quickly restored by the 
suspended particles, therefore the concentration of CF in the donor compartment 
(Cv) decreased with time such that the permeation slowed after the third hour. 
 
In vitro experiments were performed using systems having the same 
thermodynamic activity. The flux of a permeant across a non-porous barrier 
membrane (Equation 3.3) is known to be directly proportional to its applied 
concentration as a consequence of the thermodynamic activity or ‘leaving 
potential’ of the permeant (Equation 3.2) (Hadgraft et al., 2001). Previous 
experiments (Twist & Zatz, 1986) using rate-limiting (silicone) membranes have 
shown that the flux of permeant from saturated aqueous systems of different 
solubilities will yield the same flux as long as the vehicle and its components do 
not interfere (or interact to a similar extent) with the membrane. This was 
observed by permeation of a series of parabens across silicone membranes (Twist 
& Zatz, 1986). Using non-interactive solvents and mixtures of non-interactive 
solvents, the latter authors observed that saturated solutions produced similar 
fluxes of parabens, despite the differences in parabens solubility within these 
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vehicles. Saturated systems were therefore used in this investigation to ensure 
equal thermodynamic activity of the permeant in the chosen vehicles, with excess 
solute being present so as to maintain saturation throughout the experiment. Thus, 
any drug lost from the solution by diffusion was replenished by dissolution of the 
excess drug. This methodology allows any effects of the vehicle on the diffusion 
of permeants through the membrane to be determined. The use of silicone (rate-
limiting) membranes to study diffusion kinetics has been employed previously in 
permeation studies as a means of mimicking the lipoidal component of the 
stratum corneum membrane (Hatanaka et al., 1990; Cappel & Kreuter, 1991; 
Hayashi et al., 1992; Maitani et al., 1995; Pellett et al., 1997a; Müller & Kreuter, 
1999; Valenta et al., 2000; Du Plessis et al., 2001, 2002; Dias et al., 2003).   
 
The highest fluxes were achieved using MP as a permeant, which has mid-range 
physicochemical properties (when compared with BP and CF), as indicated by 
both the solubility data, as well as the octanol-water partition constant (Log P in 
Table 2.1). Its moderate lipophilicity promotes its permeation through the 
hydrophobic silicone membrane. Also its high solubility in the oil will quickly 
restore any amount lost by diffusion. The higher log P of BP enhances the 
partitioning of the compound into the hydrophobic silicone membrane, but the 
smaller size of MP maximises the diffusion of the compound through the 
membrane (Magnusson et al., 2004). According to the rule ‘like dissolves like’ 
the solubility parameter of BP is the closest to the solubility parameter of silicone 
membrane (Tables 2.1 and 4.2), therefore the former might be expected to 
partition favourably into the membrane, but its lower partitioning (compared with 
MP) into the buffer decreases the overall net flux. The higher diffusion rates 
recorded for MP in comparison to BP and CF may occur as a result of its adequate 
solubility both in oil and water.  
 
When there is no interaction between the vehicles and the membrane, all saturated 
solutions of the same permeant should produce the same steady state flux through 
the membrane. This would be expected to occur regardless of the nature of the 
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vehicle used (Higuchi, 1960; Siepmann & Peppas, 2011). Hence, the flux of a 
permeant from saturated solutions from any of the vehicles might be expected to 
be constant. In this study the diffusion of permeants through the membrane was 
changed and since the thermodynamic activity is constant in all blends, this 
indicated that the vehicles were probably not inert and interacted with the 
membrane. 
 
The diffusion studies conducted using model permeants, showed that the highest 
fluxes of model permeants were obtained from pure IPM, IHD and blends of the 
two oils (Figures 3.11-3.16). In addition, MP and BP have a higher solubility in 
IPM and IPM/IHD combinations compared with the solubility in other oils 
(Figure 3.1). The high solubility helps quickly restore the amount of permeant lost 
by diffusion which keeps the thermodynamic activity constant. Each model 
permeant has a specific activity coefficient in different oils (ɣ); therefore the 
leaving potential of the drug will be different for each vehicle. The enhanced 
permeation through the membrane might be due to the enhanced partitioning or 
diffusion of the compound through the membrane, or indeed a combination of 
both effects. The flux of model permeants from IPM/IHD combinations was in 
the order MP>BP>CF. This order is likely to be attributable to the relative 
magnitude of the partition coefficients with MP more readily partitioning from oil 
to silicone membrane to buffer than the more hydrophobic BP or the more 
hydrophilic CF. 
 
Despite the higher solubility of BP in IPM and OA compared with IHD, the flux 
from IHD was significantly higher than all other oils. Qualitative changes in the 
membrane dimensions (swelling and expansion) were noticed visually after 
diffusion studies which employed IHD as a vehicle. This suggested that IHD was 
possibly taken up by the membrane and this might lead to an enhanced BP 
partitioning and diffusion through membrane with the vehicle molecules. 
Blending oils with IHD significantly enhanced the flux of BP (Figure 3.13). In the 
case of BP, blends of IPM with IHD were found to affect the diffusion in a 
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manner that was not linearly dependent upon IHD content (Figure 3.13). A blend 
of 75 % IHD in IPM was found to be the combination that gave the highest flux 
of BP.   
 
The diffusion of MP and CF from OA/IHD blends formed parabolic curves with the 
peak at blends containing 25% OA for CF (Figure 3.15), while with MP the 
maximum flux was attained between 25 – 50% OA content (Figure 3.11). A 
parabolic relationship was also seen with OA uptake and enhanced of flux of 
piroxicam into and through porcine skin and silicone membrane from a series of 
ethanol:water vehicles (Francoeur et al., 1990). The maximum flux was attained 
with the vehicle containing 40% ethanol, as the OA was completely solubilised at 
40% or higher levels of ethanol. The authors suggested that the uptake of OA by 
silicone and porcine stratum corneum membranes was therefore controlled by the 
thermodynamic activity of OA in the applied ethanolic vehicle (Francoeur et al., 
1990).  
 
A comparison of the fluxes of model permeants from IHD and HD blends provides 
an indication on the effect of the chemical structure and shape of the oil on the 
diffusion of the model permeant. Thus the difference in the flux values through the 
silicone membranes could possibly be related to the shape and degree of 
branching, since HD and IHD have similar solubility and partitioning properties. 
The results suggest that as the degree of branching increases and the shape 
becomes more spherical and compact, this in turn might enhance the partitioning 
of the vehicle into the membrane and its interaction with the membrane. The flux 
of the permeant through the modified membrane would consequently be altered. 
The fluxes of three model permeants from the spherical branched IHD were 
significantly higher than the linear oval HD; regardless of their respective Log P 
values (i.e. their partitioning tendency).  
 
Blending IPM with HD led to lower flux results of the model permeants 
compared with those obtained for the same permeants dissolved in IPM/IHD 
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blends. As stated previously, HD and IHD differ only in the structure and shape of 
the molecules. There was no significant difference in the solubilities of any of the 
penetrants in 100% HD, IHD or the blends of either of these with IPM (Figure 
3.1). In the current study, the fluxes of BP from HD/IHD blends were higher than 
from the equivalent HD/IPM blends. In contrast, the fluxes of MP and CF were 
higher from HD/IPM blends than IHD/HD blends. These diffusion results indicate 
that there is possibly difference in the partitioning properties of the oils into the 
membrane, which might have led to the difference in the diffusion results. 
 
Diffusion studies of the model permeants were also carried out using the HD/LP 
and IHD/LP blends in order to investigate further the effects of a branched 
molecular structure and different molecular sized oil (LP) on the flux. The three 
oils are hydrocarbons with similar physicochemical properties and there was no 
significant difference in the solubility of permeants in the IHD/LP and HD/LP 
blends (Figure 3.1). The viscosity of LP is higher than IHD and HD and it has 
been reported that the viscosity of the vehicle does have an effect upon the release 
rate of a number of different dissolved solutes from the medium. The lower the 
viscosity of the vehicle the faster is the release (Malzfeldt et al., 1989; Kriwet & 
Müller-Goymann, 1995; Cle´ment et al., 2000; Trotta et al., 2003; Yener et al., 
2009). However the effect of viscosity of a vehicle on the diffusion rate of a 
permeant through a membrane might be minimal when compared to other 
potential factors, since most vehicles used are oils with similar viscosity. The flux 
of permeants depends mainly on the thermodynamic activity of the drug and the 
partitioning properties of the drug and possibly vehicle components into the 
membrane. Since all the systems were thermodynamically uniform, the 
significantly higher flux of specific model permeants, through silicone membrane 
from the IHD/LP blends compared with the HD/LP blends, is likely to be 
primarily attributed to a difference in the vehicle partitioning into the membrane. 
 
In the current studies, the diffusion of BP through silicone membrane displayed 
an increase in the flux of BP as the % of IHD increased (Figure 3.13). The order 
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of flux of BP, from the different vehicles was IHD>IPM>HD>LP>OA (Figure 
3.8). Since the thermodynamic activity of the system is constant there might be a 
difference in the interaction and uptake of oils into the membrane. BP and silicone 
membrane are hydrophobic therefore if there is any uptake of oils into the 
membrane, it might modify BP (and consequently, other hydrophobic permeants) 
partitioning and diffusion through the silicone membrane. 
 
In conclusion, it has been shown that oils (even those that are GRAS listed) have 
the potential to modify the membrane. The modified membrane can affect ‘drug’ 
diffusion in two ways (1) it acts to modify the barrier to the diffusion of many 
drugs, and (2) since the oils (from blends) may be taken up in different ratios this 
could modify the composition of the applied vehicle such that the thermodynamic 
activity of the applied drug is altered. Therefore the flux of the applied drug might 
be enhanced. The amounts of oil sorbed by silicone membrane require 
determination and it is planned to do this in the next phase of the study. 
 















INTERACTION OF OILS 
WITH MODEL MEMBRANES 
 




The penetration of a permeant through membranes is generally controlled by the 
chemical structure and physicochemical properties of that permeant. Generally the 
lipophilicity, hydrogen bonding ability and molecular size plays a major role on its 
absorption proﬁle (Pugh et al., 1996; El Tayar et al., 1991). However in some cases, the 
delivery and penetration of the vehicle to the membrane can be as important as that of 
the drug itself. This is because the permeated vehicle can alter the penetration of a 
concomitantly applied drug either by changing the partition of the latter into the 
membrane or by affecting the barrier properties of the membrane, with the consequent 
modulation of drug transport (Dias et al., 2001). Therefore, penetration of the drug can 
depend not only on the nature of the drug but also on the nature of the other components 
present in the formulation. Many of the previous studies which have investigated vehicle 
uptake into membranes and its effect on drug diffusion employed single aqueous and 
alcoholic vehicles (Twist & Zatz, 1988; Flynn, 1990; Twist & Zatz, 1990; Dias et al., 
2007; Oliveira et al., 2010). Few studies have addressed the influence of oily vehicles 
and their blends. In this chapter the uptake of different oily vehicles by membranes and 
blends of oils into silicone membrane will be investigated. A general description of the 
oily vehicle is in section 1.11. The structures of these oils are demonstrated in Figure 
4.1, the physical properties of these oils (including the molecular connectivity index to 









Figure 4.1 Structure of (a) isopropyl myristate (b) oleic acid (c) hexadecane (d) 
isohexadecane.  
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Table 4.1 Properties of the oils used in this investigation 
 IPM OA HD IHD LP 























270.4 282.5 226.4 226.4 340.0 





9.61 9.77 7.91 6.81  
Log Kow* 7.35 7.73 8.25 7.46 ˃6 
      
      
*data determined by Hansen Solubility Parameters in Practice (HSPiP) software version 4.0.04 Copyright 2013 (www.Hansen-Solubility.com). 
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Table 4.2 Some parameters and properties of oils used in this investigation  
 IPM OA HD IHD 
Molar volume* 315 319.7 294.2 295.3 
Boiling point °C* 167 360 210 240 
Melting point °C* 15 13 18 -75 
Ovality* 1.8 1.9 1.8 1.7 
Solubility parameter* 
(MPa)1/2 
16.4 17.4 16.3 14.7 
*data determined from HSPiP software version 4.0.04 Copyright 2013 (www.Hansen-Solubility.com). 
 
4.1.1 Interaction with membranes 
 
Permeation of a molecule through a membrane is inﬂuenced mainly by its activity 
gradient across the membrane thickness, and also by its mobility within the 
membrane. Solvent interactions with the membrane can alter the membrane 
physicochemical properties. This might lead to modiﬁed permeation of a co-
formulated drug through the membrane. The degree to which solvents affect and 
interact with the skin will depend on the uptake kinetics. Increasing the ethanol 
content of a vehicle was found to increase the diffusion rate of 4-
aminopropiophenone through silicone membrane from saturated water/ethanol 
solutions (Garrett & Chemburkar, 1968). Mulder et al. (1985) showed that the 
component of a solution that is sorbed preferentially into the membrane will permeate 
preferentially. Paraben permeation from a series of alcohols through silicone 
membrane was shown not to be constant, with the degree of uptake of alcohol into 
silicone membrane being well correlated with the flux data (Twist & Zats, 1988b). In 
general the amount of solvent absorbed by the membrane is related to the solubility 
parameter, molecular weight and hydrogen bonding capacity of the solvent (Cross et 
al., 2001). The latter workers showed that the log of hydrocortisone flux was linearly 
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related to the amount of vehicle sorbed by silicone membrane, although solvents with 
higher sorption did not cause a higher retention of hydrocortisone by the membrane. 
These same investigators also observed that solvent that was sorbed to the membrane 
changed both the diffusivity and the membrane solubility of solutes. The maximum 
flux of phenolic compounds was found to be related to the vehicle stratum corneum 
solubility which in turn was related to the amount of vehicle absorbed into the stratum 
corneum and the amount of phenolic compounds dissolved in that absorbed vehicle 
(Zhang et al., 2011). It is thus well documented that vehicles that are highly sorbed by 
the membrane affect the diffusional characteristics and alter the properties of the 
membrane thereby changing the partitioning and diffusion properties of the permeant 
across the membrane (Mulder et al., 1986; Twist & Zats, 1988; Cross et al., 2001; 
Dias et al., 2007; Zhang et al., 2011; Oliveira et al., 2012).  
 
The mode of action of enhancers and the molecular interactions between enhancers 
and components of stratum corneum had been investigated using various techniques 
including Fourier transform infrared spectroscopy (Jain et al., 2002; Vaddi et al., 
2002; Tokudome & Sugibayashi, 2003) and Raman spectroscopy (Caspers et al., 
1998 & 2000; Stamatas, 2006; Olsztyńska-Janus et al., 2012). These methods offer a 
non-invasive way to study cutaneous biochemical events at the molecular level. They 
give information about protein conformation and lipid structures. In general, changes 
in the absorbance frequency reflect changes in the conformational arrangement of 
functional groups. The greatest benefits of these spectroscopic techniques lie in their 
high sensitivity to biochemical changes, as well as in non-destructive application 
(Olsztyńska-Janus et al., 2012). 
 
The use of synthetic membranes has been found to be ideal in certain instances for 
studying topical formulations. Synthetic membranes have two functions: simulation 
of skin (Twist & Zatz, 1988 a&b) and quality control (Carbo et al., 1993). The 
membrane employed to simulate the skin should be broadly hydrophobic and possess 
rate limiting properties similar to skin. Synthetic membranes for quality control 
should have minimum resistance to the diffusion of the drug and act to separate the 
formulation from the receptor medium. Such synthetic membranes often have 
incorporated pores (Ng et al., 2010). A major advantage of such systems is that they 
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eliminate the requirement to obtain human or animal skin (Shin & Byun, 1996; Pellett 
et al., 1997b) and such membranes have been used to study both transdermal and 
dermal drug permeation (Fang et al., 1999; Sinico et al., 2005). Synthetic membranes 
are used in interaction studies since they are more homogenous, therefore data 
analysis is simplified, and they provide insight into the potential difficulties when 
more complex membranes such as skin are examined. Polydimethylsiloxane 
(silicone), high density poly ethylene (HDPE) and poly urethane (PU) membranes are 
examples of partitioning-membranes which have been used in these studies, where 
transport through the polymeric matrices is controlled by parameters similar to those 
of the stratum corneum. In contrast cellulose acetate nitrate membranes and all 
dialysis membranes are examples of porous barriers. 
 
4.1.2 Factors effecting vehicle interactions with membrane 
 
Many factors can influence the overall effect of vehicle interaction with the 
membranes and skin. These include its chemical structure, molecular weight and 
polarity, its hydrogen bonding capacity and the solubility parameter of the vehicle 
(Scheuplein et al., 1969; Sloan et al., 1986 a&b; Green et al., 1988; Okamoto et al., 
1990). 
 
4.1.2.1 Molecular weight, shape and polarity 
 
The molecular shape and polarity are important factors in any enhancement induced 
by a vehicle component (Hadgraft, 1991). For example, azone and oleic acid, have 
been found to interact with the intercellular lipids making them more fluid (Golden et 
al., 1987) and thereby facilitate the diffusion of topically applied drugs. Such activity 
is probably attributable to the polar regions within the vehicle interacting with the 
polar regions of the lipids, and the hydrophobic tail inserting into the ordered alkyl 
chain region of the lipids. The presence of the cis (Z) double bond of oleic acid 
creates a ‘kinked’ structure (Green et al., 1988), which imposes disorder on the 
regular packing of the lipids and imparts greater fluidity to the bilayer. Azone, 
however, does not possess a ‘kinked’ structure and computer graphic representations 
and monolayer experiments suggest that when it is incorporated into the lipid layer, 
the seven membered ring lies in the plane of the lipid polar head groups. These 
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groups are then forced apart which prevents the alkyl chains packing efficiently also 
imparting disorder and facilitating diffusion of concomitantly applied drug (Beastall 
et al., 1987; Beastall et al., 1988). 
 
The enhancement of membrane transport of estradiol by alcohols has been shown to 
be dependent upon the chain length of the latter, the dependence exhibiting a bell-
shaped curve, peaking at C10 (Santus & Baker, 1993). Also branched short chain 
alcohols blended with IPM have been shown to produce the highest estradiol flux 
compared with either linear short chain alcohols (alone or incorporated within the 
vehicle) or water (Goldberg-Cettina et al., 1995). Branched molecules are more 
compact than straight chain molecules of the same molecular formula and they are 
therefore hypothesized to penetrate into the stratum corneum more easily. Their 
penetration is expected to induce destabilization of the stratum corneum structure, and 
hence render it more susceptible to penetration by concomitantly applied active 
pharmaceutical ingredients (Rowe, 2006; Stamatas et al., 2008).  
 
The molecular weight of the solvent has an important effect on the mobility of the 
solvent inside the membrane; higher molecular weight solvents have restricted 
movement in bulky polymers and have been shown to exhibit lower permeation rates 
when compared with solvents of lower molecular weights having the same solubility 
parameters (Most, 1970). The uptake of a series of aliphatic alcohols with 2–10 
carbon numbers into silicone membranes at different temperatures was investigated 
(McAuley et al., 2010). An increase in alcohol membrane sorption with carbon 
number from ethanol to butanol (4 carbon atoms), was observed after which sorption 
decreased exponentially with increasing aliphatic chain length. 
 
4.1.2.2 Hydrogen bond capacity 
 
When a drug or a solvent partitions into the skin, there is the potential for hydrogen 
bonding to occur between that species and the polar head groups of the lipids. Mainly 
this hydrogen bonding would be primarily with the –COOH of the fatty acid, or the –
OH group and amide group of the ceramides (Hadgraft et al., 1996). The stratum 
corneum is predominantly an H-bond donor environment with donor/acceptor effects 
in the ratio 0.6:0.4 (Pugh et al., 1996). Therefore the number and type of H-bonding 
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groups is an important factor when considering the potential of candidates for 
transdermal delivery. Pugh et al. (1996) showed that the presence of a –COOH group 
reduced the diffusion coefficient by a factor of about 50; while an ether group 
reduced it by about 5. The H- bond donor/acceptor properties in the acids are more 
similar to the H- bond properties of the stratum corneum compared with the ether 
derivatives. Increasing the number of hydrogen bonding groups in a diffusing species 
increases the chances of interaction between the permeant and the skin or membranes, 
providing the membranes are capable of such an interaction (Pugh et al., 1996; Plessis 
et al., 2001). 
 
4.1.2.3 Solubility parameter 
 
The solubility parameter of the vehicle is an important predictor of the flux of the 
drug through the membrane (Cross et al., 2001; Dias et al., 2007b). The concept of 
solubility parameter was first developed by Hildebrand and Scott (1950) based on 
regular solution theory. Solubility parameters are related to the cohesion energy, as 
they derive from the energy required to convert a liquid to a gas state. All types of 
bonds holding molecules together are broken in the vaporization process. Thus the 
energy of vaporization is a direct measure of the total cohesive energy holding the 
liquid molecules together and both can be considered as being identical to each other. 
 
The solubility parameter (δ) is defined as the square root of the cohesive energy 
densities, which corresponds to the energy of vaporisation per unit volume (Equation 
4.1). 
 
δ	 = 				 (∆Ev/Vm)1/2      Equation 4.1 
Where Vm represents the molar volume and Ev is the energy of vaporization. 
 
∆Ev	 = 	 ∆Hv– RT       Equation 4.2 
 
The energy of vaporization is usually calculated by Equation 4.2 where ∆Hv is the 
heat of vaporization, R is the universal gas constant, and T is the absolute 
temperature. 
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For two materials to be mutually soluble, their cohesive energy densities must be 
similar, since this energy must be overcome to separate the molecules of the solute to 
allow the molecules of solvent to insert. For materials such as crosslinked polymers 
that do not dissolve, solubility can be measured by the degree of swelling (Lee et al., 
2003). 
 
If the solubility parameter of the vehicle is close to the solubility parameter of the 
skin, permeation may be enhanced (Dias et al., 2007b). Similarly, permeants with a 
solubility parameter close to that of the skin will have a higher permeation rate 
through the skin. The relationship between permeability coefficient of a series of 
alkanoic acids through porcine skin and solubility parameter was reported to take the 
form of a parabola with a maximum permeability near a solubility parameter of 20.46 
(MPa)1/2 (Liron & Cohen, 1984). Also the relationship between the solubility 
parameter of a series of narcotic analgesics and their permeation through cadaver skin 
was studied. It was found that narcotics with a solubility parameter close to 20.46 
(MPa)1/2 had higher permeability coefficients (Roy & Flynn, 1989). For vehicles or 
mixture of vehicles exhibiting solubility parameters in the range of δ = 16.36-24.55 
(MPa)1/2 large increases in fluxes of drug were reported in comparison to those 
obtained in the range δ = 24.55-36.82 (MPa)1/2. This was attributed to vehicle effects 
on the modified skin as a consequence of the similarity in the solubility parameters of 
the vehicles to that of skin (Sloan et al., 1986 a&b). Qualitatively, fluxes and 
permeability coefficients were found to be inversely dependent on drug solubility in 
the vehicles with a minimum corresponding approximately to the point where 
solubility parameter of the drug = solubility parameter of the vehicle (Sloan et al., 
1986a). The penetration of theophylline, salicyclic acid and 6-mercaptopurine was 
investigated from various vehicles and the permeability coefficient was found to be 
minimized when the solubility parameter of the vehicle was close to that of the 
permeant (Sloan et al., 1986 a&b; Waranis et al., 1987). The maximum flux of 
benzocaine through various silicone rubber membranes occurred when the solubility 
parameter of the vehicle was intermediate between the solubility parameter of the 
permeant and solubility parameter of the membrane, providing that the vehicle had a 
low molecular volume and high mobility in the membrane (Most, 1972). 
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4.1.2.3.1 Hansen solubility parameter  
 
Hansen parameters (Hansen, 1967) divide the total Hildebrand value (δ) into three 
parts: a dispersion force component (δD), hydrogen bonding component (δH) and a 
polar component (δP). 
 
δ2 = δ2D + δ2P + δ2H      Equation 4.3 
 
Dispersion forces are the weakest of the intermolecular forces. They occur between 
all molecules and they are the main forces that act in neutral, non-polar molecules. 
Polar forces or dipole-dipole interactions act to produce medium to weak bonds. They 
occur between neutral, polar molecules where the positive end of one molecule is 
attracted to the negative end of another molecule. Hydrogen bonding acts to form the 
strongest bonds, when compared with the dispersion and polar bonds. In hydrogen 
bonds, the positively charged hydrogen end of one molecule is attracted to the 
negatively charged end of another molecule, which must be an extremely 
electronegative element for example oxygen or nitrogen 
 
As shown by Figure 4.2, any molecular substance can be represented by a point in a 
tridimensional space, called a Hansen sphere, whose orthogonal axes are Hansen 
solubility components (HSPs: x=δD, y=δP, z=δH). In the exact centre is a green 
symbol. This shows the position of a particular molecule with values δD =18.5, δP 
=9.9, δH =7.9 in Figure 4.2.  
 
There is a set of blue cubes, which are located at the HSPs of solvents which dissolve 
this molecule; these all lie inside the sphere. All substances qualified as good solvents 
for the solute should stay within this sphere and those considered as bad solvents (or 
nonsolvents) should lie outside. Accordingly, the red cubes show the solvents outside 
the sphere which do not dissolve this molecule.  
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Figure 4.2 An example of Hansen sphere: the orthogonal axes are the Hansen 
solubility parameters corresponding to; x-axis, D=δD (the dispersion force 
component), y-axis, P=δP (the polar component) and z-axis, H=δH (the hydrogen 
bonding component). 
 
A useful parameter for comparing two substances is the solubility parameter distance 
based on their respective HSP components: 
 
Distance2= 4൫δDA-δDB൯2+൫δPA-δPB൯2+൫δHA-δHB൯2   Equation 4.4 
 
where δDA, δDB are the energy of the dispersion forces of compound A and B 
respectively, δPA, δPB are the energy of the dipolar forces of compound A and B 
respectively, δHA, δHB are the energy of the hydrogen bonds forces of compound A 
and B respectively,   
 
A high affinity between a solvent and solute requires the distance to be less than the 
interaction radius of the sphere. The radius is the distance from the centre to the 
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border of the sphere. A RED (Relative Energy Difference) number is often used to 
quantify distances relative to the interaction radius. A perfect solvent has a RED of 0 
which indicates no energy difference. A RED <1 indicates a high solute-solvent 
affinity, whereas a RED>1 indicates low affinity and a RED=1 (or around 1) reflects 
a boundary condition. 
 
4.2 Aims and objectives 
The interaction of vehicles employed in drug delivery systems with the 
membrane/skin is an important consideration in developing a suitable topical 
formulation. The importance of solubility parameter and structure of an oily vehicle 
when considering its potential to interact with membrane/skin has not been fully 
elucidated. The use of stratum corneum to interpret data correctly for the purpose of 
creating predictive models is difficult, due to the complexity of the membrane and 
therefore the nature of the possible interactions. Accordingly the use of simple 
membranes with different solubility parameters and homogenous structures might 
provide a means of identifying key factors that might be extrapolated later to human 
skin. When using blends of vehicles, one vehicle might partition to a greater extent 
into the membrane than the other, therefore the ratio of vehicle in the membrane 
could differ from the original ratio in the donor solution. The aim of this chapter was 
to investigate the nature and extent of interactions between a range of 
physicochemically diverse oily vehicles with membranes possessing heterogeneous 
physicochemical properties. The objectives of the work carried out in this study were 
to:  
1. Investigate the effect of solubility parameter and different physicochemical 
properties on the uptake of a range of oils by different membranes. 
 
2. Quantify the amount of oil(s) absorbed by silicone membrane from different oil 
blends, and compare these values with the oil ratio applied in the donor solution. 
 
3. Quantify where possible the oil depletion from donor compartment. 
 
4. Compare the effects of different oil blends on the permeation of MP across 
(silicone) membranes.  






The suppliers of materials employed in this study have been reported previously and 
are listed in Table 2.2. 
 
4.3.2 Membrane swelling experiments 
 
Silicone, HDPE, PU and cellulose acetate nitrate membranes were used in the 
swelling experiments. The membranes employed in this study and some of their 
physicochemical characteristics are listed in Table 4.3. 
 
Table 4.3 Physicochemical characteristics of membranes employed in this investigation 
*Determined from HSPiP software version 4.1.0.3 
a dispersion force component 
b polar component  
chydrogen bonding component  
** Where n is the number of repetitions and R2 is a hydrocarbon chain. R represents a hydrocarbon 
containing the OH group. 
 





(mm) 0.32 0.2 0.25 0.25 
Porosity 







*a 17 18 18.1  
δP
*b 2.9 0 9.3  
δH




17.4 18.1 20.8 28.6 
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4.3.2.1 Membrane weight 
Uptake of vehicles into silicone, HDPE, PU and cellulose acetate nitrate membrane 
was determined gravimetrically. Membranes were cut to size (the diameter being 
approximately 2 cm) and the samples were then immersed in vehicle in a sealed glass 
vial, and soaked overnight (approximately 17 h) in a temperature-controlled water 
bath at around 32°C. The membranes were blotted dry with tissue paper and 
reweighed. The percentage weight difference (% ∆W) was calculated according to 
Equation 4.5. 
%	∆W= ൫Wa-Wb൯Wb *100      Equation 4.5 
Where Wa is the weight of membrane after soaking and Wb is the weight of membrane 
before soaking. 
 
The amount of oil (mg per gram) in each membrane was calculated according to 
Equation 4.6 
 mupt	 = ∆	୵ୣ୧୥୦୲	୭୤	୫ୣ୫ୠ୰ୟ୬ୣ	୵ୣ୧୥୦୲		(୫୥)
୭୰୧୥୧୬ୟ୪	୵ୣ୧୥୦୲	୭୤	୫ୣ୫ୠ୰ୟ୬ୣ	(୥)     Equation 4.6 
 
4.3.2.2 Kinetic study of membrane swelling 
 
The experiment described in Section 4.3.2.1 was repeated using silicone membrane 
with different oil blends, except that the weight and thickness of silicone membrane 
was measured at 0, 1, 3, 6 and 24 h.  
The thickness was measured using callipers (Mitutoyo, Digimatic Calliper resolution 
0.01mm, accuracy +/-0.02mm and repeatability 0.01mm). The thickness of 
membranes was measured before their immersion in vehicle at room temperature. The 
membranes were blotted dry with tissue paper after each set time interval and the 
thickness was re-measured. The percentage difference in membrane thickness (%∆T) 
was calculated according to Equation 4.7.  
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%	∆T= ൫Ta-Tb൯Tb *100      Equation 4.7 
Where Ta is the thickness of membrane after soaking and Tb is the thickness of 
membrane before soaking. 
 
4.3.3. Quantification of oil uptake by silicone membrane from oil blends 
 
4.3.3.1 Preliminary studies 
 
Silicone membranes were cut into circular pieces (the diameter was approximately 2 
cm) weighed and immersed in the vehicle in a sealed glass vial, approximately 17 h at 
32°C (maintained in a temperature-controlled water bath). The following day, the 
membranes were blotted dry with tissue paper and reweighed. Samples were then 
soaked in 9 mL of heptane for 3 h, or soaked 3 mL of heptane for 1 h, replaced hourly 
for three hours (total 9 mL after pooling) to extract any sorbed oils from the 
membrane. After each hour the 3 mL of heptane was replaced with fresh solvent. 
Some samples were left for 5 h in heptane. 
 
4.3.3.2 Membrane extraction method 
 
The amount of oil taken up by the silicone membrane was quantified using GC 
analysis. Membranes were cut into circular pieces (the diameter was around 2 cm) 
weighed and immersed in the vehicle in a sealed glass vial, approximately 17 h at 
32°C maintained in a temperature-controlled water bath. The following day, the 
membranes were blotted dry with tissue paper and reweighed. Samples were soaked 
in 3 mL of heptane for 1 h, replaced hourly for three hours (total 9 mL after pooling) 
to extract any sorbed oils from the membrane. After each hour the 3 mL of heptane 
was replaced with fresh solvent. 
 
A control experiment was performed by soaking the membrane for 3 h in heptane. A 
sample of the heptane used to soak the membrane was subsequently assayed by GC to 
check whether the assay employed to determine the amount of extracted oil was 
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prone to possible interference with any potential extractable material present in the 
membrane. 
 
4.3.3.3 GC analysis 
 
Chromatographic measurements were carried out as described previously in section 
2.3.4. 
 
4.3.3.4 Calculation of amount absorbed 
 
The percentage of amount of any specific oil absorbed by silicone membrane from 
the oil blends was calculated according to Equation 4.8. 
 %	mupt = (mGC)mT ∗ 100      Equation 4.8 
 
Where mupt is the amount of oil sorbed, mGC amount of oil quantified by GC and mT 
the total amount of oil sorbed by silicone membrane 
 
Since OA and LP were not detected by GC analysis the amount of (LP or OA in the 
membrane from the blends) was calculated according to Equation 4.9. 
 Amount	of	LP	or	OA = 	mT − m2GC    Equation 4.9 
 
Where mT is the total amount of oil sorbed by silicone membrane and m2GC the 
amount of second oil quantified by GC 
 
4.3.4 Determination of composition of the oil in donor compartment 
 
In order to determine the ratio of the oils remaining in the donor compartment after 
diffusion experiments, silicone membrane was cut to an appropriate size and 
immersed overnight in phosphate buffer pH 7.0. On the following day the receptor 
compartment, of Franz cell having a receptor phase of 2 mL and a diffusional area of 
0.65 cm2, was carefully filled with phosphate buffer, after which the receptor 
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temperature was maintained at 32C by immersion in a temperature-controlled water 
bath. The membrane was then allowed to equilibrate with the receptor fluid for 1 h, 
after which time 200 L of 75:25, 50:50 or 25:75% w/w IHD/HD solution was 
introduced into the donor compartment. After 6 h any oil remaining in the donor 
compartment was removed for assay. The sample was diluted appropriately with 
heptane and analysed using the GC method described in section 2.3.4. 
 
Equations 4.10 and 4.11 were employed to calculate the percentage ratio of the oil 
applied and the oil remaining in the donor compartment after 6 h: 
 
	%moila= (moila)mTa ∗ 100      Equation 4.10 %moilr= (moilr)mTr ∗ 100      Equation 4.11 
 
Where moila is the amount of one the component oil applied (i.e. either IHD or HD), 
mTa the amount of both oils applied into the donor compartment. moilr  the amount of 
that component oil remaining after 6 hours and mTr the total amount of oil remaining 
in the donor compartment (i.e. the total amount of HD+IHD applied 
 
4.3.5 Effect of membrane pre-treatment with oil on permeant diffusion 
 
4.3.5.1 Franz cell experiment  
 
The donor suspension was prepared by adding an excess amount of MP to 6g of 
phosphate buffer pH 7.0. The suspension was shaken overnight in a water bath at 
32˚C. Before the experiment the membrane was cut into circular discs (around 0.8 
cm2), immersed and soaked in the HD, IHD and LP overnight at 32°C. As a control, a 
sample of the membrane was immersed and soaked in phosphate buffer overnight, 
rather than oil. Diffusion experiments were carried out using calibrated (for volume) 
Franz cells with a receptor phase of 2 mL and a diffusional area of 0.65 cm2. The 
membrane was cut to the appropriate size (around 2 cm) and placed between the 
donor and the receptor compartments of the Franz cell. The receptor compartment 
was carefully filled with phosphate buffer pH 7.0 and the cell placed on a stirring 
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plate submerged in a water-bath maintained at 32oC. A small Teflon coated magnetic 
bar (around 5 mm) was included in the receptor compartment such that stirring was 
maintained throughout the duration of the experiment. After allowing the membrane 
to equilibrate with the receptor fluid, 200 μL of the buffer suspension (the sample 
contained undissolved/suspended solid of MP at 32oC) was added to the donor 
compartment. At appropriate time intervals, 200 μL samples were withdrawn from 
the receptor compartment and immediately replaced with an equal volume of fresh 
phosphate buffer, (pH 7.0). The cumulative amounts (per unit surface area of 
membrane) of MP which diffused across membrane were plotted against time (h). 
The slope of the linear plot was taken as the flux of MP permeation. Each experiment 
was conducted five times.   
 
4.3.5.2. HPLC analysis of MP 
 
The MP concentrations of receptor samples were analysed by HPLC methods (section 
2.3.2). The values at each time were corrected for previous sample removal and the 
replacement of the previous samples with fresh media.  
 
4.3.5.3 Calculation of enhancement ratio 
Enhancement ratios (ER) were derived from: 
 ER	 = 	Js(E)/Js(C)    Equation 4.12 
 
Where Js(E) and Js(C) are the flux values of the MP following pre-treatment of the 
membrane with oils (enhanced) or phosphate buffer (control), respectively. Results 
were expressed as the mean ± standard deviation (SD) of 4–5 determinations. 
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4.3.6 Calculation of Hansen solubility parameter and spheres 
 
Hansen Solubility Parameters in Practice HSPiP software version 4.1.0.3 was used to 
calculate the Hansen solubility parameter (HSP) values and derive a graphical plot of 
the Hansen spheres. The HSP distance from the centre of the sphere to the oil is 
calculated by Equation 4.4. 
 
The HSP values for the oil blends were calculated using the linear mixing rule. 
 
4.3.7. Statistical analysis  
 
Data reported in this study are usually the mean of n ≥ 3 with the standard deviation 
(sd) given. In order to establish differences in the parameters measured in this study, 
statistical tests were conducted. The analysis of variance (ANOVA) method and 
student’s t- test were used as the major statistical tests where applicable. Post hoc 
comparisons of the means of individual groups were performed using Tukey’s test,and 
the level of significance was taken at p≤ 0.05 in all cases.  
 
4.4 Results 
4.4.1 Swelling data for model permeants in membranes 
 
The absolute amount of oils sorbed into the different membranes is shown in Table 
4.4. The percentage weight increases in the silicone, HDPE, PU and cellulose acetate 
nitrate membranes due to solvent uptake are shown Table 4.5. Membranes sorbed 
oils in different ratios with the order being silicone>HDPE>PU for IPM, HD and 
IHD. OA was highly sorbed into PU; however it acted as a plasticizer for the 
membrane and PU lost its consistency, becoming sticky when soaked in the oil. 
Generally the difference in membrane weight after being soaked in the buffer was 
the lowest, when compared with the resultant weight gain after incubation with oils. 
However the reverse was found when cellulose acetate nitrate membrane was 
employed and weight gain was greatest in buffer. The difference between membrane 
weight after incubating with buffer at 32°C was 0.06 ± 0.05 % for silicone 
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membrane, 18.16 ± 0.72 % for HDPE, 1.01 ± 0.40 for PU and 70.14 ± 16.16% for 
cellulose acetate nitrate. 
 
Table 4.4 Amount of oil indifferent membranes after being soaked in different 
vehicles for approximately 17 h at 32°C (mg oil/ g membrane). 
Data represent mean ± sd (n≥3). 
 
Table 4.5 The percentage difference in weight of membranes after being soaked in 
different vehicles for approximately 17 h at 32°C. 
Data represent mean ± sd (n≥3). 
 
4.4.2 Kinetic study of silicone membrane swelling 
 
A kinetic study was carried out to monitor oil uptake by incubating the membrane at 
32°C, over a 24 h period. Generally most of the eventual total weight increase 
occurred in the first hour. Also there was no significant difference in the thickness of 
the membrane between that measured after the first and that at hour 24; any change 
in thickness occurring during the first hour. Figure 4.3 provides a typical example of 
rate of oil uptake; in this instance the change in membrane weight after different 
Membrane IHD IPM HD OA LP 
Silicone 1048.6 ± 17.6 662.1 ± 19.8 464.6 ± 9.2 31.2 ± 1.3 137.5 ± 5.2 
HDPE 364.0 ± 24.1 188.7 ± 11.7 262.7 ± 9.6 297.0 ± 19.5 300.7 ± 17.2 
PU 22.4 ± 1.1 51.7 ± 1.9 20.4 ± 0.98 885.8 ± 27.2 23.4 ± 0.98 
Membrane IHD IPM HD OA LP 
Silicone 105.6 ± 1.1 64.2 ± 1.4 43.9 ±0.7 3.1 ± 0.1 13.8 ± 1.8 
HDPE 36.2 ± 2.0 18.3 ± 2.1 25.3 ± 3.1 29.1 ± 2.2 29.1 ± 2.9 
PU 2.3 ± 0.2 5.1 ± 0.4 2.2 ± 0.1 88.1 ± 5.1 2.2 ± 0.2 
Cellulose 
acetate nitrate 
20.3 ± 2.1 25.4 ± 2.0 16.2 ± 0.7 14.1 ± 0.8 13.2 ± 3.2 
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time intervals is shown after immersion in IPM/IHD blends. Immersion of silicone 
membrane in other oils/oil combinations produced similar profiles. 
 
Figure 4.3 Percentage differences in weight of silicone membrane during soaking in 
IPM/IHD blends for 24 h at 32°C. 
 
4.4.3. Quantification of oil uptake by silicone membrane from oil blends 
4.4.3.1 Change in membrane weight 
 
Distinct differences were found in the weight increase of samples of silicone 
membrane when incubated with different combinations of oil in different ratios 
(Figures 4.4, 4.5 and 4.6). The highest amount sorbed was when the membrane was 
incubated with IPM/IHD blends. The lowest amount of oil uptake was determined to 
occur from HD/OA blends. 
 
Figure 4.4 Percentage weight changes in silicone membrane immersed in different 
oil combinations comprising IHD with () HD ( ) IPM ( ) LP and (*) OA for 








































Figure 4.5 Percentage weight changes in silicone membrane immersed in different 
oil combinations comprising HD with () IHD ( ) IPM ( ) LP and (*) OA for 
approximately 17 h at 32°C. The IHD blend is also presented in Figure 4.4. Data 




Figure 4.6 Percentage weight changes in silicone membrane immersed in different 
oil combinations comprising IPM with () HD ( ) IHD ( ) LP and (*) OA for 
approximately 17 h at 32°C. The IHD and HD blends are also presented in Figure 
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4.4.3.2 Measurement of oil uptake by silicone membrane 
 
The amount of oil taken up by silicone membrane was analysed by GC 
chromatography. The quantity extracted from the membrane using heptane was then 
related to the ratio of oil originally present in the oil solution. The efficiency of 
recovery of all oils using the extraction technique described was shown to be ≥ 97% 
in preliminary studies. Figures 4.7 – 4.15 show the composition of oil extracted 
versus the composition of the oil blend at the start of incubation. Please note, that 
only mean composition values are presented in the bar charts, below. However, in 
Tables 4.7 – 4.9, the total amount (including measures of variability) are presented 
from which the data for Figures 4.7 – 4.15 have been calculated. The extraction 
results for IHD with other oils showed that IPM and IHD were sorbed to the same 
extent, and hence the composition of the amount of oil absorbed from the different 
ratio blends was close to the ratio present in the starting blend (Figure 4.7). On the 
other hand when IHD was blended with HD, LP or OA, then the IHD appeared to be 
absorbed preferentially in comparison to the other oil present in the blend (Figures 
4.8-4.10). There was no significant difference in the amount of HD and IPM sorbed 
as a function of starting composition (Figure 4.11), whilst when IPM was blended 
with either LP or OA then less of the latter two oils was sorbed by the membrane 
than was present in the original mixture (Figures 4.12 and 4.13). In all blends the 
RSD between the samples was ≤5, which was deemed to be within acceptable limits 
for the GC method employed.  
 
 




Figure 4.7 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in IPM/IHD blends expressed as a 




Figure 4.8 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in HD/IHD blends expressed as a 


















































Figure 4.9 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in LP/IHD blends expressed as a 




Figure 4.10 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in OA/IHD blends expressed as a 




















































Figure 4.11 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in IPM/HD blends expressed as a 




Figure 4.12 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in LP/IPM blends expressed as a 


















































Figure 4.13 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in OA/IPM blends expressed as a 
function of the percentage of IPM in solution ()OA () IPM. 
 
 
There were no significant differences between the percentages of HD and LP 
extracted and that present in the original blend (Figure 4.14). However the 
percentage of HD in the extracted oil was significantly higher than the percentage 
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Figure 4.14 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in LP/HD blends expressed as a 
function of the percentage of HD in solution ()HD () LP. 
 
 
Figure 4.15 Percentage of individual oils extracted from silicone membrane after 
being incubated for approximately 17 h at 32°C in OA/HD blends expressed as a 
function of the percentage of HD in solution ()HD () OA. 
 
Table 4.6 shows the amounts of IHD, IPM and HD that were extracted from silicone 
membrane in each of the separate oils. The amount of IHD sorbed to/in the 
membrane was significantly higher than that of HD and IPM. Tables 4.7-4.9 shows 
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incubated in different oil blends. Generally blending oils incorporating IHD were 
taken up by the membrane in higher amounts than similar blends containing either 
HD or IPM. 
 
Table 4.6 Total amount of oil extracted and quantified by GC (mg oil/ g membrane) 
after incubation at 32°C for 17 h 
Oil 
Amount extracted by GC (mg oil/ 
g membrane) 
IHD 1026.4 ± 20.7 
IPM 648.8 ± 13.7 
HD 449.1 ± 12.8 
 
Table 4.7 Amount of oil extracted from silicone membrane after immersion for 17 h 
at 32°C in various IHD oil blends and quantified by GC (mg oil/ g membrane) 
%IHD IHD/IPM IHD/HD IHD/LP IHD/OA 






















































Table 4.8 Amount of oil extracted from silicone membrane after immersion for 17 h 
at 32°C in various IPM oil blends and quantified by GC (mg oil/ g membrane) 
%IPM IPM/HD IPM/LP IPM/OA 
 IPM HD IPM LP IPM OA 
25 138.2 ± 4.1 403.0 ± 6.0 64.8 ± 1.8 149.6 ± 2.8 20.6 ± 0.2 39.5 ± 0.5 
50 313.4 ± 6.8 280.8 ± 5.5 196.6 ± 3.5 144.1 ± 2.7 73.6 ± 2.1 52.9 ± 1.4 
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Table 4.9 Amount of oil extracted from silicone membrane after immersion for 17 h at 
32°C in various HD oil blends and quantified by GC (mg oil/ g membrane) 
%HD HD/LP HD/OA 
 HD LP HD OA 
25 36.2 ± 0.6 104.5 ± 3.7 23.7 ± 0.98 46.8 ± 2.3 
50 108.7 ± 4.2 103.2 ± 1.7 82.4 ± 3.9 64.8 ± 2.1 
75 223.0 ± 2.1 69.3 ± 2.4 207.3 ± 1.1 62.5 ± 2.2 
 
4.4.4 Determination of composition of the oil in donor compartment 
 
Oil (200 µL) was added to the donor compartment of a Franz cell containing silicone 
membrane and a sample of the oil remaining in the donor compartment after 6 h (the 
duration of the diffusion experiments) was analysed. The results in Figure 4.16 show 
the calculated (Section 4.3.4) percentage of oil applied and the percentage of oil 
remaining in the donor compartment after 6 h. These results indicate that the 
composition of the applied vehicle in the donor compartment is changing 
significantly within the time that the experiment was conducted (p≤ 0.05). In 
addition it indicated that one oil is being sorbed preferably compared to the other. 
Accordingly, therefore both the thermodynamic activity of any incorporated 
permrant might be altered, and the membrane structure could be modified.  
 
Figure 4.16 Percentage of individual oils (HD/IHD blends) remaining in the donor 
compartment after six hours, expressed as a function of the percentage of IHD applied in 








73.71 ± 0.53 
46.78 ± 0.51
23.96 ± 0.36
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4.4.5 Effect of membrane pre-treatment on permeant diffusion 
The permeation profiles of the MP through silicone membrane pre-treated with 
different oils in comparison to a control comprising membrane pre-treated with 
buffer are shown in Figure 4.17. Steady state fluxes were in the order of 
IHD>HD>LP, as shown in Table 4.10. Generally, the flux of MP from pre-treated 
silicone membrane was found to be significantly higher than that of MP flux through 
silicone membrane soaked in buffer. These results indicate that the membrane is 
modified by the oil that has partitioned into the matrix, leading to the modification of 
the flux of drug presented at the same thermodynamic potential. 
 
Table 4.10 MP fluxes from buffer through silicone membrane pre-treated with IHD, 
HD, LP and buffer 
Pre-treatment Flux (μg cm-2 h-1) ER 
IHD 113.46 ± 1.83 2.62 ± 0.03 
HD 75.60 ± 1.43 1.74 ± 0.03 
LP 56.87 ± 1.99 1.31 ± 0.04 
Buffer 43.25 ± 0.94 1.00 ± 0.03 
Data are expressed as mean ± sd (n≥4) 
(ER) Enhancement ratio 
 
 
Figure 4.17 MP permeation profile through pre-treated silicone membrane showing 
the cumulative amount of MP in the receptor compartment from buffer as a function 
of time. Permeation was measured after pre-treatment of the membrane by soaking 
for approximately 17 h at 32°C in either () IHD, () HD,() LP or (x) buffer. 
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4.4.6 Hansen Solubility Parameter values and plots 
 
The various HSP parameters and the molar volume of the different oils are shown in 
Table 4.11. LP displays the highest molar volume (Mvol), while HD and IHD have 
the lowest Mvols. The δD values for all oils were of similar magnitude. IHD and HD 
are pure hydrocarbons therefore the δP and δH are zero. OA displays a higher value 
of δH compared with other oils. 
 
Table 4.11 Hansen Solubility Parameter values and molecular volume of oils used 
Oil δDa δPb δHc Mvold 
OA 16.0 2.8 6.2 319.7 
IPM 16.0 2.7 2.7 315.0 
HD 16.3 0 0 294.2 
IHD 14.7 0 0 295.3 
LP* 16.1 1.8 3.7 424.1 
adispersion component  
bpolar component 
chydrogen bonding component 
d molecular volume 
*values from Abbott, 2012 
 
 
The Relative Energy Difference (RED) is the ratio of the distance between the HSP 
values of the solvent and membrane to the radius of the Hansen sphere. The RED 
values for the oils calculated by the HSPiP software are shown in Table 4.12. Table 
4.13 shows the distance between the HSP values of membranes and oils. Generally if 
two components are chemically similar then it would be expected that their HSP 
values would be the same; and when the sum of the absolute differences of the three 
HSP values is calculated, then difference would be zero. If the two components are 
chemically fairly similar then it would be expected that their HSP values would be 
similar, and the differences would be small. So the definition of a perfect solvent is 
the one that has the difference of 0 MPa1/2. 
 
 
Chapter 4.  Interaction of oils with model membranes 162 
 
Table 4.12 Relative energy differences (RED) values expressed for the oils when compared 
with different membranes 
Oil OA IPM HD IHD 
Silicone 0.72 0.39 0.72 1.05 
HDPE 3.40 2.55 2.25 3.75 
PU 0.99 1.06 1.36 1.55 
 
 
Table 4.13 Hansen solubility parameter (HSP) distance between the HSP of the oils and 
different membranes MPa1/2 
Oil OA IPM HD IHD LP 
      
Silicone 4.1 2.2 4.1 6.0 2.4 
HDPE 6.8 5.1 4.5 7.5 5.1 
PU 7.9 8.5 10.9 12.4 8.5 
 
 
The plots of the Hansen spheres for the different oils and membranes are shown in 
Figures 4.18-4.20, If a solvent blend is inside the sphere then it is likely to be 
miscible with the polymer and the closer it is to the centre, the more effective it is in 
its solvency. Figure 4.18 shows that the solubility parameter of all the oils lay inside 
the Hansen sphere generated for silicone membrane consequently they are all 
expected to swell the silicone membrane. It should be borne in mind that the radius of 
the Hansen sphere is also a function of the experimental data used for their 
calculation in the HSPIP software. Failure to study a sufficient range of solvents may 
underestimate the true radius of the sphere, where a more extensive range of solvents 
studied. Whereas the same solubility parameters of the oils were sited outside the 
spheres for HDPE (Figure 4.19) and PU (Figure 4.20, this indicates that these oils are 
not perfect for the membranes. However the blue colour of the cubes indicates that 
these solvent still possess solvency power on the selected membranes. 
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Figure 4.18 Schematic of the Hansen Solubility sphere. Each axis is one of the three 
component Hansen solubility parameters, δD, δH, or δP (representing the magnitude of 
the dispersive or van der Waals forces, the hydrogen bonding, and the polar bonding, 
respectively). The centre of the sphere (green symbol) represents the three-
dimensional solubility parameter for the silicone membrane. The blue symbols are the 
Hansen solubility parameters of oils used in this investigation. The radius of the 
sphere is 5.7 MPa1/2. 
 
Figure 4.19 Schematic of the Hansen Solubility sphere. Each axis is one of the three 
component Hansen solubility parameters, δD, δH, or δP (representing the magnitude 
of the dispersive or van der Waals forces, the hydrogen bonding, and the polar 
bonding, respectively). The centre of the sphere (green symbol) represents the three-
dimensional solubility parameter for the HDPE membrane. The blue symbols are the 
Hansen solubility parameters of oils used in this investigation. Radius of the sphere 
is 2 MPa1/2. 




Figure 4.20 Schematic of the Hansen Solubility sphere. Each axis is one of the three 
component Hansen solubility parameters, δD, δH, or δP (representing the magnitude 
of the dispersive or van der Waals forces, the hydrogen bonding, and the polar 
bonding, respectively). The centre5 of the sphere (green symbol) represents the 
three-dimensional solubility parameter for the PU membrane. The blue symbols are 
Hansen solubility parameters of the oils used in this investigation. Radius of the 
sphere is 8 MPa1/2. 
 
The HSP values for the different oil blends and the distance between HSP of oils and 
silicone membrane are shown in Tables 4.14-4.22. OA blends were found to display 
low distance value comparatively, while IHD blends were associated with the 
highest values. The highest distance values for the mixtures were obtained when the 
IHD was mixed with HD (Table 4.16). 
 
Table 4.14 Hansen solubility parameters (HSP) values and distance between the 
HSP of the IHD/IPM oil blends and silicone membranes MPa1/2 
% IHD/IPM δD δP δH Distance 
25/75 15.7 1.6 2.0 3.0 
50/50 15.4 1.1 1.4 4.0 
75/25 15.0 0.5 0.7 5.0 
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Table 4.15 Hansen solubility parameters (HSP) values and distance between the 
HSP of the HD/IPM oil blends and silicone membranes MPa1/2 
% HD/IPM δD δP δH Distance 
25/75 16.1 1.6 2.0 2.4 
50/50 16.2 1.1 1.4 2.8 




Table 4.16 Hansen solubility parameters (HSP) values and distance between the 
HSP of the IHD/HD oil blends and silicone membranes MPa1/2 
% IHD/HD δD δP δH Distance 
25/75 15.9 0 0 4.5 
50/50 15.5 0 0 4.9 




Table 4.17 Hansen solubility parameters (HSP) values and distance between the 
HSP of the IHD/OA oil blends and silicone membranes MPa1/2 
% IHD/OA δD δP δH Distance 
25/75 15.7 2.1 4.7 3.4 
50/50 15.4 1.4 3.1 3.7 
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Table 4.18 Hansen solubility parameters (HSP) values and distance between the 
HSP of the HD/OA oil blends and silicone membranes MPa1/2 
% HD/OA δD δP δH Distance 
25/75 16.1 2.1 4.7 2.9 
50/50 16.2 1.4 3.1 2.3 




Table 4.19 Hansen solubility parameters (HSP) values and distance between the HSP 
of the IPM/OA oil blends and silicone membranes MPa1/2 
% IPM/OA δD δP δH Distance 
25/75 16.0 2.6 5.3 3.4 
50/50 16.0 2.5 4.5 2.8 




Table 4.20 Hansen solubility parameters (HSP) values and distance between the HSP 
of the IHD/LP oil blends and silicone membranes MPa1/2 
% IHD/LP δD δP δH Distance 
25/75 15.8 1.4 2.8 3.0 
50/50 15.4 0.9 1.9 3.9 
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Table 4.21 Hansen solubility parameters (HSP) values and distance between the HSP 
of the HD/LP oil blends and silicone membranes MPa1/2 
% HD/LP δD δP δH Distance 
25/75 16.2 1.4 2.8 2.3 
50/50 16.2 0.9 1.9 2.7 




Table 4.22 Hansen solubility parameters (HSP) values and distance between the HSP 
of the IPM/LP oil blends and silicone membranes MPa1/2 
% IPM/LP δD δP δH Distance 
25/75 16.1 1.9 3.5 2.3 
50/50 16.1 2.0 3.2 2.2 
75/25 16.0 2.0 3.0 2.2 
  




Stratum corneum comprises a complex molecular and supramolecular structure 
composed primarily of a mixture of lipids and proteins (Section 1.2.2). The extent to 
which a vehicle is sorbed and interacts with these structures, can affect the 
penetration kinetics of any topically applied drug. However (due to the complex 
number and diverse nature of types of interactions possible between vehicles, 
stratum corneum and drug), the interpretation of transcutaneous diffusion data with a 
view to identifying the key factors affecting these interactions is not simple. The use 
of simpler membranes, with distinctive properties such as silicone, polyethylene and 
polyurethane membranes might provide one means of identifying some of the prime 
parameters controlling the overall transport process through the markedly more 
complex stratum corneum. The permeation process consists of initial partition of the 
solute into, and then diffusion through, the polymer matrix (Roberts & Anderson, 
1975; Roberts & Horlock, 1978; Jiang et al., 1998). Silicone membranes are 
extensively used to characterize interaction and drug transport processes because of: 
their ease of preparation (Most, 1970), hydrophobic character and the relatively high 
diffusivities of drugs through the core matrix (Most, 1970; Flynn et al., 1971). 
Silicone membranes have been used extensively to study the influence of topical and 
transdermal formulation components on solute transport (Scott, 1986; Nakano & 
Patel, 1970; Pellett et al., 1997; Twist & Zatz, 1990; Schwarb et al., 1999; Iervolino 
et al., 2001; Geinoz et al., 2002; Dias et al., 2007a ; McAuley et al., 2009; 
Watkinson et al., 2009 a&b; Wasdo et al., 2009; Sloan et al., 2013), despite their 
failure in providing an analogous model for the complexity of the stratum corneum 
(Hatanaka et al., 1992; Cronin et al., 1998; Moss et al., 2006). 
 
It is well established that transdermal drug absorption is influenced by the vehicle in 
which the applied drug is incorporated (Twist & Zats, 1986; Cross et al., 2001). One 
commonly used method to improve the absorption of a drug molecule across the skin 
is to formulate the active agent in an appropriate vehicle which could enhance the 
former’s permeation. There is a large range of vehicles which have the capacity to 
fulfill this function including alcohols, esters and fatty acids (Friend, 1991; Friend et 
al.,1991; Liu et al., 1991; Ogiso et al., 1995; Oh et al. 1998; Gorukanti et al., 1999 ; 
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Takahash et al., 2002; Brinkmann & Muller-Goymann, 2003; Artusi et al., 2004; 
Hadgraft, 2004; Brinkmann & Muller-Goymann, 2005; Liu et al., 2009; Watkinson 
et al., 2009 a&b; Williams & Barry, 2012; Lane, 2013). The drug solubility in the 
formulation and its partition coefficient between formulation and epidermis are 
factors that affect the diffusion of drug from the vehicle and the subsequent sorption 
of the drug by the skin. In addition some of the formulation components can interact 
with the skin to modify the delivery of drugs to the stratum corneum, epidermis or 
beyond (Cross et al., 2001). The greater the degree of interaction of the vehicle with 
the stratum corneum then the greater is the potential of that vehicle to alter the 
physicochemical properties of the membrane matrix. This could occur due to 
modification of the packing of the constituent lipids and protein, leading to a 
modified permeation of any concomitantly administered topical agent through the 
membrane due to the modified diffusivity and partitioning of the drug in the altered 
membrane. However in some cases when the drug solubility is low, the solvent 
might permeate into the skin leaving the drug on the surface. Therefore an 
understanding of the interaction of vehicles or mixture of vehicles with the 
membranes might be expected to assist in the optimization of the design of a topical 
formulation.  
 
The uptake of different oils by the silicone, HDPE, PU and cellulose acetate nitrate 
membranes was studied by monitoring the change in weight of the membranes after 
immersion in oil. The gravimetric method, although simple, has been shown by 
many other workers to yield reliable results (Aithal & Aminabhavi, 1990; Dias et al., 
2007; Oliveira et al., 2011). The membranes selected in this study have a range of 
solubility parameters 17.4-28.6 (MPa)1/2 and the oils, which by definition are 
hydrophobic in nature, have solubility parameters in the range of 14.5-17.4 (MPa)1/2. 
The order of interaction with the silicone on the basis of swelling parameters was 
IHD>IPM>HD>LP>OA. While for HDPE it was IHD>LP≥OA≥HD>IPM, the order 
of interaction with PU was OA>IPM>IHD≥HD≥LP and the order of uptake into 
cellulose acetate nitrate was IPM>IHD>HD>OA≥LP. These results indicate that 
membranes interact with oils differently depending on the properties of both the 
membrane and oil. The uptake of the buffer by the membranes was in the order of 
cellulose acetate nitrate>HDPE>PU>silicone. The buffer is much more hydrophilic 
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than any of the oils and might be expected to have a solubility parameter close to 
that of water 48 (MPa)1/2 which is markedly higher than the oils. It thus showed a 
greater affinity for the more hydrophilic cellulose acetate nitrate membrane but 
induced no swelling in the silicone membrane and relatively little swelling in the PU 
and HDPE membranes. The amount of different oils sorbed into cellulose acetate 
nitrate was possibly as a consequence of the porous structure of the membrane’s 
polymer matrix, since the originally open pores of the membrane are likely to fill 
with oil, contributing to the overall weight increase of the membrane. 
 
The transport process of drugs and oils (if interaction occurs) can be rationalised by 
considering diffusion in terms of a net jump of a permeant occurring when an 
adjacent “hole” large enough to accommodate it exists in the polymer matrix 
(Aminabhavi & Khinnavar, 1993). The molecular size of a permeant is expressed in 
terms of molar volume (Table 4.2), which can only be described as an average value 
due to changing bond angles, rotations and chain conformations. To describe the 
vehicle properties the size, shape, HSP values and total solubility parameter and 
relative interactions (with itself and with the polymer matrix) should be taken into 
account. The solubility parameter is directly proportional to the extent to which a 
material coheres to itself upon vaporization. Based upon the familiar rule of “like-
dissolves-like”, the solubility parameter of the vehicle and membrane should match 
in order to enhance the compatibility between them. Accordingly swelling might be 
expected to be a maximum when the difference between the solubility parameter of 
membrane and the solubility parameter of vehicle is zero. 
 
A Hansen plot for the HDPE membrane and oils (Figure 4.19) showed that the 
membrane has a small radius compared with the other membranes, and all the oils 
were located outside the sphere. Such a small radius lowers the chances of finding a 
good solvent for the membrane. This is also confirmed by the high RED values and 
the large distance between the HSP values of the solvents and membrane. Therefore 
generally only small amounts of the oils were taken up by the HDPE membrane 
when compared with silicone membrane. Nevertheless, IHD was sorbed in the 
highest amounts by HDPE membrane, whilst IPM was sorbed in the lowest quantity. 
This occurred despite IHD having the highest RED value and distance from the HSP 
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of the membrane, its greater uptake might be due to physicochemical factors 
including molecular shape, flexibility, volume and homogeneity of polarity. OA 
shape and high molecular volume hinders its sorption into the HDPE membrane. LP 
is a viscous mixture of different hydrocarbons; comprising linear and branched 
alkanes and a small amount of naphthenes (consisted of alkyl-substituted cyclo-
alkanes) (European food safety authority, 2012). It may also include minor amounts 
of nitrogen- and sulphur-containing compounds. Within each of these classes of 
hydrocarbon compounds, there are enormous numbers of individual components, 
which will each partition with varying degrees of affinity depending upon their 
specific molecular structures.  The distance between the HSP values of LP and the 
membranes is similar to the distance of IPM; however the size and viscosity of LP 
might hinder its uptake into different membranes. The distance between the HSP of 
HDPE and HD is the smaller than the distance between the membrane and IHD. HD, 
therefore, was expected to be taken up in greater quantities than IHD since both 
molecules possess the same molecular size. However it would appear that the 
sphericity in structure of IHD compared with HD promotes the sorption by the 
membrane of the former to a greater extent than the latter. These results show that 
the HSP indicates if there is a tendency of sorption, but other molecular properties 
may dictate the extent to which this actually occurs. HDPE membrane is comprised 
of hydrocarbons with a low degree of branching. The absence of branching in a 
closely packed structure, being formed with a higher density leads to somewhat high 
stability and excellent chemical resistance (Harper, 2002; Berins 1991). The 
differences in membrane structure are most likely to contribute to the significant 
differences between the amounts of oil sorbed by silicone and HDPE membranes. 
 
PU is a relatively hydrophilic, non-porous, membrane; it has a solubility parameter 
of 20.84 (MPa)½. Despite the PU membrane possessing a comparatively large 
Hansen Solubility sphere (with a radius of 8 MPa1/2), the oils (with the exception of 
OA) did not lie within the sphere (Figure 4.20). As indicated above, an increased 
interaction between vehicle and membrane might be expected to occur for any 
membrane structure where the solubility parameter of the vehicle approaches the 
solubility parameter of the membrane. Being a comparatively (to silicone and 
HDPE) hydrophilic membrane so the distance between the HSP values of the oils 
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and PU was high. Accordingly the affinity of the oils for PU membrane was, 
perhaps, predictably low with the amounts of most oils sorbed being small. However 
as can be seen from Figure 4.20 the position and colour of the symbols relating to 
the oils, indicate that the latter still possess some degree of solvency power on the 
membrane. IPM contains a free ester group within its structure that might have the 
potential to interact with and might even ‘dissolve’ the PU membrane. HD, IHD and 
LP, in contrast, are hydrocarbons and therefore the aliphatic nature of these latter 
oils might only be expected to lead to the involvement of van der Waals and 
dispersion forces between oil and membrane. This lowers the chances of a strong 
interaction between vehicle and solid matrix. However the amount of IPM sorbed 
into the membrane is still very low (compared with other membranes), in agreement 
with the differences between its solubility parameter and that of the membrane, as 
compared to the differences in the solubility parameter value of IPM and those for 
other membranes. OA in contrast to the other oils was located inside the Hansen 
solubility sphere and displayed the lowest HSP distance. Consequently, it was 
associated with polymer chain dissolution-type interactions with PU membrane, 
behaving as an effective plasticizer of the membrane and indeed changed the 
properties and shape of the latter. As a consequence of this plasticization, a large 
increase in weight of the membrane was recorded when it was soaked in OA (this 
corresponded to an increase of around 885.8 mg. g-1 of membrane).  
 
Silicone membrane is cross-linked in structure, and it is likely that the weight gain 
observed following equilibration with a specific oil is more associated with chain 
solvation and subsequent membrane swelling interactions rather than polymer 
dissolution which can occur with non-cross-lined barriers. Figure 4.18 shows the 
Hansen sphere for silicone membrane and the oils. All the oils are located inside the 
sphere. This indicated that all the oils can be considered good solvents for this 
polymer. Therefore since there were differences in the amounts of oil uptake then 
other factors must also affect the extent and degree of interaction with silicone 
membrane such as the molecular size, shape and the HSP distance of the different 
oils.  
 
Chapter 4.  Interaction of oils with model membranes 173 
 
IPM and OA have similar molecular weights (270 g/mol and 282 g/mol respectively) 
and molecular volume (315 and 319.5 respectively), but the effect of each on the 
hydrophobic membranes was different. Almost three times as much IPM was sorbed 
to silicone membrane than OA, thus the differences in sorption could not be 
attributed to the differences in molecular weight. The HSP distance for IPM was 
lower than that for OA. This suggests that both the distance and the molecular nature 
(e.g. shape, polarity, molecular flexibility) are also key factors affecting the 
interactions between the solvent and the membrane. For example, the low interaction 
of OA with the membrane may be related to its molecular shape since oleic acid 
contains a cis double bond which provides OA with a ‘kinked’ structure (Green et 
al., 1988). Such molecular geometry will lead to a less flexible molecule which 
requires a greater expenditure of energy to penetrate into the membrane. The 
presence of carboxylic acid group in oleic acid may also contribute to the decreased 
uptake of this oil by the silicone membrane (Cross et al., 2001). The –COOH group 
will increase the polarity of the oil and this moderate polarity would be anticipated to 
decrease its uptake by the silicone membrane (Lee et al., 2003).  
 
The lower the HSP distance value, the more alike the polymer and solvent, therefore 
the vehicle that has similar partial components to the partial components of the 
membrane might be expected to induce the greatest swelling of the membrane. The 
values for solubility parameters reported previously for IPM were for the Hildebrand 
(or total) solubility parameter. The previously reported values for IPM are 17.2 
(MPa)½(Dias et al., 2007), 16.4 (MPa)1/2 (Cross et al., 2001) and 16.8 (MPa)½ 
(Oliveira et al., 2012). The values reported for silicone membrane are: 15.3(MPa)½ 
(Most, 1972; Liron et al., 1984; Cross et al., 2001) and 16.4 (MPa)½ (Dias et al., 
2007). Comparing the Hildebrand solubility parameter of OA and IPM (Table 4.2) to 
the Hildebrand solubility parameter of silicone membrane shows that the solubility 
parameter value for OA is closer to the value of the membrane than the 
corresponding value for IPM. Hence the preferential uptake of IPM compared with 
OA is hypothesized to derive from the distance between partial HSP components and 
not the total solubility parameter. Therefore the HSP values and distance between 
the Hansen solubility sphere values oils and membranes should both be taken into 
account. It can be concluded therefore, that the HSP distance, combined with the 
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shape, polarity and other physicochemical properties of OA most likely explain these 
observed differences in IPM and OA uptake by the membrane. The results of this 
study confirmed the findings of an earlier study (Dias et al., 2007a), when it was also 
reported that OA was taken up in lower amounts than IPM by silicone membrane..  
 
IHD was the oil that was taken up in greatest quantity by the silicone membrane, an 
amount that was significantly higher than all the other oils studied. HD has the same 
molecular formula as IHD but in contrast to the latter comprises a linear 
hydrocarbon structure. The solubility parameter of HD is higher than the solubility 
parameter of IHD but since both oils are hydrocarbons, they interact almost entirely 
through dispersion forces. The magnitude of the dispersion forces is related to the 
surface area of the molecule; the larger the molecule, the greater the number of 
temporary dipoles, and the greater the intermolecular attractions. Molecules with 
straight chains contain more surface area, and thus greater dispersion forces, than 
branched-chain molecules of the same molecular weight.  
 
Despite both oils having the same molecular size, the molecular shape of IHD is 
almost spherical, while the shape generated by HD is oval (Table 4.2). Both oils are 
inside the Hansen sphere which means both oils are good solvents for the membrane. 
In spite of this occurrence, the RED value and the HSP distance of HD are lower 
than IHD value, although IHD was sorbed in greater amounts than HD. Indeed, the 
amount of IHD that was sorbed by the silicone membrane was more than twice that 
of HD (Table 4.4). In addition, IHD uptake by other membranes was in most cases 
significantly higher than HD (Table 4.5). This suggests that again the chemical 
structure and shape of the vehicle might be of relevance to the degree of swelling. 
Silicone membrane is polydimethylsiloxane which itself comprises branched chain 
molecules. Cross-linked polymers generally are less compact than their linear 
counterparts and small spaces will exist between the polymer chains. Thus the 
branched structure of IHD along with its compact spherical shape could enable a 
greater partitioning of the oil into the space between the branched cross-linked 
membrane structure. If this occurs in stratified membranes composed of non-
covalently linked molecules then this could affect the packing of those membranes. 
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All other oils had smaller RED values and HSP distances, when compared with that 
of IHD. 
 
The kinetic study which was aimed at determining the vehicle interaction with 
silicone membrane indicated that the swelling of the silicone membrane in all oils 
was complete after the first hour of soaking. There was no significant difference in 
either the measured thicknesses of the membrane between 1 and 24 h of immersion. 
Therefore the thickness of the membrane was not expected to be changed after the 
first hour of the diffusion study. 
 
Binary mixtures of some vehicles have been reported previously to offer synergistic 
effects in terms of leading to higher epidermal drug transport and reduced skin 
irritation (Cooper et al., 1985; Catz & Friend, 1990). If binary formulations exhibit a 
pure additive effect of the composite vehicles, a good correlation between the ratio 
of vehicles and the effect on the permeation of drugs through the membrane should 
be apparent. However this has not proved to be the case for a number of transdermal 
formulations (Karande et al., 2006). It has been shown previously that permeation of 
a molecule through a barrier membrane can (and does) occur independently of 
permeation of a co-applied molecule (Dias et al., 2001; McAuley et al., 2009). 
However, this has not been shown in the case of co-administered oils nor to 
differentiate between other co-applied vehicle components. When two oils are mixed 
and applied to a membrane, it has not been established whether the oils are sorbed in 
the same ratio as that in the applied solution. Different oily vehicles were blended 
together and the amount of swelling was measured by weight increase and then 
subsequently the partitioned oils were extracted and quantified by gas 
chromatography. All of the studied oil blends exhibited total miscibility with each 
other. The results presented in Figures 4.4 - 4.6 show the percentage amount of oil 
absorbed by silicone membrane from different oil blends. 
 
There was no significant difference in the total weight of oil sorbed when IHD was 
blended with either IPM or HD (Figure 4.4). However when the partitioned oil was 
extracted there was a significant difference between the relative amount of IHD 
absorbed compared with HD (Figure 4.8). IHD was absorbed into the silicone 
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membrane in a greater proportion than the ratio present in the original applied blend. 
In contrast the ratio of IHD/IPM sorbed from different ratios of the two oils was the 
same as that in the applied vehicle. The amounts of IPM and IHD extracted from the 
membrane were superimposable and correlated linearly with the amounts of each in 
the original solution (Figure 4.7). Similar results were obtained for HD/IPM blends 
(Figure 4.11). IPM displayed a lower HSP distance value compared to that of HD 
relative to silicone membrane. On the other hand HD displays a smaller molecular 
size than IPM (Table 4.2). All these factors might be expected to affect the solvent 
uptake and the swelling of the silicone membrane; nevertheless both oils were 
sorbed in similar amounts. Koszinowski (1986) studied the diffusion behaviour of 
linear alkanes, linear alcohols and substituted phenols in polyolefins. The results 
showed that as the number of carbon atoms increased, both the alcohols and phenols 
approached the behaviour of the alkanes as a consequence of the increased shielding 
of the –OH group. This is due the high degree of rotational freedom about the 
carbon–carbon bond of the longer chains, leading to chains folding back upon 
themselves, as a consequence of intramolecular interactions through the flexible 
methylene groups composing the carbon chain. These methylene moieties are able to 
form ‘ring’ structures with an adjacent moiety on the molecule (ester group) (Nisbet, 
1977; Forster et al., 1991), whilst still retaining the linear structure. IPM could be 
behaving in the same way. IPM comprises a molecule containing a polar ester head 
group at the end of a relatively long hydrocarbon chain. As the number of carbon 
atoms is increased, the polarity is “diluted” by the presence of a longer hydrophobic 
tail, and this in turn leads to a lowering of the solubility parameter of any long ester. 
When blending IPM with HD or IHD, the partition behaviour of the blends into a 
silicone membrane was the same, indicative of the weak specific interactions 
between silicone membrane and the ester group of IPM. The long alkyl chain 
attached to the ester group dominates the overall size and shape of the molecule and 
diffusion occurs preferentially along the direction of greatest length of the molecule. 
 
Blends of OA with IHD, HD or IPM, showed that there were resultant significant 
differences in the amounts and the ratios of oleic acid sorbed to the membrane 
(compared to that present in the original applied blended oil). IHD appeared to be 
sorbed preferentially in comparison to both IPM and HD (in descending order) from 
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blends of each with OA. From the values determined using the HSPIP software, OA 
has a solubility parameter (17.4 MPa½) that is similar to that of silicone membrane 
(17.4 MPa½). OA and HD display similar distance value relative to silicone 
membrane which is lower than the distance between IHD and silicone membrane. 
Therefore although OA might have been expected to be taken up into the silicone 
membrane in greatest quantity, it was in fact the less preferentially sorbed oil from 
the different blends. This is likely to be a consequence of both the higher molecular 
weight of OA in comparison to other oils as well as its larger molecular shape, 
discussed above. It has been reported that OA in conjunction with a polar solvents 
such as propylene glycol has been shown to be a more potent penetration enhancer 
(Mahjour et al., 1989; Larrucea et al., 2001). The proposed explanation for this 
synergistic effect was the facilitated incorporation of OA into the stratum corneum 
lipid alkyl domains by the interaction of propylene glycol with the polar head groups 
(Oh et al., 1998). It was also reported that short chained fatty acids were able to 
disrupt lipids when applied in a lipophilic mineral oil-based formulation, while the 
uptake of long chained fatty acids, such as OA were enhanced when applied with 
hydrophilic, polar solvents such as propylene glycol (Wang et al., 2004). In this 
study blending IHD with OA enhanced the uptake of OA into the membrane. IHD 
swelled the silicone membrane and this affected the packing of the cross-linked 
polymer chains, which might allow chain extension resulting in extra free volume, 
and facilitate OA uptake. This enhancement did not occur to the same extent as with 
HD or IPM blends with OA. Blending OA with HD, IPM and IHD produced the 
same trends where the amount of OA taken up by the membrane did not change 
between 50 and 75% (Tables 4. 7 - 4.9). 
 
Blending LP with IHD, HD and IPM, led to an increase in the total amount of oil 
sorbed by the silicone membrane and this amount was larger as the ratio of the IPM, 
HD and IHD present in the blend increased (Figures 4.4 - 4.6). The amount of oil 
sorbed by silicone membrane of both oils was the highest when LP was blended with 
IHD and lowest when blended with HD. The results of GC analysis after oil 
extraction show that the amount of IHD and IPM extracted was significantly greater 
than the amount of LP (Figures 4.9 and 4.12). The solubility parameter of LP is 14.5 
(MPa)1/2, which is close to the solubility parameter of IHD 14.7 (MPa)½. Light liquid 
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paraffin consists of a mixture of alkanes, the latter comprising single-bonded carbon 
and hydrogen atoms, which renders them relatively inert to interacting with matrices. 
HD and IHD are present in small amounts as natural components of LP. It has been 
reported that the paraffinic hydrocarbon mixture consist of 87.9 w/w% normal 
alkanes and 12.1 w/w% isoalkanes from C10 to C25 (Postnov, 1972). The amount of 
LP sorbed by the membrane is low compared with the IPM, HD and IHD, possibly 
due in part to the content of molecules having a high molecular weight and a high 
molecular volume; the higher molecular volume decreases the ability of the oil to be 
sorbed into the membrane. IPM and IHD were preferentially taken up by silicone 
membrane since they are smaller in size and have a higher affinity to the membrane. 
LP viscosity is around 30 mPas, whilst the viscosities of IPM, HD and IHD 
viscosities are 5 mPas at 20°C, 3.34 mPas at 25°C and 5.2 mPas at 20°C 
respectively. The higher viscosity of LP may also reduce its tendency to be sorbed 
into silicone membrane as a consequence of the lower diffusion coefficient of 
viscous liquids. The percentage of oil sorbed by silicone membrane when soaked in 
HD/LP was lower compared with IHD and IPM blends (Figures 4.4 - 4.6). When the 
oil was extracted there was no significant difference in the ratio of HD and LP 
sorbed in comparison to the ratio present in the applied oil (Figure 4.14). Hence both 
the total amount of oil sorbed was low, and the affinity of the hydrocarbons in the 
LP mixture to the membrane appears to be comparable with that of HD affinity to 
silicone membrane.  
 
In diffusion studies the silicone membrane was soaked in buffer overnight, then it 
was sandwiched between the donor and receptor chamber of the Franz cell. Oily 
vehicles were introduced into the donor compartment, whilst the receptor contained 
phosphate buffer. In order to determine the ratio of the oil remaining in the donor 
compartment under such conditions, blends of HD/IHD were added to the donor 
compartment and a sample of the applied and remaining oils in the donor 
compartment were analysed. HD/IHD blends were employed since both oils have 
close physicochemical characteristics and the ratio of the two oils sorbed by silicone 
membrane from the blends was found to be significantly different in the uptake 
studies, to that present originally in the solution applied to the membrane. Also both 
oils could be readily detected and quantified by gas chromatography analysis, rather 
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than the method being dependent upon a gravimetric analytical factor (as with some 
oils). The results show that the composition of the oil has changed. IHD was sorbed 
to greater extent compared with HD over a period of six hours therefore altering the 
original weight ratio. These results were comparable to those obtained in the silicone 
membrane uptake studies. These results indicated that since one vehicle was 
preferably sorbed compared to the other from this particular blended vehicle, then 
the thermodynamic activity of any applied drug in that vehicle would also be likely 
to be changed as a function of time. It would be either enhanced or reduced, 
depending on the drug solubility in the two vehicles and the amount of vehicle 
sorbed by the membrane. In addition the nature of the membrane might also change 
and possibly present an environment in which the agent is more soluble – promoting 
the potential uptake into the membrane, alternatively if the oil that is preferentially 
absorbed is one in which the agent is less soluble then uptake may be reduced. 
Karande et al. (2006) studied the effect of pure penetration enhancers and mixtures 
on the skin's barrier properties and concluded that a random combination of two 
penetration enhancers was not necessarily more effective at enhancing transport than 
the individual components. The results of the current study indicate that this might 
be due to the preferential uptake of one penetration enhancer into the membrane 
compared to the other. Also fatty acids were found to produce a significantly lower 
enhancement ratio compared to many other categories of ‘enhancer’ (Karande et al., 
2006). Herein, OA was often found to be the oil sorbed into the membrane in lowest 
amounts. 
 
In order to assess the effect of oils on silicone membrane, the membrane was soaked 
in LP, HD and IHD and the diffusion of MP from buffer across such membranes was 
studied. These three oils were selected for study since they were sorbed into the 
membrane in different ratios from oil binary blends. However the three oils have 
similar solubility parameters, and physicochemical characteristics, but comprise 
hydrocarbons that differ in the shape. MP was selected because it has moderate 
hydrophilic/hydrophobic characteristics with an intermediate partition coefficient 
and exhibits relatively high diffusivity through silicone membranes (Twist & Zatz, 
1986; Romonchuk & Bunge, 2006; Oliveira et al., 2012 a&b).Therefore any pre-
treatment solution that increased the MP permeation is likely to modify the 
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permeation of other compounds (Nanayakkara et al., 2005).The pre-treatment of the 
silicone membrane with any of the oils was found to increase MP flux from all oils 
in comparison with the use of buffer (Table 4.10).  The amount of oil sorption into 
silicone membrane correlated well with the enhancement ratio, the order of 
enhancement being IHD>HD>LP. The highest enhancement of IHD might be due to 
its higher sorption and presumably more favourable interactions with silicone 
membrane, leading perhaps to a greater disruption of its barrier properties. It might 
also by its presence in the membrane enhance the partition of MP into the oil-
containing matrix of the membrane. It can be concluded from the results that as the 
amount of oil sorbed into silicone membrane increases, the diffusion of the applied 
drug was promoted. Since the solubility of MP in the oils, and the physicochemical 
properties of HD and IHD are the similar, it appears that the branching of IHD and 
the spherical shape of the molecule produce a positive enhancement in the uptake 
and subsequently on the penetration of MP. Figure 4.17 shows that the cumulative 
amount of MP that penetrated the silicone membrane was highest when the 
membrane was pretreated with IHD. This indicates that the membrane properties 
have been changed and silicone membrane diffusional resistance might have 
changed. Therefore as the degree of solvent uptake increases the diffusional 
behaviour of the membrane will change, depending on the membrane and sorbed 
solvent properties.  
 
In conclusion this study has shown that oils interact with membranes to different 
extents depending on the molecular size, shape and structure. The results also 
suggest that the Hansen solubility parameter values and distance are factors that may 
require consideration when studying the membrane interaction with different 
vehicles. It would appear that oils that are highly sorbed by membrane might either 
affect the packing of the membrane or provide a modified matrix into which a drug 
might more favourably partition, thereby influencing drug permeation. 
Chapter 5.     Multivariate analysis of vehicle uptake  181 

















MULTIVARIATE ANALYSIS OF VEHICLE UPTAKE BY 







Chapter 5.     Multivariate analysis of vehicle uptake  182 




Recently there has been much interest in computer models to investigate the 
relationship between the structure of a molecule and its dermal penetration 
(Mitragotri et al., 2011; Chen et al., 2013; Hathout, 2014). Molecular permeation 
across the epidermis has previously been demonstrated to be determined by a 
number of physicochemical properties, for example, the lipophilicity, molecular 
weight and hydrogen bonding ability of the permeant. In the current work it has 
also been shown that interactions between the membrane and some oily vehicles 
(previously unreported to modify membrane barriers) can occur. Therefore there 
are several physicochemical parameters that may determine the rate and degree of 
permeation of any compound formulated within a topical vehicle across a 
membrane. As such it is likely that permeant, vehicle and membrane descriptors 
will be integral components of any model that seeks to understand the significant 
factors that influence the process of membrane permeation. Should it be possible 
to identify a correlation between the chemical structures and physicochemical 
properties of vehicles and permeant to membrane penetration it might be possible 
to define the desirable features of both compound and vehicle that might promote 
transport. This would enable a better approach to formulation and lead to a 
reduction in the amount of screening, involving in vitro and in vivo testing, that is 
currently required to identify suitable topical agents and vehicles.  
 
5.1.1 Multivariate analysis 
 
Multivariate data analysis can be defined as: ‘the investigation of many variables 
simultaneously, in order to understand the relationships that may exist between 
them’. A univariate approach only provides part of the overall picture. For 
example an examination of the mean with standard deviation describes one 
variable, but provides no information on how that one variable is related to the 
others. Therefore a univariate approach provides an over-simplistic assessment of 
the data. Moreover it fails to detect any relationship that may exist between the 
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variables being studied because it treats all such variables as being independent of 
each other (Rencher, 2002). This latter phenomenon is known as covariance or 
correlation and it forms a central theme in multivariate analysis. The term 
covariance is a measure of the joint variance of two variables and it describes the 
influence that one variable has on other variables. Multivariate data analysis can 
be classified into three main areas (Wold & Sjostrom, 1998): 
 
 Exploratory data analysis: sometimes this is termed ‘data mining’. Such action is 
useful for gaining deeper insights into large complex data sets. It enables any 
hidden structure which results from the influence of all variables acting together 
to be extracted. This will show the data-specific patterns or groups and such 
patterns enable new data to be classified into similar groups.  
 
 Regression analysis: is the process of developing a model from the relationship 
between the variables in the available data to predict response. These models can 
be used later to predict a new and future event.  
 
 Classification: is the separation (or sorting) of a group of objects into one or more 
classes based on distinctive features. This could be used to separate the objects 
according to their behaviour or composition. 
 
5.1.2 Quantitative structure property relationships 
 
The in vitro and in vivo experimental measurement of skin permeability is a 
difficult and complex process, due in part to ethical difficulties with respect to 
human and animal experimentation. In addition, there are a high number of 
chemicals that come in contact with the skin; also it is costly and time consuming. 
There are also difficulties in obtaining excised human skin, which is the best 
membrane to use for in vitro measurements. As a consequence, there has been a 
great interest over the past years to avoid unnecessary and costly in vitro testing 
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and develop models that would allow the formulation scientist to predict the 
ability of a compound to cross the skin using its physicochemical characteristics. 
A number of attempts have been made to develop quantitative structure–
permeability relationship (QSPR) models based on the skin permeation of 
compounds derived from in vitro experiments, with skin permeability linearly 
correlated to the physicochemical properties and/or molecular structure 
parameters of the chemical compounds (Flynn, 1990; Potts & Guy, 1992; 
Wilschut et al., 1995; Pugh et al., 1996; Moss et al., 2002; Mitragotri, 2003; 
Yamashita & Hashida, 2003; Mitragotri et al., 2011). Such models have been used 
by environmental agencies for safety assessment of dermal exposure to industrial 
and environmental hazards, and also by pharmaceutical companies to screen and 
select drugs for possible transdermal delivery potential.  
 
The physicochemical descriptors most employed in QSPR include 
hydrophobicity, molecular size or weight and hydrogen bonding. Such models are 
expected to be consistent with the transport mechanisms by which permeants 
traverse the skin barrier (Potts & Guy, 1992). For the development of QSPR 
models, a key feature is that all data must be consistent and reliable. Ideally all 
experiments should be performed under standardised conditions (i.e. employing 
the same skin type from the same anatomical region and constant laboratory 
conditions (such as temperature, concentration and receptor medium, for 
example)). However, practically this has not been the case, and therefore a 
limitation of QSPR models is that the data used in most QSPR models are derived 
from an extensive database from different investigators and laboratories using 
different experimental protocols. Controlled studies involving inter- and intra-
laboratory measurement of the diffusion of MP across a synthetic membrane 
using a defined protocol produced a variability of 35% with a fourfold difference 
between the highest and lowest flux values (Chilcott et al., 2005). A much larger 
inter- and intra-subject variability in the skin permeation of exogenous materials 
has also been previously reported (Tsai et al., 2003). Accordingly nearly all QSPR 
models are inherently subject to experimental error (Moss et al., 2002).  
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Many of the developed QSPR models are based on a data base assembled by 
Flynn (1990). This comprised 97 human skin permeability coefficients for 94 
compounds obtained in vitro through human skin, from 15 different literature 
sources. However other investigators have shown that Flynn's data set contains a 
high degree of experimental error resulting from combined inter- and intra-
laboratory error as well as variation due to the skin being from different sources 
and locations on the body (Johnson et al., 1995; Abraham et al., 1997; Degim et 
al., 1998; Moss et al., 2002). 
 
The main focus of the development of QSPRs has been with a view to assessing 
the permeability coefficient (Kp) of compounds untested either in vitro or in vivo. 
The Kp of a compound is the ratio of steady-state flux expressed as a function of 
the concentration of the test compound with units of m.s-1 (Wilkinson & 
Williams, 2002). Kp is therefore generally constant over a range of concentrations. 
In addition over time, a substantial database of experimentally determined Kp 
values from aqueous vehicles has built up, allowing theoretical predictions to be 
directly compared with real measurements (Mitragotri et al., 2011). 
 
One of the most widely used empirical models is that developed by Potts and Guy 
(Equation 5.1), which predicts permeability coefficient (Kp) based on Log octanol 
water partition coefficient (Log Koct) and molecular weight (Mwt) (Potts & Guy, 
1992): 
 
Log	Kp=	6.3	+	0.71	Log	Koct	-0.0061Mwt  Equation 5.1 
 
These workers studied more than 90 chemicals with MWs ranging from 18 to 
over 750 and Log Koct values from −3 to +6 applied in different vehicles. The r2 
of the multiple regressions was 0.67 suggesting that approximately two thirds of 
the variability in the data was explained by the model. In Equation 5.1, the rate-
limiting transport barrier of the skin is implicitly assigned to the lipophilic stratum 
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corneum and, as a result, the model can generate unfeasible values of Kp for 
compounds that are extremely lipophilic (Mitragotri et al., 2011). 
 
Later, Potts and Guy attempted to describe the effects of descriptors for the solute 
hydrogen bond acidity (∑α2H) and the solute hydrogen bond basicity (∑β2H) and 
the molecular volume (MV) on Kp (Potts & Guy, 1995): 
 Log	Kp	 = 	0.0256MV	– 	1.72	ߑߙ2ு– 	3.93ߑߚ2ு– 	4.85  Equation 5.2 
 
These workers used 37 samples and the r2 of the multiple regressions was 0.94 
indicating an improved fit to the model. 
 
Several QSPRs have been derived since the publication of Potts and Guy’s model. 
However Moss et al. (2011) have shown that there were significant differences 
between permeability values measured experimentally and those determined using 
the Potts and Guy (and other QSPRs) equations. They showed that the greatest 
difference between experimental and predicted values was found at high Log Koct 
values. 
 
5.1.3 Principal component analysis  
 
Principal component analysis (PCA) is a descriptive or exploratory technique for 
reducing the amount of dimensionality in complex data when there is a correlation 
between variables (Han et al., 2006; Reid & Spencer, 2009). PCA reduces the 
dimensionality by extracting the smallest number of components or factors that 
account for most of the variation in the original data, and summarizes the data 
with little loss of information. It is not a useful technique if the variables are 
uncorrelated (Miller & Miller, 2010). In addition, it aids in the visualization of the 
relationship and correlation among different variables; by graphing the variables 
in different groups or patterns and removing the noise (un-useful information) 
from the data (Abdi & Williams, 2010). This results in more easily interpretable 
Chapter 5.     Multivariate analysis of vehicle uptake  187 
 by membranes and permeation data 
 
output which contains relevant information (Barcelo & Petrovic, 2011). PCA 
separates the data into principal components (PCs). Each principal component 
(PC) contributes to explaining the total variability in the observed results in a data 
set. However, the PCs are also chosen so that the first PC (PC1), accounts for 
most of the variation in the data set, the second (PC2), accounts for the next 
largest variation and so on (Wold, 1987). Hence, when a significant correlation 
occurs the number of useful PCs is much less than the number of original 
variables. 
 
In mathematical terms the PCs are the eigenvectors of the covariance matrix and 
the technique for finding these eigenvectors is called eigenanalysis. 
Corresponding to each PC (i.e. eigenvector) is an eigenvalue, which gives the 
amount of variance in the data set that is explained by that specific PC. Therefore 
obtaining the PCs is entirely equivalent to finding the eigenvectors of the 
covariance matrix: each eigenvector generating one PC. The corresponding 
eigenvalue provides the variance of that PC, and the PCs with the largest 
variances are the most important (Miller & Miller, 2010). The PCs are derived by 
finding the projections which maximize the variance, with the first PC being the 
direction in feature space along which projections have the largest variance. The 
second PC is the direction which maximizes variance among all directions 
orthogonal to the first. The kth component is the variance-maximizing direction 
orthogonal to the previous k-1 components. 
 
PCA uses two graphical visualization tools that must be displayed together to map 
the co-variance structure in the data. These comprise a: 
 
 scores plot: which provides a map of the samples, showing a summary of the 
relationship between the samples. Score plots can reveal patterns, such as clusters, 
trends and outliers in the data (Idborg-Björkman, 2003).  
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 loadings plot: which provides a map of the variables, showing a summary of the 
variables. It is useful for identifying the important variables. Loading plots reveal 
covariances among variables and can be used to interpret patterns observed in the 
score plot (Idborg-Björkman, 2003). 
 
Applications of PCA have found widespread use in most stages of pharmaceutical 
research and industry. For example it has been used in distinguishing, quantifying 
and predicting the compression behavior of pure excipients and binary blends on 
tablet formation and properties (Haware et al., 2009). Other research workers 
have used PCA to gain a general overview of the relationship between four 
groups of excipients (filler, binder, disintegrant and lubricant) with respect to 
desirable tablet properties (i.e. good mechanical strength and short disintegration 
time) (Gabrielsson et al., 2000 & 2004). The effect of powder properties on the 
segregation tendency has also been studied using PCA (Xie et al., 2008). Other 
formulation scientists have used PCA analysis for characterizing the performance 
of nebulizers (Shi et al., 2009). In addition, it has been used to study the relative 
importance of certain structural characteristics in terms of their contribution to 
transdermal permeation (Ghafourian et al., 2010; Hathout, 2014). It has also been 
employed in connection with studies concerned with the: accumulation of 
essential oil in herbs (Shiyab et al., 2012); characterization of pharmaceutical 
solids (Laitinen et al., 2004; García-Muñoz & Carmody, 2010); investigation of 
drug and excipient content in pharmaceutical formulations (powders and tablets) 
(Sarraguça & Lopes, 2009); evaluation of dissolution profiles (Tsong et al., 1997; 
Adams et al., 2001, 2002; Maggio et al., 2008); the analysis and differentiation of 
polymorphic forms (Jorgensen et al., 2006; Kogermann et al., 2007, 2008; 
Maggio et al., 2009); and classification of drugs according to their mode of action 
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5.1.4 Data pretreatment 
 
Data for PCA and QSPR should be arranged into a table (matrix) in such a way 
that each row represents one sample and each column represents one measured 
variable (e.g. molecular size). The matrix is presented in two co-existing spaces, 
variable space and object space, which together contain all available data 
(Kvalheim, 1988). Subsequent to the analysis, constant descriptors are eliminated, 
since such descriptors cannot provide useful statistical information. 
 
Also prior to analysis, data are often pre-treated, in order to transform the data 
into a form suitable for analysis. The first step of pretreatment is data scaling. 
Variables often have substantially different numerical ranges and a variable with a 
large range has a large variance, whereas a variable with a small range has a small 
variance. Unless the data are scaled, a variable with a large variance will 
dominate. The most common scaling technique employed is unit variance scaling. 
Unit variance scaling shrinks the long variables and stretches the short ones. 
Therefore no variable is allowed to dominate over another because of its length 
(Figure 5.1) (Eriksson et al., 2006). In some instances, if all the data are on the 
same scale, no scaling for the data is needed for example spectroscopic data. 
 
The second part of data treatment is to effect ‘mean-centering’. In mean-centering 
the average value of each variable is calculated and subtracted from the data 
(Figure 5.2). The subtraction of the averages from the data corresponds to a 
repositioning of the system such that the average point is the origin (Geladi & 
Kowalski, 1986). 
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Figure 5.1 Data after mean–centering and unit variance scaling all variables will 
have equal length and mean value zero (Eriksson et al., 2006). 
 
 
Figure 5.2 The mean-centering procedure corresponds to moving the origin of the 
co-ordinate system to coincide with the average point (Eriksson et al., 2006). 
 
5.2 Aims and objectives 
 
One important goal for the pharmaceutical industry is the identification of an 
appropriate vehicle which could enhance the diffusion of the administered drug. 
To reduce the risk, cost and workload, it is useful if a relationship between 
chemical/structural properties and diffusion parameters could be found. One 
approach to find this relation is the use of multivariate analysis. The application of 
multivariate analysis to data derived using synthetic membranes and relating the 
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analytical results to data obtained employing epidermis, may provide the 
knowledge to enhance dermal delivery, develop new therapeutic formulations, 
boost the cosmetic industry, whilst additionally lead to a reduction in  toxicity and 
irritancy (caused by dermal exposure of chemical substances).  
 
The permeability through skin is controlled by the properties of the permeant and 
the vehicles, which are related to the molecular descriptors of both. The chemical 
structure of a vehicle can determine the effect that it will have on the membranes 
or on the partitioning of the penetrant, leading to the observed changes in the skin 
penetration profile of the penetrant. Most previous models have largely 
concentrated on the chemical structure of the drug; they did not take into account 
the effect of vehicle or membrane on the diffusion process. The vehicle is as 
important as the drug itself, since it could enhance or retard the permeation of the 
administered drug. Therefore in this study the permeant, vehicle and membrane 
descriptors were all considered in the statistical analysis. The aim of this study 
was to seek to understand the influence of chemical/structural descriptors of 
permeants, oily vehicles and membranes on solvent uptake by the membrane, flux 
and permeability coefficient of the compounds through the membrane, and the lag 
time before diffusion of the compound can be detected.  
 
In order to fulfill these aims the following objectives were identified: 
 
 Detect the important descriptors of oily vehicles which enhance solvent uptake 
into membranes having different characteristics.  
 
 Extract the main descriptors of the vehicles and permeants responsible for 
identifiable patterning of behaviour in the uptake or diffusion studies. 
 
 Examine the range of descriptors for permeants, vehicles and membranes to 
determine if a statistical relationship exists between the properties of all three, and 
dermal absorption. 
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Materials used in this study have been reported previously and are listed in Table 2.2. 
 
5.3.2 Franz cells studies 
 
The fluxes of the model permeants through synthetic membranes (silicone, HDPE and 
PU) and human epidermal sheets were assessed as described below. 
 
5.3.2.1. Synthetic membranes 
 
5.3.2.1.1 Diffusion through silicone membrane 
 
The diffusion through silicone membrane was carried as described previously 
(Section 3.3.3.2). 
 
5.3.2.1.2 Diffusion through high density polyethylene and polyurethane 
membranes 
 
The diffusion of the model permeants from the suspensions was examined using 
HDPE and PU membranes. Each suspension was prepared by adding excess 
permeant to 6 g of oil and was incubated at 32˚C in a shaker water bath overnight. 
Diffusion experiments were carried out using calibrated Franz cells with a 
receptor phase of 2 mL and a diffusional area of 0.65 cm2. Before the experiment 
the membrane was immersed and soaked in the receptor media overnight. The 
membrane was cut into circular discs and placed between the donor and the 
receptor compartments of the Franz cell. The receptor compartment was carefully 
filled with phosphate buffer pH 7.0 and the cell placed on a stirring plate 
submerged in a water-bath maintained at 32˚C. A small teflon-coated magnetic 
bar (about 5 mm length) was included in the receptor compartment such that 
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stirring occurred throughout the duration of the experiment. After allowing the 
membrane to equilibrate with the receptor fluid, 200 μL of the oily suspension 
(the sample contained undissolved/suspended solids of permeants at 32oC) of 
model permeant was then introduced into the donor chamber. At appropriate time 
intervals, 200 μL samples were withdrawn from the receptor compartment and 
immediately replaced with an equal volume of fresh phosphate buffer, (pH 7.0). 
The duration of the experiment was 7 h through HDPE and 6 h through PU. Each 
sample was analysed for permeant using the HPLC method described previously 
(Section 2.3.2). The concentration of the permeant in the receptor solution at any 
time point was corrected for previous sample removal. Each experiment was 
conducted five times. 
 
The cumulative amounts (per unit surface area of membrane) of permeant which 
diffused across membrane were plotted against time (h). The slope of the linear 
plot was taken as the flux of permeant permeation. 
 
5.3.2.2 Human epidermis  
 
5.3.2.2.1 Preparation of epidermal sheets  
The preparation of epidermal sheets was carried as described previously (section 
2.3.5.2). 
 
5.3.2.2.2 Diffusion through human epidermis 
 
The permeation of MP, BP and CF from the oily vehicle and buffer pH 7.0 was 
determined using Franz cells. The receptor compartment was carefully filled with 
phosphate buffer, after which the receptor temperature was maintained at 32C.  
The epidermal membrane was then allowed to equilibrate with the receptor fluid 
for 1 h, after which 200 μL of the oily suspension (as prepared in Section 
5.3.2.1.2) was then introduced onto the stratum corneum (i.e. donor 
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compartment). At appropriate time intervals 200 L of the receptor phase were 
withdrawn and immediately replaced by an equal volume of fresh receptor 
solution.  The duration of the skin permeation experiments was 8 h for MP and 
BP and 10 h for CF. A minimum of four cells was used for each vehicle, and the 
permeant concentration of receptor samples was analysed by HPLC methods 
(Section 2.3.2). 
 
The concentration of the permeant in the receptor solution at any time point was 
corrected for previous sample removal. The cumulative amount of permeant 
permeating per unit skin surface area was plotted as a function of time, and the 
slope of the linear portion of the plot was determined and taken as a measure of 
the average flux (between 4&8h for MP and BP, 4-10h for CF)   (J, µg cm-2 h-1). 
The permeability coefficient (KP, cm-2 h-1) for each solute was calculated as 
follows: 
 Kp	 = 	Js	/	Cv     Equation 5.3 
Where CV is saturated solubility of the permeant in the applied vehicle. 
 
5.3.3 Statistical analysis 
 
Data reported in this study are usually the mean of n≥3 with the standard 
deviation (sd) given. In order to establish differences in the parameters measured 
then statistical analysis of the data was undertaken using either analysis of 
variance (ANOVA) or student’s t- test, as appropriate. Post hoc comparisons of 
the means of individual groups after carrying out ANOVA were performed using 
Tukey’s test. ANOVA and Post hoc Turkey’s test were performed using SYSTAT 
version 5.0 (SYSTAT Software Inc., CA, USA), and the level of significance was 
taken at p≤0.05 in all cases.  
 
QSPR models were generated using Microsoft Excel® software regression 
analysis. Data were evaluated by multivariate analysis PCA using The 
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Unscrambler® (CAMO Software, Oslo, Norway). The analysis was performed to 
identify both the most important factors that affect, and to quantify the influence 
on, the solvent uptake and diffusion of compounds through model membranes and 
human epidermis. An important factor in the strategy is to characterise the 
materials in terms of multiple variables. A separate PCA was calculated to 
identify patterns in the dependent variables due to the range of input descriptors 
for each of the following dependent variables: membrane solvent uptake, flux, Kp, 
lag time through synthetic membranes and flux through epidermis. In order to 
carry out the analysis, data were scaled and mean-centered using Microsoft 
Excel® software. 
 
The correlation was performed on the following descriptors: solvent uptake into 
membranes and solubility of the permeant in the oil with various molecular 
descriptors, such as: δD, δP, δH, solubility parameter MPa½, Mvol, Mwt, density,  
Mpoint, Log Ko/w, ovality, molecular connectivity index, weight, Log P, TPSA, 
vdw_vol, vdw_area, a_nH, a_nC, a_nO, b_1rotN, b_1rotR, b_count, b_double, 
b_rotN, b_rotR, b_single, lip_acc, lip_don, opr_brigid, opr_nrot, chi0, chi0_C, 
chi1, chi1_C, chi0v, chi0v_C, Kier1, Kier2, Kier3, Kier flex, balabanJ, 
Q_VSA_HYD_PEOE_VSA_HYD, being used. However some descriptors were 
eliminated from the analysis since they had the same value therefore they would 
not have any statistical contribution on the analysis. The descriptors eliminated 
were: b_ar, opr_nring, Q_VSA_POL_PEOE_VSA_POL, 
Q_VSA_FHYD_PEOE_VSA_FHYD, Q_VSA_FPOL_PEOE_VSA_FPOL). An 
account of the meaning of these abbreviated descriptors is given in Appendix I. 
The molecular descriptors used in PCA analysis were determined using Molecular 
Operating Environment 2012, produced by Chemical Computing Group Inc., 
Montreal, Canada, and by HSPiP software version 4.0.0.4. The solubility and 
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5.4.1 Synthetic membranes diffusion studies 
 
The cumulative amount of permeant diffused across the synthetic membranes was 
plotted versus time; and the flux was derived from the slope of the linear portion 
of the curve. Figure 5.3 shows an example of the cumulative amount of MP 
permeated across silicone, HDPE and PU from saturated solutions in IHD as a 
function of permeation time. The fluxes through the membranes from IHD were 
in the order silicone>PU>HDPE. The curve shows a typical lag time phase 
followed by a linear portion corresponding to the steady state flux. The shapes of 












Figure 5.3 An example of the cumulative amount of methyl paraben permeated 
across silicone, high density polyethylene and  poly urethane membranes 
versus time when applied in IHD. Data represent mean ± sd (n=3-5). Error bars 
lie within the symbols. 
 
The derived flux results of the in vitro diffusion studies of the three model 
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and BP respectively and 5.6 and 5.7 for CF, due to scaling issues CF results are 
shown in two figures. The highest measured fluxes of BP from oils were obtained 
for diffusion of the compound through silicone membrane. In contrast, the highest 
fluxes recorded for MP and CF were those obtained for its diffusion through PU. 
There was no significant difference between the fluxes of MP from either LP or 
buffer through silicone membrane. All oils enhanced the permeation of MP 
through HDPE compared with buffer. The fluxes of MP from LP and OA through 
HDPE were not significantly different from each other (Figure 5.4), and although 
low in magnitude, flux of MP from both was higher than from buffer. All oils 
enhanced BP permeation through silicone and HDPE membranes compared with 
the buffer. However, with PU, the flux of BP from the buffer was higher than its 
flux from OA (Figure 5.5). There were no significant differences in the fluxes of 
CF from OA, LP and buffer through silicone membrane. In addition, there were 
no differences in the fluxes of CF from either OA or HD through HDPE. 
Generally all oily vehicles enhanced the permeation of CF through HDPE 
membrane compared with the buffer (Figure 5.6). However the flux of CF from 
saturated buffer solutions was higher than from oily solutions through PU 
membrane (Figure 5.7). 
 
 
Figure 5.4 Comparative flux data for methyl paraben across silicone, high 
density polyethylene and  polyurethane membranes when applied in different 
















IHD – isohexadecane; 
IPM – isopropyl myristate; 
OA – oleic acid; 
HD – hexadecane; 
LP – liquid paraffin 
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Figure 5.5 Comparative flux data for butyl paraben across silicone, high 
density polyethylene and  polyurethane membranes when applied in different 




Figure 5.6 Comparative flux data for caffeine across silicone and high density 
polyethylene membranes when applied in different oils and phosphate buffer. 







































IHD – isohexadecane; 
IPM – isopropyl myristate; 
OA – oleic acid; 
HD – hexadecane; 
LP – liquid paraffin 
IHD – isohexadecane; 
IPM – isopropyl myristate; 
OA – oleic acid; 
HD – hexadecane; 
LP – liquid paraffin 
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Figure 5.7 Comparative flux data for caffeine across  polyurethane membrane 
when applied in different oils and phosphate buffer. Data represent mean ± sd 
(n=3-5). 
 
5.4.2. Human epidermis diffusion studies 
 
The diffusion profile of the model permeants from the different vehicles across 
human epidermis is depicted in Figures 5.8, 5.9 and 5.10 for MP, BP and CF 
respectively. The amounts of model permeants penetrating the skin when the 
compounds were applied in IHD as a vehicle were found to be significantly 





















IHD – isohexadecane; 
IPM – isopropyl myristate; 
OA – oleic acid; 
HD – hexadecane; 
LP – liquid paraffin 
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Figure 5.8 Epidermal permeation profiles showing the cumulative amount of MP 
in the receptor compartment from the different vehicles as a function of time (●) 
buffer () IPM () LP (x) IHD (*) OA and () HD. Data represent mean ± sd 




Figure 5.9 Epidermal permeation profiles showing the cumulative amount of BP 
in the receptor compartment from the different vehicles as a function of time (●) 
buffer () IPM () LP (x) IHD (*) OA and ()HD. Data represent mean ± sd (n 
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Figure 5.10 Epidermal permeation profiles showing the cumulative amount of CF 
in the receptor compartment from the different vehicles as a function of time (●) 
buffer () IPM () LP (x) IHD (*) OA and () HD. Data represent mean ± sd 
(n=4-5). Error bars lie within the symbols. 
 
The parameters derived from the in vitro epidermal diffusion studies are shown in 
Table 5.1. The mean fluxes (calculated between 4-8h for MP and BP, 6-10h for 
CF) were in the order of MP (Log P 1.96) >BP (Log P 3.57) >CF (Log P -0.07). 
Generally, all oils significantly enhanced the diffusion of model permeants 
through the human epidermis compared with phosphate buffer (p0.05). BP and 
CF have Log P values which fall outside the generally reported range required for 
optimal transdermal delivery (Log P values 1-3). The highest flux for all model 
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Table 5.1 The in vitro eipdermal permeation parameters permeability coefficients and 
fluxes for MP, BP and CF Data represent mean  sd (n= 4-5). 
  
Permeant Vehicle Js (g cm-2 h-1) KP (10-2 cm h-1) 
MP Buffer 26.28  0.42 1.09  0.02 
 IHD 115.6  10.54 152.61  13.9 
 IPM 67.82  2.49 0.19  0.007 
 OA 56.27  1.06 0.86  0.02 
 HD 47.78  2.51 60.47  3.17 
 LP 43.24  2.94 61.77  4.19 
    
BP Buffer 17.60  0.57 7.04  0.22 
 IHD 86.02  3.80 11.03  0.49 
 IPM 56.11  2.27 0.06  0.002 
 OA 54.05  1.49 0.09  0.002 
 HD 44.61  4.61 5.95  0.61 
 LP 26.98  1.20 3.70  0.16 
    
CF Buffer 4.22  0.69 0.02  0.002 
 IHD 36.60  1.41 49.47  1.90 
 IPM 14.56 ± 1.11 1.75  0.13 
 OA 11.23 ± 0.53 0.21  0.010 
 HD 9.43 ± 0.53 12.74 0.71 
 LP 9.66 ± 0.46 12.54  0.60 
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5.4.3 Statistical analysis 
 
5.4.3.1 Data pretreatment 
To visualize the data, all datasets were normalised and correlated using MS 
Excel® software. The normalization of data was performed to ensure that all the 
physicochemical descriptors employed had a zero mean with unit variance. 
Stepwise correlation analysis was performed between the dependent variables (the 
dependent variables were: flux through membranes, solvent uptake, lag time, 
permeability coefficient and flux through epidermis) and the independent 
variables: the molecular descriptors of the permeants, vehicles and membranes 
(Appendix I). The significance level used was (-0.8 > r < 0.8). This enabled the 
identification of the significant molecular descriptors affecting penetration of 
model permeants. An example of a correlation matrix is shown in Table 5.2. 
Table 5.3 shows an example of a final correlation matrix, indicating the 
descriptors that were used in the epidermis PCA and QSPR analysis. All 
correlations are in Appendix II. Since all descriptors used in QSPR and PCA are 
derived from a correlation analysis, they are independent from one another but 
related to a dependent variable. Table 5.4 shows the descriptors used for all 
dependent variables. All permeants and non-porous membranes were employed in 
the statistical analysis. However, LP as vehicle was removed from the analysis 
since it is comprised of a mixture of molecularly different components (of poorly 
defined composition) and there were insufficient descriptors available for it to be 
included in the subsequent analysis. 
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Table 5.2 An example of a correlation matrix  
 
 
The correlation level used was (-0.8> r <0.8). The numbers noted in red are correlated with each other, and one of them was 
removed according to the following methodology: the correlation values with the dependent variable (weight ratio) were  
assessed and descriptors with the highest absolute value of correlation were retained. For example the δPexp vehicle was highly 
correlated with the Mwt of the vehicle (0.99954); since the δPexp has a higher correlation to the solvent uptake (0.00558) than 
























weight ratio 1 
         
δT/δHildebrand vehicle -0.11361 1 
        
δD vehicle -0.22941 0.82753 1 
       
δP vehicle 0.00558 0.77548 0.39622 1 
      
δH vehicle 0.03913 0.80810 0.35327 0.95288 1 
     
Mvol vehicle 0.00792 0.74174 0.36857 0.99800 0.93481 1 
    
Mwt vehicle 0.00203 0.76862 0.39910 0.99954 0.94325 0.99913 1 
   
Density vehicle -0.00382 0.79943 0.43247 0.99918 0.95324 0.99561 0.99863 1 
  
Mpoint vehicle -0.21546 0.87561 0.98744 0.52838 0.46551 0.50541 0.53251 0.56132 1 
 
LogKo/w vehicle -0.14545 0.29482 0.55170 -0.36753 -0.20809 -0.41910 -0.38100 -0.33308 0.42179 1 
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Table 5.3 The final correlation matrix showing the descriptors that were included in the PCA and QSPR of epidermal 
permeation. 
 



















normalised Flux 1        
normalised solubility -0.136441149 1       
normalised opr_nring  permeant 0.303021372 -0.355178569 1      
normalised chi0 permeant 0.283118962 0.163330809 0.523049 1     
normalised chi0_C  permeant 0.044159893 0.50011073 -0.31262 0.646066 1    
normalised Density vehicle -0.393531438 0.463783616 0 4.76E-18 1.9E-17 1   
normalised opr_brigid vehicle -0.275673538 0.078625536 0 2.85E-17 -2.6E-17 0.729591786 1  
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Table 5.4 Physicochemical descriptors used in the PCA of solvent uptake, flux 
through membranes, permeability coefficient, lag time and flux through epidermis 
 
Dependent variable Independent variables 
Solvent uptake δD vehicle 
Log Ko/w vehicle 
molecular connectivity index vehicle 
opr_brigid vehicle 
chi0_C vehicle 
HSP distance between the oils and membranes 
Flux through membranes solubility of the permeants in the oils 






HSP distance between the oils and membranes 
Permeability coefficient solubility of the permeants in the oils 
weight ratio of treated: untreated membranes 
Mpoint permeant 
Mpoint vehicle 
Log Ko/w vehicle 
molecular connectivity index vehicle 
opr_brigid vehicle 
chi0 vehicle 
HSP distance between the oils and membranes 
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Table 5.4 Descriptors used in the PCA of solvent uptake, flux through 
membranes, permeability coefficient of the permeants in the oils, lag time and flux 
through epidermis (continued) 
 
Dependent variable Independent variables 
Lag time solubility  
weight ratio of treated: untreated membranes 
δT permeant 
b_count permeant  
opr_brigid vehicle 
chi1 vehicle 
chi0v_C vehicle  
HSP distance between the oils and membranes 
Flux through epidermis  solubility of the permeants in the oils 





Kier flex vehicle 
  
 
All correlations contained permeant, vehicle and membrane input descriptors. In 
the solvent uptake correlation the descriptors are mainly related to the 
lipophilicity, size and flexibility of the vehicle. In the flux, permeability 
coefficient and lag time correlations the solubility, solvent uptake, shape and size 
of the oil molecules which constituted the vehicle were important descriptors. The 
H-bond ability of the vehicle and permeant were found to be important descriptors 
in determining the flux and permeability through synthetic membranes. The 
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solubility of the permeant, shape, size and flexibility of the permeant and vehicle 
are important descriptors to determine flux through the epidermis. 
 
5.4.3.2 Quantitative structure-property relationships 
 
Regression analysis was initially performed for the dependent variable of solvent 
uptake by synthetic membranes using independent variable descriptors of the 
vehicle and membrane properties. The results showed that a single equation could 
not explain the solvent uptake into the range of membranes used. The r2 value of 
the multiple regressions was low (r2=0.49) and the p-values were high (p> 0.05), 
indicating the model was poor and not robust. 
 
To model the flux through different membranes from the oily (IPM, OA, HD and 
IHD) vehicles, regression analysis was carried out. Permeant flux was correlated 
to permeant, vehicle and membrane descriptors. A number of molecular 
descriptors: the chi0 permeant, chi1_C vehicle and δD membrane were found to be 
highly correlated with the flux. However when they were included in the 
regression analysis to model the flux, high p-values (i.e. p> 0.05) were obtained 
for chi0 permeant (p=0.97) and δD membrane (p= 0.87); whilst the coefficient for 
chi1_C vehicle was zero, therefore these descriptors were removed from the 
model. A high p-value suggests that changes in the variable may not be associated 
with changes in the flux response. This suggests that these descriptors do not have 
a significant effect on the flux model. Chi0 permeant, chi1_C vehicle are 
descriptors related mainly to the molecular shape of the permeant and vehicle 
respectively.  
 
The solubility of the permeant in the oil variable yielded high p-value (p=0.37); 
however, this factor was not removed since it was clearly an important descriptor 
for both the vehicle and permeant. Although the p-value of this descriptor is high 
and not ideal, it is however lower than the p-values of the removed descriptors.  
The p value depends on the sample size and variability of the data, therefore due 
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to the limited range of oils and permeants, it is possible that this contributed to the 
high p-value identified for the solubility of the permeant in the oil. Although the 
analysis indicates that the solubility in the vehicle is not a significant predictor of 
permeation, it is well documented that adequate solubility is an important factor 
of the flux obtained (Hadgraft, 1999; Ceschel et al., 2005), since the permeant has 
to be in its dissolved state in order to partition into the synthetic membrane. In 
addition the solubility in the vehicle is important to replenish the amount of 
permeant lost by diffusion so that the thermodynamic activity of the permeant 
remains constant. Following the correlation analysis, seven descriptors were 
highly correlated with the flux: (Appendix II Table A2.1) the solubility of the 
permeant in the vehicle, weight ratio, δP permeant, Log Ko/w vehicle, lip_acc 
vehicle, lip_don vehicle, δH membrane. Therefore these descriptors were 
employed in the regression analysis to model the flux. The flux of permeants from 
oily vehicles through the synthetic membranes was modeled by Equation 5.4. The 




Where Jm is the flux of permeants through synthetic membranes, Sv is the 
solubility of permeant in the oil, mupt is the relative mass uptake of each oil of 
membrane, which was derived by the difference between the weight of the 
membrane before and after soaking (Equation 5.5). δPP the polar component of the 
HSP for the permeant, Ko/wv octanol water partition coefficient for the vehicle, 
∑αH is the hydrogen bonding donor ability of the vehicle, ∑βH the hydrogen 
bonding acceptor ability of the vehicle and δHm the hydrogen bonding component 
of HSP for the membrane. 
 mupt = ୫aି୫b୫b        Equation 5.5 
ma is the weight of membrane after soaking and mb is the weight of membrane 
before soaking. 
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It is accepted that the permeability coefficient is a more reliable parameter than 
simple flux in describing the permeation potential of chemical substances 
(Wilkinson & Williams 2002; Fitzpatrick et al. 2004); therefore regression 
analyses were performed to model Log Kp using permeant, vehicle and membrane 
descriptors. The descriptors retained in the model after the correlation were (Table 
A2.3): the (Sv) solubility of the permeant in the oil, MPTd and MPTv (i.e. the 
melting point of the permeant and vehicle respectively), chi0 permeant (which is a 
descriptor related to the shape of the permeant), Log Ko/wv of the vehicle, 
opr_brigid vehicle (a descriptor related to the number of rigid bonds, shape and 
flexibility of the vehicle), δTm (the Hildebrand solubility parameter of the 
membranes) and δDm (the dispersion forces component in HSP value of the 
membranes). Chi0 vehicle and molecular connectivity index for the vehicle were 
removed from the correlation because these descriptors had a coefficient of zero, 
while the solvent uptake per se was removed due to the high p value (p=0.23). 
Through the construction of the correlation matrices, the extent of solvent uptake 
was correlated with several other variables. Therefore, despite its removal, the 
importance of solvent-membrane interactions achieves its impact through the 
retained descriptors with which it was, itself, correlated. Equation 5.6 models the 
Log Kp through the synthetic membranes. The r2 of the multiple regressions was 
0.98 and N=36. 
 
Log	Kp=0.34-0.30	Sv+1.10	MPTP-0.44	chi0P-0.43MPTV+0.38	Log	Ko/wv -0.54	opr_brigid-0.66	δTm+0.22	δDm                                     Equation 5.6 
 
The solubility of the permeant in the oil is a descriptor that was found in both 
QSPRs (Equations 5.4 and 5.6); the value of the coefficient was similar in both 
QSPRs, however the coefficient was positive with the flux model, which means 
increasing the solubility led to an increase in the flux, and negative in the Log Kp 
model, increasing the solubility decreased the permeability coefficient. This is 
expected since for a drug to permeate through a membrane it should be in the 
solubilized form so high solubility will enhance the replenishment of the lost drug 
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by diffusion. The permeability coefficient is derived from dividing the flux over 
the solubility in the oil, so increasing the solubility will lead to a decrease in the 
permeability coefficient value for a constant flux value. Diffusion is a passive 
process where the permeant moves down its activity gradient. However as the 
solubility of the permeant in the vehicle increases it means that there is higher 
affinity and interaction between the permeant and the vehicle and hence the 
tendency of the permeant to leave the vehicle and partition into the membrane will 
decrease and therefore the permeability will decrease. High solubility of the 
permeant in the membrane and low solubility in the vehicle is desired to enhance 
the permeation. The activity coefficient or the potential of the permeant to be 
released from the vehicle into the membrane is at maximum when the vehicle is 
saturated. Since the permeants in this state are in dynamic equilibrium, the 
molecules are continuously precipitating out of the solution and then re-entering 
the solution state, they undergo the least degree of vehicle bonding interaction and 
are most likely to escape from the formulation and enter the membrane. 
 
Log Ko/w of the vehicle, which describes the hydrophobicity of the vehicle, is 
another descriptor which was important in both QSPRs. Equations 5.4 and 5.6 
indicate that increasing the Log Ko/w of the vehicle leads to a decrease in the flux 
and increase in the permeability coefficient. This is because, although all systems 
were originally of unit thermodynamic activity, the permeability coefficient (Kp) 
being the ratio of flux to actual concentration in the vehicle (Equation 5.3), will 
differs from system to system. The value of the coefficient for the Log Ko/w in the 
flux model was almost twice its value in the Log Kp model. The vehicles used in 
this study are all hydrophobic oils; therefore increasing the Log Ko/w of the vehicle 
could lead to a decrease in partition of hydrophobic drug from the oil (or oil-
modified membrane phase) and subsequent permeation.  
 
Melting point is a physicochemical property which is has also been considered as a 
determinant of the solubility of the permeant in both the vehicle and membrane; 
since the value is highly dependent upon hydrogen bonding. Therefore the melting 
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point and the hydrogen bonding donor and acceptor descriptors introduce the 
importance of hydrogen bonding on the diffusion process. The melting point of the 
vehicle and permeant were of importance when modeling the Log Kp, while in the 
flux model the hydrogen bonding donor and acceptor ability of the vehicles were 
the highly correlated descriptors. Increasing the number of hydrogen bond donors 
in the vehicle decreases the flux through the membranes, while increasing the 
number of hydrogen bond acceptors in the vehicle increase the flux. The hydrogen 
bonding donor ability is more relevant and contributes more to the flux through 
synthetic membrane when compared with the hydrogen bonding acceptor. In the 
membranes used in the modeling, silicone and polyurethane membranes are both 
capable of interaction and hydrogen bonding with the vehicles, which supports 
findings of a modification in the flux. 
 
Equation 5.4 indicates the importance of solvent uptake (mupt) on flux; it shows 
that increasing the amount of solvent sorbed into the membrane leads to higher 
flux. According to the analysis carried out chi0 of the permeant is correlated to δP 
of the permeant, therefore one of these descriptors encodes the other in the model. 
In equation 5.4 there is a negative correlation between the δP of the permeant and 
flux. Since all the vehicles are hydrophobic increasing δP of the permeant means 
that the permeant is becoming more polar and this would be expected to lower the 
solubility of the permeant; in addition, it would lead to a lower partitioning into 
the hydrophobic membranes, therefore the flux would be predicted to decrease. 
However since solubility depends on all molecular interactions, in some situations 
even should δP increase and the molecule become more polar, it is the value of δH 
that might determine the high molecular interaction between the polar compound 
and the hydrophobic oil, therefore high solubility values might be achieved. For 
example the solubility of CF in OA is similar to the solubility of MP in OA 
despite CF being considered a polar compound. In Equation 5.6 there is also a 
negative correlation between chi0 permeant and the Log Kp. The chi0 descriptor 
encodes the importance of the molecular size of the permeant and this means that 
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increasing the molecular size of the permeant decreases its permeation through 
synthetic membranes. 
 
Increasing the number of rigid bonds in the vehicles (opr_brigid) leads to a 
decrease in the permeability coefficient. The lower number of rigid bonds leads to  
higher flexibility of the vehicle, which in turn increases the uptake and interaction 
of the vehicle with the membrane therefore it enhances the flux.  
 
The membrane descriptors were also important when modeling the flux and Log 
Kp. Increasing the δH of the membrane led to lower flux. In addition increasing 
the δT of the membrane decreased the permeability coefficient. On the other hand 
increasing δD led to an increase in the Log KP. As mentioned earlier the vehicles 
are hydrophobic; therefore increasing δH and δT of the membranes means that the 
membrane is becoming more hydrophilic. In general, this will decrease the level 
of interactions between the vehicle and membrane and hence the flux and Kp are 
decreased for hydrophobic penetrants such as MP or BP. In contrast as δD of the 
membrane is increased, then the membrane becomes more hydrophobic, which 
decreases the flux of more hydrophilic compounds such as CF.  
 
In both models there were descriptors related to the permeant vehicle and 
membrane indicating the importance of all three in the diffusion process. In the 
flux model the membrane descriptor δH had the highest coefficient in the model 
followed the hydrogen bond donor and acceptor descriptors for the vehicles 
respectively. In the Log Kp model the melting point of the permeant had the 
highest coefficient, as indicated previously this descriptor is related to the 
hydrogen bonding ability of the permeant and the solubility of the permeant. 
These results demonstrate that the permeation through synthetic membrane is 
controlled primarily by the hydrogen bonding ability of the vehicle and permeant 
with the membrane. 
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Since it proved possible to perform QSPR on the flux and Log Kp of permeants 
through synthetic membranes, a correlation and regression of the permeant and 
vehicle descriptors against the flux through epidermis was carried out. However 
due to the limited data N=12, the descriptors could not be fitted to one equation. 
Therefore despite the r2 value of the multiple regressions being 0.91, the p-values 
associated with the descriptors proved to be high (i.e. p>0.05). 
 
5.4.3.3 Principal component analysis 
 
A PCA score plot is useful in finding the clustering of samples, whilst a loading 
plot is useful in identifying important variables. PCA analysis loading plots show 
which variables are influential, and also how the variables are correlated. 
Positively correlated variables are the variables close to each other on the same 
side of the plot. When the numerical value of a variable increases or decreases the 
numerical value of the correlated variable has a tendency to change in the same 
way. When variables are negatively (“inversely”) correlated they are positioned 
on opposite sides of the plot origin, in diagonally opposed quadrants. 
Furthermore, the distance to the origin also conveys important information. The 
further away from the plot origin a variable lays, the stronger impact that variable 
has on the model (Eriksson et al., 2006). 
 
To ensure data quality, the absence of outliers was assessed employing 
Hotelling’s test (Jackson, 1991; Tracy et al., 1992).  This statistic is a multivariate 
generalization of Student’s t-test, and provides a check for observations adhering 
to multivariate normality. Strong outliers are found in the score plots. They have 
high leverage on the model, i.e. strong “power” to pull the PCA model toward 
them, and may “consume” one principal component (PC) just because of their 
existence. The term leverage derives from the Archimedean principle that 
anything can be lifted out of balance as long as the lifter has a long enough lever. 
Leverage is a measure of the influence of an observation and is proportional to the 
distance of the observation from the center of the data (Eriksson et al., 2006). 
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Hotelling’s test was employed with 95% confidence limit and no outlier data in 
the score plots were found. 
 
PCA for the solvent uptake and interaction with membranes was used to provide 
an overview of trends in the data, with the results being displayed in bi-plot 
graphics (Figure 5.11). The descriptors of both the vehicle and membrane were 
used to perform the solvent uptake PCA. The first two PCs describe 76% of the 
total variance in the data. δDm and δTm were removed from the analysis because 
they skewed the data. They contributed very little to describing the variance 
captured by either PC1 or PC2. First δDm was removed and the plots were 
regenerated, but the data were still skewed by δTm, and the latter term was also 
found not to contribute to the description of the variance captured by both PC1 
and PC; therefore δTm was removed from the analysis. The PCA plots were re-
generated again and then all of the available descriptors were found to contribute 
to the description of variance captured by PC1 and PC2. When a descriptor skews 
the data it pulls the PC strongly toward itself because its influence is enhanced; its 
influence is enhanced because it is so far from the mean. It is similar to 
undertaking PCA without centering the data. δDm and δTm were the only 
descriptors relevant to the characteristics of the membrane and since the 
membrane descriptors cannot be ignored in the analysis, then the distance 
between the HSP values of the membranes and vehicles (which is a derived 
descriptor; Table 4.13), was introduced instead. The distance represents a measure 
of the degree of matching (i.e. similarity) between the solubility parameters of the 
vehicles and the membranes. Therefore it represents a descriptor relating the 
vehicle to the membrane.  
 
As mentioned previously LP as vehicle was removed from all the analysis since it 
is comprised of a mixture of molecularly different components (of poorly defined 
composition) therefore the available descriptors were insufficient for it to be 
included. In the PCA of solvent uptake (Figure 5.11), the score plot shows that  
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Fig. 5.11 (A) Score plot from the PCA of solvent uptake of vehicles into 
membranes showing the grouping of scores representing different vehicles. The 
two displayed PCs explain 76% of the total variability; 45% and 31% of the 
variability are explained by PC1 and PC2 respectively. (B) Loading plots from 
the PCA of the solvent uptake of vehicles into membranes showing descriptors 
explaining the solvent uptake.  
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there is no special clustering for the membranes; each membrane was found in all 
the groups. The clustering was more related to the vehicle; IPM and OA were 
close to each other on the plot. OA and IPM have heteroatoms, compared with 
IHD and HD which are simply hydrocarbons; this could indicate that the same 
descriptors are related to their behaviors. Although HD is the linear counterpart of 
IHD, they were on the opposite sides of the plot; this indicates that the 
combination of descriptors which make up the PCs separates the behaviour of 
these two oils. In general silicone membrane was closer to HDPE membrane 
compared with PU. This might be due to the more hydrophilic properties of PU 
compared with the other membranes. There are three distinct groups, and 
although in each group the behaviour of the solvent uptake is described by the 
same descriptors, the descriptors are different between different groups. A QSPR 
model could not be developed for the solvent uptake, because each group was 
explained by different descriptors, and therefore the terms cannot be combined 
into a single linear relationship. 
 
The six descriptors, (δD vehicle, Log Ko/w vehicle, molecular connectivity index 
vehicle, opr_brigid vehicle, chi0_C vehicle, distance) found in the loading plot 
(Figure 5.11) are responsible for the changes in the solvent uptake into 
membranes. The descriptors are distributed across the loading plot. δD of the 
vehicles appears to have the biggest effect on describing the variance of the data 
captured by PC1, OA and IPM had the same value of δD (16 MPa)½  while HD has 
the highest value of δD (16.3 MPa)½ and IHD has the lowest value of δD (14.7 
MPa)½. Chi0_C also describes the variance of the data explained by PC1. OA and 
IPM has similar values of chi0_C, while IHD has the highest value and HD the 
lowest value. The molecular connectivity index has the greatest effect on the 
variance described by PC2. IPM and OA have close values of molecular 
connectivity index. These descriptors which were found to be highly loaded on 
both PC1 and PC2 were able to describe the variance between IHD and HD, but 
they were not involved in describing the variance between OA and IPM to the 
same extent, because OA and IPM have similar values of these descriptors. 
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Therefore, IPM and OA were found to lie close to each other on the plot, while 
IHD and HD were separated on different sides of the plot. 
 
A similarity of molecular behaviour is expected between molecules which have 
similar properties than molecules with dissimilar characteristics. However in PCA 
plots, molecules behave in the same way when they have similar values of the 
dominating descriptor. This is the descriptor that is highly loaded on either PC1 or 
PC2. Therefore in some instances molecules will have the same value of some 
descriptors but they will be located on opposite sides of the plot, if these 
descriptors were not the main descriptors contributing to explaining the variance 
either on PC1 or PC2. For example HD and IHD have more than one descriptor in 
common but are located on opposite sides of the plot because they differ in the 
dominating descriptor. In Figure 5.11 IPM, IHD and HD have the same value of 
opr-brigid while OA has a different value, if this descriptor was dominant IPM 
and OA will be separated from each other and HD, IPM and HD will be closer, 
however since it is not a dominant descriptor it did not affect the clustering. 
 
PCA analysis was also carried out using the data obtained for the flux, 
permeability coefficient and the lag time of permeant diffusion through synthetic 
membranes. Descriptors of the permeant, vehicle and membranes were used in the 
correlation analysis. As in the analysis of the solvent uptake, δDm , δHm and δTm 
polarized the data and did not contribute to explain the variance captured by PC1 
and PC2, since only three membranes were employed and the differences in their 
properties was not sufficient. Accordingly these descriptors were omitted from the 
analyses and the HSP-distance was introduced instead. 
 
The score plot for the flux and Kp (Figures 5.12 and 5.13) shows that the data are 
distributed across the plot. In Figure 5.12 the data in the score plot of the flux are 
distributed in four groups. The groups were clustered according to the vehicle 
used regardless of the membrane and permeant. Within vehicle clusters (e.g. IPM 
and OA clustered groups) the clustering was according to the permeant identity 
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(e.g. in the OA cluster in the lower left quadrant, clusters of CF, BP or MP were 
identifiable). On the other hand in the HD and IHD groups MP and BP from the 
same membrane were closer to each other compared to CF  
 
In the loading plot of the flux (Figure 5.12) each descriptor has a unique position 
on the PC1 and PC2 axes. The H-bond acceptor of the vehicle has the greatest 
effect in describing the variance of the data accounted for PC1. The H-bond 
acceptor of the vehicle has a positive correlation with the solubility of the model 
permeants in the oil. Both OA and IPM have two H-bond acceptor groups, in 
general the solubility of the model permeants in these oils was higher, when 
compared with HD and IHD. The Log Ko/w vehicle and solubility are the main 
descriptors which contribute to the variance captured by PC2. HD and IPM have 
the highest and lowest values of Log Ko/w respectively. Chi1_C is also highly 
loaded on PC1. Chi1 _C is a descriptor relating to localized branching within a 
molecule indicating its importance to the overall topology of the oil. The 
descriptor relates the effect of branching in the molecule to its overall shape by 
considering the connectivity between two carbon atoms.  
 
In the studied vehicles, OA had the highest value of localized hydrocarbon 
branching (chi1_C) owing to its alkene-bond and it is the only vehicle that 
contains a H-bond donor group. These descriptors were able to separate the 
behaviour of the four vehicles across the plot. Although OA and IPM have H- 
bond acceptor groups, the variance in their behaviour was separated by the 
chi1_C and Log Ko/w effect on the plot. In addition the HD and IHD behaviour 
was separated mainly by the Ko/w and chi1_C. Since the main descriptors 
influencing PC1 and PC2 were related to the vehicle, the variances in the 
permeant and membrane behaviours were not explained as sufficiently as those 
associated with the vehicles. 
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Fig. 5.12 (A) Score plot from PCA showing the relationship between permeant-
oily vehicle –membrane descriptors with flux. The two displayed PCs explain 54 
% of the total variability; 33% and 21% of the variability are explained by PC1 
and PC2 respectively. (B) Loading plots from PCA showing the relationship 
between permeant-oily vehicle-membrane descriptors with flux.  
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The Kp score plot (Figure 5.13) shows that the data are arranged in three distinct 
groups, one group consists of IPM and OA data, while HD and IHD are found in 
two groups separately. In the HD group HDPE and silicone membrane data were 
closer to each other compared to PU. While in the IHD group the grouping was 
according to the membrane regardless of the permeant. In contrast, when the IPM 
and OA groups are considered, the separation was according to permeant, where 
MP and CF were closer to each other compared to BP.  
 
In the Kp loading plot (Figure 5.13) the descriptors were scattered across the plot. 
The molecular connectivity index had the biggest effect in explaining the variance 
of the data which is captured by PC1, while the variance captured by PC2 was 
mainly described by Log Ko/w. Chi0 vehicle also contributes to explaining the 
variance captured by PC1. As mentioned previously, IPM and OA have similar 
values for the molecular connectivity index and chi0, therefore these descriptors 
are unable to extract and capture the variance between OA and IPM. On the other 
hand these descriptors are different for IHD and HD, therefore the behaviour of 
both oils is separated from each other and also separated from OA and IPM. The 
main descriptors involved in explaining the variance captured by PC1 and PC2 
are related to the vehicle; consequently the membrane and permeants were 
clustered together.  
 
Comparing Figures 5.12 and 5.13: The same amount of variance is explained in 
both plots, PC1 and PC2 described 54% of the total variance in the data for both 
the flux and Kp analysis. The molecular connectivity index is the descriptor 
related to the position and influence of heteroatom patterns of adjacency, these 
atoms are responsible for the hydrogen bond acceptor ability of the molecule. 
This means that similar descriptors are influencing the flux and Kp loading plots. 
Furthermore Log Ko/w was the main descriptor affecting PC2 in both plots. These 
results indicate that the lipophilicity, in addition to the hydrogen bond ability of 
the vehicle were the major determinants of the diffusion across synthetic 
membranes. This might explain the clustering of IPM and OA in the Kp loading 
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plot, and also the finding that OA and IPM were closer to each other in the flux 




Fig. 5.13 (A) Score plot from PCA showing the relationship between permeant-
oily vehicle –membrane descriptors with Kp. The two displayed PCs explain 54 % 
of the total variability; 34% and 20% of the variability are explained by PC1 and 
PC2 respectively. (B) Loading plots from PCA showing the relationship between 
permeant-oily vehicle–membrane descriptors with Kp.  
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The score plot for the permeant-vehicle –membrane descriptors correlated with lag 
time (Figures 5.14) shows that the data are scattered across the plot. PC1 and PC2 
described 55% of the variance in the data. Generally CF and MP are clustered 
together in the plot. HDPE and silicone membrane were closer to each other 
compared to PU. In the loading plot Figure 5.14, chi1 vehicle and the solubility of 
the permeant in the oils has the greatest effect in describing the variance in the data 
obtained by PC1, while δT of the permeant and b_count of the permeant provided 
the biggest contribution to the description of the variance captured by PC2. The 
solubility of the permeant in the vehicle is negatively correlated with the 
Hildebrand solubility parameter of the permeant, which means a permeant that has 
high δT will have low solubility in the vehicle. Such a relationship may be expected 
since the vehicles used are oils and hydrophobic, and increasing the δT means that 
the permeant is becoming more hydrophilic. Since the permeant descriptors are 
contributing to explaining the variance of the data, the clustering was both related 
to the permeant and vehicle. The used descriptors were able to separate the 
behaviour of BP more readily than that of MP from CF.  
 
The clustering and behaviour of the score plot in the lag time is different when 
compared with the flux and Kp score plots. In the flux and Kp plots the same 
vehicle was clustered together while in the lag time the scattering is dependent 
upon the vehicle, permeant and membrane descriptors. Furthermore, in the flux 
and Kp plots the vehicle descriptors have the biggest effect in describing the 
variance captured by both PC1and PC2, which means most of the 54% of the 
variance was described by the vehicle descriptors. However in the lag time plots 
both the vehicle and permeant descriptors, combined, to describe 55% of the 
variance. 
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Fig. 5.14 (A) Score plot from PCA showing the relationship between permeant- 
oily vehicles – membrane descriptors with lag time. The two displayed PCs 
explain 55 % of the total variability; 31% and 24% of the variability are 
explained by PC1 and PC2 respectively. (B) Loading plots from PCA showing the 
relationship between permeant-oily vehicle–membrane descriptors with lag time. 
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The PCA was carried out on the permeant and vehicle descriptors for the flux 
through epidermis (Figure 5.15). The first two PCs describe 59% of the variance 
in the data. The PCA score plot shows that, unlike the synthetic membranes flux 
data, there is no specific clustering according to the oil or permeant, data are 
distributed across the score plot. However there is a notable trend in the 
distribution of the oils and permeants. The permeants from the same vehicle are 
distributed in a curved shape. This trend is broken by the flux of BP from IPM; 
this might be a consequence of the comparatively high solubility of BP in IPM 
relative to the other oils.  
 
The descriptors in the loading plot are distributed on the positive side of PC1 
except for opr_nring of the permeant, which is located on the negative side of 
PC1; in addition it is only described by PC1. All the descriptors have unique 
positions on the PC1 and PC2 axes. Kier flex and opr_brigid of the vehicle are 
positively related to each other, the more rigid the bonds in the compound, the 
less flexible it is. The Kier flex descriptor is related to the flexibility and shape of 
the molecule; the lower the value, the higher the flexibility of the compound. The 
density of the vehicle, the solubility and opr-brigid were found to have the 
greatest effect on the variance in the data captured by PC1.In contrast, the Chi0_C 
and chi0 values of the permeant were shown to induce the highest variance in the 
data captured by PC2. This indicated that both the permeant itself and the vehicle 
are important in determining the overall diffusion of the compound through 
epidermis studies.  
 
The descriptors used were able to separate the behaviour of the three permeants; 
each permeant having different values of these descriptors. OA and IPM possess 
similar density values (0.62 and 0.61 g/cm-3 respectively), whilst IHD and HD 
have the same density (0.56 g/cm-3). Hence it is the differences in the permeant 
solubility in these oils along with the difference in the values of the chi0_C and 
chi0 of the permeants that lead to the distribution of the permeants across the plot. 
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Fig. 5.15 (A) Score plot from PCA showing the relationship between permeant-oily 
vehicles descriptor with epidermis flux. The two displayed PCs explain 33% and 
26% of the variance, respectively. (B) Loading plots from PCA showing the 
relationship between permeant-oily vehicle descriptors with epidermis flux. 
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5.5 Discussion  
 
In order for any permeant to reach its target receptor it must cross a number of 
different body membranes. As discussed previously in section 1.7.1 the passage 
of compounds through a biological membrane after topical application is divided 
into four main stages. First the drug has to be liberated from the formulation. 
Next it penetrates into the outermost skin layer and then it permeates (or 
partitions) from one layer into the other, and finally it reaches the vascular 
system. Most biological membranes are lipophilic and they are composed of one 
or more layers and this generally leads to slow drug diffusion (Camenisch et al., 
1996). However, biological membranes are generally complex and variable and 
therefore in order to study the permeation of different model penetrants it can be 
advantageous to use less complex membranes such as synthetic polymers 
(Watkinson et al., 1995; Feldstein et al., 1996, 1998; Russeau et al., 2009). In 
this study human epidermis was used as a biological membrane and silicone, 
HDPE and PU membranes were selected as examples of different synthetic 
membranes. The selected membranes possess different solubility parameters and 
different chemical characteristics. 
 
The vehicles used in these studies were all saturated and in all cases contained 
sufficient excess solute to maintain a constant donor concentration during the 
experimental time frame. Under equilibrium conditions flux will be at a maximum 
when the outer layer of a membrane is saturated and this will occur when the 
vehicle is a saturated solution of the solute with excess permeant in suspension. In 
an ideal situation all saturated solutions of the same permeant in any solvent 
system should produce an equal flux through a membrane that is independent of 
solute concentration (Higuchi, 1960). Examination of the flux results shows that 
flux of permeants from different vehicles through all membranes was not 
constant. The direct implication of this result is that all of the situations 
investigated were not ideal, i.e. there was some interaction between the vehicle 
and the membrane. Such an interaction may involve diffusion of the solvent into 
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the membrane where it may increase or decrease the partition and/or diffusion 
coefficient of the solute.  Alternatively, it is possible the vehicle may act as an 
extraction solvent and remove some components of the membrane, e.g. a 
plasticizer, thus modifying its resistance to permeation of the solute in the 
membrane. In addition, any sorbed vehicle component(s) may increase the 
solubility of the incorporated drug in the membrane (Crawford & Esmerian, 1971; 
Amnuaikit et al., 2005; Alexander et al., 2012). The differences in the cumulative 
amount of a given permeant diffusing across the different membranes are 
therefore likely to be a consequence of the different physicochemical properties of 
the membranes. 
 
CF is the most hydrophilic model permeant therefore it has a relatively low 
solubility in the oils but a higher solubility in the buffer (Table 3.1). The 
diffusion of CF from the buffer through silicone and HDPE membranes was 
comparatively low. This is likely to be due to the low partitioning of the buffer 
and CF into the hydrophobic membranes. However that was not the case when 
the PU membrane was employed. The diffusion of CF from the buffer was 
significantly higher than from any of the oils (p≤ 0.05). The more relatively 
hydrophilic properties of the PU membrane, particularly following its solvation 
with the aqueous buffer could have enhanced partitioning and diffusion of CF 
through the membrane, compared to both CF from oils through HDPE or silicone 
membranes. In addition, CF with its higher solubility in the buffer relative to the 
other permeants might diffuse concurrently with the buffer through the 
(comparatively) hydrophilic PU membrane. CF has been reported previously to 
diffuse through a hydrophilic Carbosil® membrane with a rate that was very 
similar to the diffusion of water, therefore concurrent diffusion of the compound 
with water was proposed to occur (Russeau et al., 2009).  
 
The highest amounts of CF that permeated from oily vehicles through all model 
membranes were achieved when IPM was the vehicle. IPM was sorbed by the 
model membranes therefore it might alter the overall structure of the membrane, 
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consequently enhancing the diffusion of CF through the membrane, and 
subsequently when CF reaches the receptor compartment it will readily partition 
into, and dissolve in the buffer. Despite the low solubility of CF in IHD, high 
flux values were achieved when IHD was the vehicle. This could be due to the 
high amount of IHD sorbed by the hydrophobic membranes (Table 4.4), which 
presumably does modify the membrane properties. Although higher amounts of 
IHD were sorbed into the HDPE and silicone membranes, the flux of CF from 
IPM was higher because IPM has higher solvation capacity for CF compared to 
IHD. Therefore, it follows that: (a) the amount lost by diffusion will be 
replenished quickly when IPM is the vehicle; and (b) the solubility of CF in the 
membrane is most likely higher in the IPM-modified membrane, compared to an 
IHD-modified membrane.  
 
OA has the greatest capacity to dissolve CF. However the lowest amount of CF 
that permeated through silicone membrane was when OA was the vehicle. This 
could be due to the low interaction between OA and silicone membrane (Table 
4.3). Although the results presented in Section 5.4 identified multiple 
physicochemical properties of both vehicle and permeant those determine the 
extent of oil-membrane interaction, the ʻkinkedʼ shape of OA compared to other 
oils is perceived to play a role in restricting the diffusion of OA into the 
membrane. On the other hand, OA behaved as a plasticizer for PU changing the 
membrane properties and rendering it ‘sticky’ by the end of the experiments. 
Thus the resistance of the membrane to penetration would have been modified. 
Comparing the results of the model permeant (i.e. CF) diffusion from OA 
through the three membranes, the diffusion through PU was the highest. 
However the diffusion of CF from OA through PU was significantly lower than 
its diffusion from the buffer. 
 
CF was similarly soluble in all of the hydrocarbon vehicles, but the amount of 
IHD sorbed by HDPE and silicone was greater than the other oils. Therefore the 
amount of CF permeating through the membranes from an IHD vehicle proved to 
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be significantly higher. The viscosity of LP is higher than HD or IHD and the 
higher viscosity may decrease diffusivity of the permeant, both within the 
vehicle and in a vehicle-modified membrane. LP viscosity is approximately 30 
mPas, whilst the viscosities of HD and IHD are 3.34 mPas at 25°C and 5.2 mPas 
at 20°C respectively, as supplied by the suppliers. In addition the amount of HD 
sorbed by silicone and HDPE was higher than LP, thus leading to a lower 
amount of CF permeating form LP compared with HD. 
 
MP was chosen as a model permeant as being representative of a compound 
having intermediate lipophilicity, and it also demonstrated it has intermediate 
solubility in the oils and buffer (Table 3.1). The amount of MP that permeated 
through silicone membrane when the buffer was the vehicle was higher than BP 
and CF. Its moderate solubility and partitioning between hydrophilic and 
lipophilic regions aids in its ability to partition and diffuse through the lipophilic 
membrane and later become solubilised in the receptor compartment. The flux of 
MP through PU membrane was lower than CF, due to the higher lipophilicity of 
MP, when compared with CF. HDPE membrane posed the highest resistance to 
MP permeation from the buffer, this might be due to the structure of HDPE since 
it is not a branched cross-linked membrane, and therefore it has a more compact 
structure while also being poorly solvated by an aqueous solvent phase.  
 
MP permeated faster through all membranes when presented in IPM (Figure 
5.4). Since IPM was sorbed by all membranes, it tended to improve the 
partitioning and diffusion of all permeants. The oil sorbed by the membrane 
might therefore promote the permeation of the model permeant molecules 
through the modified matrix. IPM is therefore, likely to enhance the penetration 
of the model permeant across the membrane because the oil was taken up well 
into the membranes (Table 4.5), and the solubility of the permeants in IPM is 
relatively high. Therefore the high permeation through the membrane could be 
correlated with the solvent uptake of IPM (Tables 4.4 and 4.5). The confirmation 
of the importance of solvent uptake was demonstrated by the QSPR model; in 
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the flux model (Equation 5.4) it was shown that increasing the amount of oil 
sorbed (mupt) by the membrane will lead to an increase in the flux. IPM has been 
reported previously to act as a good penetration enhancer for different drugs 
through silicone membrane (Dias et al., 2007; Liu et al., 2009; McAuley et al., 
2009). A particularly novelty of the current study has been the study of 
alternative membranes of differing structure and physicochemical properties (e.g. 
solubility parameters) to silicone membrane. This was effected with a view to 
seeking to identify any parameters of the membrane that might be employed in a 
capacity to achieve parameterization during in vitro experiments to predict the 
diffusion of topically applied compounds to the more-difficult to acquire (and 
experimentally manipulated) skin. 
 
As discussed previously HD, IHD and LP are oils constituted mainly of 
hydrocarbon chains, therefore there is no special interaction with the model 
permeants, and this is confirmed by the solubility results, since similar solubility 
values were achieved in the three vehicles (Table 3.1). The main difference 
between these oils was in their ability to interact with the membrane, described 
by the amount of oil sorbed into membranes (Table 4.4). The amount of oils 
sorbed by silicone membrane was in the order of IHD>HD>LP which was the 
same ranking for MP flux through silicone membrane from these oils. This 
identifies the existence of a correlation between the amount of oil sorbed by the 
membrane and amount of drug permeating through it, even if the compound 
demonstrates a similar solubility in both oils. The latter finding is compatible 
with the theory of a vehicle modifying the properties of a barrier membrane due 
to preferential uptake. Vehicles which are taken up by the membranes occupy a 
larger solvent fraction in the membrane and accordingly a larger overall amount 
of permeant might be expected to diffuse through the membrane. Also the 
properties of the membrane would change (a decrease in the resistance by 
providing a more extended molecular structure due to swelling) and this might 
also enhance the flux. Therefore higher fluxes of the permeant were determined 
when IHD was employed, when comparing only the hydrocarbon vehicles. A 
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positive correlation between the amount of drug in the membrane and the 
corresponding uptake of the vehicle has been previously reported (Oliveira et al., 
2012b).  
 
There was no significant difference in the amount of HD and IHD sorbed by PU 
membrane, and the flux results for MP from these vehicles through PU were 
similar. However, although there was also no significant difference in the 
amount of LP sorbed by the membrane (in comparison to IHD and HD), the 
fluxes of the permeants from LP were significantly lower than from the other 
oils. It is possible that the higher viscosity of LP compared to IHD and HD was a 
factor contributing to this difference. The LP viscosity is also hypothesized to 
affect the amount of MP permeating through HDPE membrane, where a lower 
amount of MP permeated through the membrane from LP even though the 
uptake of LP into HDPE was higher compared to HD.  
 
BP was the most lipophilic of the model permeants that was employed, and 
therefore generally oily vehicles enhanced the permeation of BP through silicone 
and HDPE membranes compared to the buffer. This is likely to be due to the 
interaction of the oily vehicles with the hydrophobic membranes which leads to 
an enhancement in the BP flux. CF and MP are more likely to exhibit enhanced 
partitioning and diffusion through the relatively more hydrophilic PU membrane 
compared to BP. BP diffused markedly slower than MP and CF probably as a 
consequence of the low solubility of BP in buffer compared with the other two 
compounds. The comparatively greater lipophilicity of BP results in its lower 
affinity to the PU membrane, particularly following membrane hydration. 
 
The highest amount of BP that permeated through silicone membranes was when 
IHD was the vehicle. The primary factor contributing to this enhancement is the 
high solvent uptake of IHD into silicone membrane. As described previously the 
relatively large amount of IHD that was sorbed by the membranes might lead to 
an opening-up of the polymer chains within the silicone membrane structure and 
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this could lead to an enhanced diffusivity of the permeant through the membrane. 
In addition since BP is a lipophilic permeant it could partition favourably into the 
lipophilic silicone membrane, especially following extensive uptake of the 
hydrocarbon vehicle. 
 
IPM also provided a marked enhancement of BP diffusion through different 
membranes. BP has high solubility in IPM, and IPM was sorbed into different 
membranes, therefore it would have changed the properties of the membrane, 
leading to enhanced partitioning of the permeant from the donor into the 
membrane phase. The results of BP diffusion through HDPE and PU membranes 
show that although BP has higher solubility in IPM there was no significant 
difference between the flux of this permeant whether it is suspended in IPM or 
IHD. The importance of uptake of the vehicle into the membrane has been 
demonstrated previously, using ATR-FTIR spectroscopy (McAuley et al., 2010). 
In the latter study, permeation of the model permeant through silicone membrane 
was similar for two solvents. The greater extent of IPM uptake into the membrane 
enhanced the flux to overcome the effect of the greater solubility of the permeant 
in decanol. Similarly, the fluxes of BP from IPM and IHD through HDPE are 
significantly higher than from OA, LP and HD. 
 
There was no significant difference between rate of diffusion of BP from OA 
through HDPE and PU membranes. This was attributed to the relatively high 
lipophilicity of BP and despite OA clearly modifying the properties of the PU 
membrane, BP did not partition favorably into the oil-modified membrane. All 
model permeants were highly soluble in OA compared with other vehicles; 
however the low OA sorption by the membranes correlated with lower diffusion 
rates; whilst there appeared less of an effect imposed by the increased solubility. 
Clearly both the solvent uptake and the solubility of permeant in the membrane 
affect the concentration of the permeant in the membrane at equilibrium 
(McAuley et al., 2010).  
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In an attempt to understand the effects of permeant-vehicle-membrane 
interactions in relation to the specific molecular properties of vehicles, permeants 
and membranes, multivariate data analysis was applied. Regression analysis was 
used to build a QSPR model and PCA was used to extract the important 
information from a set of data. 
 
Since the variables used in the analysis have different numerical ranges. Before 
the analysis, the data were normalised and mean centered to confirm that all 
variables make the same contribution to the model. This improves the 
interpretability of the model. Then the descriptors were correlated to the 
dependent variable. In the QSPR and PCA some descriptors were removed in the 
correlation, for example the parameters relating to molecular volume and size; 
this was because the retained descriptors proved to be more correlated to the 
dependent variable. In addition, the excluded descriptors were correlated and 
explained by the descriptors used in the analysis. Therefore an effect relating to 
the original descriptors are still present in (and therefore making an impact upon) 
the analysis. 
 
QSPR models were constructed for the flux of the permeants through membranes 
and Log Kp. An acceptable r2 of the multiple regressions was achieved and the P-
values were below 0.05. Each QSPR consisted of permeant descriptor, vehicle 
descriptor and combined vehicle-permeant or vehicle membrane descriptors. 
However due to the limited data size the QSPR of the solvent uptake failed. Most 
QSPR models are generated from data taken from different laboratories. 
Accordingly, unlike these earlier QSPR models, the data used in this study were 
consistent; all the experiments being conducted in the same laboratory under the 
same conditions, and this might decrease the error if the number of permeants 
were to be increased. 
 
The generated QSPR models showed that the permeant, vehicle and membrane 
descriptors are important in determining the flux through synthetic membranes. 
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Therefore all of them should be taken into consideration when predicting 
permeation of topically applied compounds. A limitation of most of the 
previously generated models is that they only consider the permeant descriptors 
and ignore the effect of the physicochemical properties of the vehicle or the 
membrane under study on the permeant diffusion process (Potts and Guy 1992 & 
1995; Lien & Gao, 1995; Pugh et al., 1996; Moss & Cronin, 2002; Lam et al., 
2010). Such a restriction may impact upon the ability to develop representative 
models based on in-vitro experimental data. 
 
Equations 5.4 and 5.6 shows that the hydrogen bond ability of the vehicle and 
membrane are important descriptors to predict the flux through synthetic 
membranes. The Log Kp model showed that the melting point of the permeant, 
which is related to the hydrogen bond ability of the permeant, has the highest 
coefficient (1.10 MPTd) in determining the permeability coefficient through 
synthetic membranes. Also the melting point of the vehicle was one of the 
descriptors to determine the Log Kp. This indicated the importance of the 
hydrogen bonding of the vehicle, permeant and membrane in influencing the 
diffusion of permeants through synthetic membranes. The hydrogen bond donor 
ability of the vehicle (-1.67 ∑αH) was more important that the hydrogen bond 
acceptor ability (-1.18 ∑βH). The importance of the hydrogen bond donor of the 
drug has been reported previously in human skin and silicone (Cronin et al., 1999; 
Geinoz et al., 2002). The present study confirms its importance for the drug, 
however, unlike previous studies, it has been shown here that the H-bonding 
behaviour of the vehicle is also a determinant of pemeant flux across a barrier 
membrane. 
 
In the current analysis the lipophilicity and hydrogen bonding were important 
determinants of diffusion through the synthetic membranes. However it is well 
documented that the Mwt is also important (Potts & Guy, 1992; Cronin et al., 
1999) but this was a factor that was not investigated here because of the limited 
range of molecules employed in this study where compounds within a narrow 
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range of Mwt but with different lipophilicities were deliberately selected. This 
was a deliberate component of the initial experimental and hypothesis design in 
an attempt to effect a degree of consistency during, what was an attempt to pilot 
multivariate analytical methods for application to dermal permeation processes. 
 
The amount of solvent sorbed into the membrane (mupt) was positively correlated 
with the flux through membranes. This was also confirmed by the diffusion 
results, since as mentioned previously a correlation was found between the 
amount of vehicle sorbed and the flux. The lipophilicity of the vehicle was an 
important descriptor in determining both the flux and permeability coefficient of a 
permeant from a vehicle donor across barrier membranes. 
 
The shape and size of the permeant and vehicle (chi0 permeant and opr-brigid 
vehicle) were also important descriptors for determining Log Kp. The coefficients 
were -0.44 chi0 permeant and -0.54 opr-brigid vehicle, respectively. The negative 
sign indicates that increasing the size or number of rigid bonds would lead to 
lower permeability of a permeant. Therefore the smaller flexible molecules will 
permeate the membranes more easily than large, rigid permeants. High flexibility 
leads to higher mobility and rotational freedom (Lemont & Kier, 1989), and it 
should be borne in mind that the size and flexibility of vehicle molecular 
components will also determine the degree to which vehicles can partition into 
(and modify the properties of) barrier membranes. This might elucidate the 
preferential uptake of IHD into synthetic membranes when compared with HD. 
 
In order to understand the effect of the descriptors on the solvent uptake and 
diffusion through membranes, PCA was conducted examining solvent uptake, 
flux, Kp and lag time of the diffusion of model permeants through membranes. In 
addition it was performed on the diffusion of model permeants through the 
epidermis. 
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In all correlations, the solubility of the permeant in the oil was an important 
descriptor (Table 5.5). This was expected since the permeant must have sufficient 
solubility in order to diffuse through the membranes, and particularly so in the 
case of a vehicle-modified membrane. Previous studies have shown the 
importance of the drug solubility in the vehicles which are sorbed by the 
membrane (Dias et al., 2001; McAuley et al. 2010). The Log Ko/w of the vehicle 
has been reported to be an important descriptor for describing the solvent uptake 
and Kp and previous QSPR models have also used Log Ko/w of the permeants as a 
descriptor for Log Kp (Potts & Guy, 1992; Lien & Gao, 1995; Moss & Cronin, 
2002). The hydrogen bonding ability of the vehicle and the δH of the membranes 
play a role in the flux of the selected permeants through the different membranes. 
Generally the oils used had a wide range of values for δH (0-6.2) MPa1/2 compared 
with δD (14.7-16) MPa1/2 and δP. (0-2.8) MPa1/2. Cronin and others have 
developed a QSPR model for the prediction of the maximum steady state flux 
through the silicone membrane (Log J), in which the number of hydrogen bond 
acceptor and donor groups for the permeant were important descriptors in their 
model (Cronin et al., 1998). 
 
Six vehicle descriptors described the behaviour of the solvent uptake and Kp, five 
of them were identical in the solvent uptake and Kp: (Log Ko/w, molecular 
connectivity index, opr_brigid, distance and chi0 descriptors). This might indicate 
that the behaviour of the vehicle in solvent uptake is similar to it in the Kp. The 
difference in the general distributions in the two plots is due to the existence of 
the permeant descriptors in the case of Kp.  
 
In the PCA plots of solvent uptake and Kp (Figures 5.11 and 5.13 respectively) 
OA and IPM were clustered together and exhibited similar behaviour in terms of 
influencing membrane uptake and Kp. HD and IHD each displayed unique 
behaviour with the descriptors that are highly loaded on PC1 and PC2 being able 
to separate the two oils. This finding could be because although OA and IPM 
have similar values of the molecular descriptors that influence both solvent uptake 
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and Kp, they are different for IHD and HD. The descriptors in question were δD 
and molecular connectivity index for solvent uptake; and molecular connectivity 
index and Log Ko/w for Kp. Since the main descriptors that were highly loaded on 
PC1 and PC2 are only related to the vehicle no special separation for the 
membranes or permeants was seen in the score plot.  
 
In the flux score plot (Figure 5.12) there were four main groups. The main 
descriptors that explained the variance were able to separate the behaviour of each 
vehicle. As mentioned previously this is because the combination of the values of 
each vehicle was different for the main descriptors. The descriptors were H-bond 
acceptor ability, solubility and Log Ko/w. In the PCA of lag time (Figure 5.14), the 
data were scattered across the plot. Both chi1 and δT permeant were the main 
descriptors contributing to the explanation of the variance captured by both PC1 
and PC2. Since the latter descriptors are inherently related to both the vehicle and 
permeant, the clustering that was found was attributable to both of these 
components. However although the descriptors were able to separate the 
behaviour of BP, the descriptors for MP and CF were clustered together. In the 
case of permeant flux analysis, therefore, the PCA accommodated both permeant 
and vehicle properties in explaining the complex interactions during permeation 
across the membranes.  
 
Diffusion studies of model permeants through the epidermis were conducted to 
study the effect of the oily vehicle on the diffusion through skin. Molecules are 
thought to transverse the skin by one of the three main pathways: the polar, non-
polar or polar/non-polar pathways, the relative importance of each being 
dependent upon their physicochemical properties (Section 1.2). The molecular 
weight and the Log Ko/w can be used to predict its distribution within a biological 
system (Potts & Guy, 1992). The diffusion law predicts an inverse relationship 
between membrane diffusivity and permeant size (Lieb & Stein, 1971). Since the 
three permeants selected for this study have similar molecular weights, their rates 
of permeation through skin might be expected to correlate with their Log Ko/w 
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values. An ideal candidate for transdermal delivery should ideally possess Log 
Ko/w values between 1 and 3 in order for high fluxes through the skin to be 
achieved (Yano et al., 1986; Potts & Francoeur, 1991; Lee et al., 1994). 
Therefore MP would be expected to be the best candidate in this context (with its 
Log Ko/w being 1.96), since BP is more hydrophobic, in terms of its Log Ko/w 
(3.57) and CF more hydrophilic Log Ko/w (-0.07). However, in light of the 
analysis using a range of model membranes, permeants and vehicles above, it 
was deemed appropriate to also perform multivariate analysis accommodating a 
wider range of physicochemical parameters in estimating permeant flux across 
epidermis.   
 
The flux of the model permeants (MP>BP>CF) from the buffer across human 
epidermis, reflected the differences in lipophilicity of each of the permeant and 
the ease of the compounds in traversing the skin barrier. The physicochemical 
properties of MP promote its ability to traverse the lipophilic and hydrophilic 
regions of the stratum corneum as well as the more hydrophilic components of 
the underlying epidermis (Soni et al., 2002). Despite its moderate hydrophilicity, 
its principal diffusion pathway is presumed to be through the relatively non-polar 
lipid route of the stratum corneum. BP is also expected to penetrate the skin by 
this route. Previous studies involving the use of normal (intact) and de-lipidised 
guinea pig skin concluded that penetration of parabens tended to occur primarily 
via the lipoidal pathway obeying a parabolic relationship as a function of 
lipophilicity (Kitagawa et al. 1997). The trend of parabens flux in this study was 
consistent with the previous findings. 
 
Treffel et al. (1992), suggested the main route of CF permeation through skin 
was via the transcellular keratin matrix, due to the inability of occlusion to 
enhance CF skin absorption. However, CF has also been proposed to traverse the 
skin via the lipoidal pathway (Dias et al., 1999). These findings could suggest 
that CF permeation across skin involves multiple pathways. The slower 
permeation profiles of CF, compared with the parabens, would be expected, due 
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to the difficulties associated with hydrophilic compounds traversing the 
lipophilic stratum corneum. This is confirmed by the results obtained in the 
current studies which demonstrated the lower fluxes obtained for CF from the 
vehicles compared to those found for the two other permeants. 
 
All oily vehicles enhanced the permeation of the model permeants through the 
human epidermis relative to the buffer. The factors affecting the diffusion of 
permeants from these vehicles may include differences in either (i) vehicle–skin 
effects and/or (ii) permeant–vehicle affinity. Using a cellulose acetate nitrate 
membrane (non-rate limiting), it was shown that all permeants were readily 
released from the vehicles (Figure 3.2, 3.3 Table 3.3). This may imply that 
differences in diffusion are likely to be attributable to the interaction of the oily 
components with the membrane; since saturated systems were used in all cases 
(Barry et al., 1985; Twist & Zatz, 1986). The highest permeation was attained 
using IHD. IHD is highly branched molecule which is more flexible than other 
vehicles (Kier, 1989). Such results support the hypothesis that shape and size of 
the vehicle is a key determinant in any modification of epidermal structure 
brought about by sorption of the oil. Such modification may enhance the 
permeation of all permeants including the more hydrophilic CF.  
 
Among the possible effects of hydrocarbons on the skin is the increased fluidity 
that might be imparted to the intercellular lipid layer by their presence and the 
possible extraction of lipids and/or other components that could occur (Rahman 
et al., 1992). Without the specific effects of the vehicle on the skin, the 
equivalent thermodynamic activity produces very similar permeation rates of the 
drug across skin (Barry et al., 1985; Twist & Zatz 1986). Diffusion would appear 
therefore to be highly dependent on the uptake of the vehicle and solubility of the 
permeant in that sorbed vehicle. However in the current study all permeants have 
a poorer solubility in IHD compared with OA and IPM. Nevertheless IHD was 
highly taken up to a greater extent by the hydrophobic synthetic membranes 
employed in this study, although the HSP distance between IHD and the 
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membranes was the highest comparatively. However, since all factors should be 
taken into consideration, IHD might have been taken up in greater amounts 
because of its high flexibility, small size and spherical shape. The enhanced flux 
of the model permeants with different lipophilicity indicated that IHD might be 
affecting the structure of the stratum corneum and reducing its resistance. 
 
LP which is also a hydrocarbon (a mixture of liquid hydrocarbons from 
petroleum) appeared to have the least interaction with the human epidermis; this 
is consistent with the lower flux values of the permeants from this vehicle. LP 
has been reported to interact weakly with mouse skin compared with other 
vehicles (Roberts et al., 1975; Rahman et al., 1992). The fluxes of MP and CF 
were similar from LP to those from HD; whereas BP diffusion from HD was 
significantly higher than from LP. This indicates that HD might improve the flux 
of the lipophilic compounds. HD and IHD were used together in this study in 
order to investigate the effect of structure, ovality and flexibility of the vehicle 
on the penetration. Since all permeants have similar solubility and interaction 
with both vehicles, the difference in the flux is most likely due to the difference 
in interaction of the vehicles with the skin. It is interesting that the fluxes of all 
permeants were greater from IHD than from HD. Both vehicles are hydrocarbons 
and, as a consequence, do not have specific functional groups that could interact 
with the skin differently. This might suggest again that the interaction between 
IHD and skin is mainly attributed to its structure, flexibility and shape. This 
assumption was confirmed by the PCA of the flux of model permeants through 
the epidermis where kier flex and opr-birgid were explaining part of the total 
variance explained by both PC1 and PC2. In addition the chi descriptors, which 
are related to the size and shape of the molecule, were also correlated with the 
flux through synthetic membranes. 
 
The distance between the HSP values of the skin and OA or IPM is smaller 
compared with IHD. This suggests that these two oils might be expected to be 
better vehicles for the skin when compared with IHD. However IPM and OA are 
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less flexible comparatively and have two hydrogen bonding acceptor groups (and 
OA also has a hydrogen donor group). In addition the molecular volumes of 
these two oils are greater than molecular volume of IHD. Therefore taking all 
these factors into consideration IHD appeared to act as a better enhancer for the 
diffusion of the model permeants through the epidermis. 
 
OA enhanced the permeation of the three model permeants through the 
epidermis compared with that from the buffer. However IPM and IHD were 
comparatively better enhancers than OA for MP diffusion through epidermis. 
Although all permeants yielded higher flux values from IPM through synthetic 
membranes compared with from OA, there proved to be no significant difference 
between the fluxes of CF from IPM and OA through the epidermis. The same 
behaviour was seen with BP, however this was not the case with MP, the flux of 
MP from IPM as a vehicle was significantly higher than from OA. OA has been 
reported to function by partitioning into the lipid regions of the stratum corneum, 
disrupting the structure and lipid fluidity of the stratum corneum (Kim et al., 
1993). Barry (1987) explored the mechanism of OA as a penetration enhancer 
using differential scanning calorimetry of human stratum corneum. OA was 
demonstrated to ‘melt’ the lipid chain portion buried within the bilayer structure 
together with some non-polar material. It is also thought to break associations 
between lipid polar groups together with disruption of cholesterol-stiffened 
regions. It is hypothesized that the cis double bond at C9 on OA causes a kink in 
the alkyl chain, which is likely to disrupt the ordered array of the predominantly 
saturated straight chain skin lipids and increase the fluidity of the lipid regions 
(Barry, 1987; Golden et al., 1987). In order for long-chained fatty acids including 
OA to induce the maximum disruption of lipids, they should be applied in a 
hydrophilic polar vehicle such as propylene glycol (Wang et al., 2004). OA has 
also been blended with ethanol and the maximum lipid disorder occurred at 1% 
OA and no additional disorder was induced by increasing the OA concentration 
to 10% (Mak et al., 1990). However in this study OA was not blended with any 
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other hydrophilic vehicle, only the effect of the pure oily vehicle structure, and 
the characteristics and descriptors of the oil itself are being studied. 
 
IPM has been widely used as a penetration enhancer in previous studies and has 
shown to be superior when compared with other vehicles (Gwak & Chun, 2002; 
Dias et al., 2007; Rhee et al., 2007; Oliveira, et al., 2012b; Santos et al., 2012). 
The sorption of IPM by the stratum corneum has been reported also (Oliveira, et 
al., 2012b). Since the permeation of any drug through different membranes 
depends on the interaction of the vehicle with the membrane; therefore IPM is a 
good vehicle for the selected permeants. High fluxes of MP and BP have been 
achieved from IPM due to its ability to modify the membrane after the sorption 
of the oil. Previous studies found a linear correlation between the amount of 
drugs partitioning into the membranes, solvent uptake and the concentration of 
the solute in the vehicle (Twist & Zatz, 1988 & 1990; Shah et al., 1993; Dias et 
al., 2001; Dias et al., 2004). Despite the proven capacity of IPM to enhance 
permeation through skin, and the weaker ability of LP, both vehicles increased 
the permeation of CF to a similar extent. Similar results have been noted 
previously by other authors (Dias et al., 2007).  
 
When CF was suspended in IPM, OA, HD and LP similar results were obtained 
for its diffusion through epidermis, while CF diffusion from IHD was 
significantly higher. However when model membranes were used the flux of CF 
from IPM was significantly enhanced compared to the flux from all other 
vehicles. Such a contrast in the results obtained using the model membranes and 
epidermis was also apparent for CF diffusion from OA. OA enhanced the 
permeation of the model permeants through the skin but it was less effective 
using the model membranes. This could be due to its shape since as outlined 
above; OA can disturb the lipids of the skin whilst it is relatively poorly sorbed 
into the synthetic membranes. Cross-linked polymers chains are joined by strong 
covalent bonds. The solvent can intercalate between the macromolecular chains 
and solvate the polymer, leading to membrane swelling. Since OA has a 
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relatively large structure it might not easily enter into these spaces, between the 
polymer molecules. On the other hand it more readily enters between the skin 
lipids, which are formed mainly from: ceramides, cholesterol, and saturated long 
chain free fatty acids which are packed together (Section 1.1.2.2). As discussed 
above OA (which shows molecular structure similarity to stratum corneum 
lipids) can then integrate into the highly ordered packing of the lipid bilayers and 
the central position of the double bond can lead to an increase in its potential in 
lipid order disruption. Other authors have noted the non-specificity of the effect 
of some vehicles on the model membranes and skin (Cross et al., 2001; Dias et 
al., 2007). 
 
Multivariate data analysis was also applied to the epidermis diffusion data to 
understand the effects of permeant-vehicle-epidermis interaction. Regression 
analysis was used to build a QSPR model but because of the limited data size the 
development of a QSPR model of permeant flux through epidermis failed. 
 
Some key descriptors used to account for the permeation of compounds through 
epidermis proved to be different to those identified for synthetic membranes. For 
example, chi descriptors remained after the correlation of synthetic membrane 
dependent variables, while Kier flex remained after the correlation with the 
epidermis flux; therefore the chi descriptors were found in the PCA of the 
membranes while the Kier flex descriptor was found in the epidermis PCA. Both 
descriptors are related to each other, both of them are topological descriptors 
related to the shape and branching of the structure. The chi descriptors do also 
encode the size of the molecule, whilst the Kier flex values (Kier molecular 
flexibility index) account for the structural features aiding in the flexibility of the 
molecules, which are: (i) few atoms, (ii) the presence of cycles (iii) the presence 
of branching. 
 
The behaviour of the data presented in the score plot of the flux through 
epidermis (Figure 5.15) was different to those derived using synthetic 
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membranes. A typified trend was seen for each vehicle and membrane, however 
this trend was broken by BP in IPM; this might be as a consequence of the high 
solubility of BP in this oil. The scattering of the data was because the main 
descriptors to describe the variance (density, solubility, Chi_C permeant) were 
able to separate the behavior of vehicles and permeants. 
 
The vehicle descriptors were the dominant terms in explaining the variance of the 
diffusion through the synthetic membranes as compared with the epidermis PCA. 
Also in the PCA score plots of the data relating to synthetic membranes, 
clustering is apparent according to the specific vehicle employed, regardless the 
membrane and permeant used. However this was not the case with the epidermis 
PCA plots. The data were distributed along the plot and no special clustering was 
seen and therefore both the permeant and vehicle descriptors were of importance. 
 
The chi descriptors (chi0 and chi0_C) and the opr_nring descriptors for the 
permeant were important defining the flux of the compounds through epidermis. 
The chi descriptors were also correlated to the Kp of synthetic membranes, and 
this might indicate that the permeant shape, size and flexibility is an important 
factor in the diffusion through epidermis in the limited number of permeants used. 
Three descriptors related to the vehicle were important in the epidermis flux, 
density, opr_brigid and Kier flex, two of these being related to the flexibility of 
the vehicle. These results indicate that, for the permeants and vehicles that were 
employed in the current study, the flexibility of the molecules was an important 
factor to consider in molecules capable of traversing the human epidermis. 
However this tentative conclusion requires further study using a wider dataset, to 
confirm the results and produce a more robust model.  
 
The highest flux values for all model permeants were obtained when the 
compounds were suspended in IHD. Branched molecules are smaller and more 
compact in size and they have higher flexibility (lower Kier flex) which might 
increase their mobility and ease their uptake into different membranes, this will 
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have a positive effect on promoting the diffusion of different permeants. The 
diffusion of model permeants through the membranes was in most instances 
correlated with the solvent uptake into the different membranes. IHD was sorbed 
into different membranes enhancing the diffusion of permeants, the high fluxes 
of model permeants through the epidermis when IHD was the vehicle, indicates 
that it might be sorbed by the epidermis and in turn modify the properties of the 
membrane. However a wider range of branched vehicles need to be studied in 
order to confirm whether molecular branching truly has an effect on membrane 
permeation. 
 
It is well established that the preferential diffusion of one drug over the other is 
dependent upon the lipophilicity, size and hydrogen bond ability of the drug. The 
PCA of the epidermis flux (Figure 5.15) showed that the chi descriptors (chi0 
and chi0_C) and the opr_nring descriptors for the permeant were important 
descriptors in explaining the variance in the flux results obtained using 
epidermis. These descriptors encode the size, shape and flexibility of the 
permeant. The shape and flexibility have not been taken into consideration in 
previous models. Including these descriptors with the lipophilicity and hydrogen 
bonding ability in QSPR models might improve the correlations obtained in 
future developed QSPR models.  
 
In conclusion, these results show that the use of synthetic membranes to 
determine the flux of permeants from oils should be treated with care. This is 
because the oils can interact differently with each of the membranes and alter the 
diffusion of each compound. The shape of the oil molecule affects its uptake into 
the membrane and the subsequent interaction with either synthetic or epidermal 
membrane. The diffusion results showed that the vehicles containing the highest 
molecular branching tended to promote the permeability of the model 
compounds employed. Molecular branching leads to a more spherical molecular 
shape with a higher flexibility, and ultimately sorption in high amounts by the 
membranes. The fluxes of concomitantly applied permeants were then modified. 
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Multivariate analysis confirms that the vehicle, the membrane and the permeant 
should be considered when determining permeability. This strategy of 
monitoring the diffusion of permeant across synthetic membranes might prove 
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Transdermal delivery offers a number of potential advantages over more 
traditional drug delivery methods (Hadgraft & Guy, 1989; Smith & Maibach, 
1995; Guy, 1996). However the skin is an efficient barrier, which prevents both 
excessive water loss from the body and the ingress of xenobiotics (Hadgraft, 
2001). The first transdermal patch, which contained scopolamine, was granted a 
licence by the FDA in 1979 (Langer, 2004). It comprised a small reservoir type 
patch where the drug was dispersed in liquid and this suspension sealed between 
an impermeable backing layer and a rate-controlling membrane. The membrane 
was adhered directly to the skin surface and was responsible for the sustained 
delivery of the drug. However, since then fewer than two dozen of drugs have 
been approved by the regulatory authorities for transdermal administration 
(Gratieri et al., 2013). This short list of “deliverable” drugs highlights the 
physicochemical restrictions imposed on skin delivery. 
 
In order to fully explore the potential benefits of the transdermal route for drug 
delivery, the number of potential drug candidates that might reach the circulation 
in sufficient amounts so as to attain therapeutic efficacy has to be increased. 
Accordingly, various enhancement strategies designed to overcome the 
permeability barrier of stratum corneum have begun to emerge, and these can be 
categorised into passive and active methods. The passive approach relies upon 
optimising the formulation in order to provide an improved driving force to 
increase the rate of transport and the permeability of the skin to the agent (i.e. 
modify the formulation in some way) (Gratieri et al., 2013). Examples of this 
strategy include the use of penetration enhancers, prodrugs, lipid vesicles and 
supersaturated systems. Active methods normally involve physical or mechanical 
methods of enhancing delivery, and they aim to modify the properties of the 
microenvironment through which permation must occur (i.e. act on the stratum 
corneum) (Gratieri et al., 2013). Active strategies include the use of iontophoresis, 
electroporation, radio frequency and needleless injection. 
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Drug permeation through membranes will often be dependent upon both the 
physicochemical properties of the drug and those of the vehicle comprising the 
formulation. The use of vehicles that are sorbed by the membrane, which might 
also interact with components of the membrane, might induce changes in the 
physicochemical properties of the membrane. Such an action might be expected to 
modulate the transport rate of permeants, and is a common strategy when seeking 
to improve dermal delivery (Williams & Barry, 2004). Additionally, penetration-
enhancing chemical agents are often co-formulated in the vehicle, which serve to 
improve the permeability of the epidermal barrier to xenobiotics. The 
understanding of vehicle-membrane interactions is therefore a critical step not 
only in the selection of an optimal penetration enhancer but also a prime factor 
affecting formulation design. Investigation of possible membrane-vehicle 
interaction, using solvent uptake, and then seeking to correlate this with the effect 
on drug permeation, has been employed by a number of previous workers, 
although almost exclusively employing aqueous- and alcoholic-based vehicles. 
Their findings have shown that high solvent sorption can alter the 
physicochemical properties of the membrane and result in changes to the partition 
and diffusion properties of the drug, leading to a modified permeation (Most, 
1972; Twist & Zatz, 1988 & 1990; Cross et al., 2001; Dias et al., 2007; McAuley 
et al., 2010; Oliveira et al., 2010 Zhang et al., 2011). Nevertheless, oily vehicles 
have received little attention despite their inclusion as vehicle components in 
many topical formulations.  
 
Oils have been incorporated into transdermal and cosmetic preparations since 
ancient times. In most preparations oils are thought to be inert, being integrated 
for the purpose of providing a matrix or medium for the formulation, although 
sometimes they are used to dissolve the drug or act as phase modifiers for 
organoleptic properties. The effect of combining two oils within a vehicle, 
applying that vehicle topically to the membrane and then considering the 
interaction of those oils with membranes and the possible effects on permeants 
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presented in the formulation has not previously been studied, despite the 
common practice (especially within cosmetic formulations) to blend oily 
vehicles to enhance organoleptic properties. Little attention has also been given 
to the ability of the oils included in cosmetic and topical products to enhance the 
unwanted permeation of formulation ingredients for example preservatives.  
 
The vehicles investigated in this present study are oils which have been used 
previously either in transdermal delivery or cosmetic products and are generally 
regarded as safe (GRAS). Oleic acid (OA) and isopropyl myristate (IPM) have 
been previously used in transdermal formulations to enhance drug delivery 
whereas although hexadecane (HD) and isohexadecane (IHD) have both been 
used in cosmetic products, their ability to enhance drug permeation has not been 
studied previously. Liquid paraffin (LP) has been used in both transdermal and 
cosmetic preparations. The potential of these selected oily vehicles to promote 
the diffusion of model solutes with different physicochemical properties through 
synthetic and human epidermis was investigated in this present study. Equal 
thermodynamic activity of the incorporated permeant was maintained in the 
Franz cell donor chamber in all experiments. This was to ensure that effects 
associated with the enhancement could be solely attributed to the effect of the 
vehicle on the membrane, rather than to changes in the activity of the permeant 
within the vehicle. 
 
The use of human skin for studying the effect of formulation components is 
associated with several difficulties and limitations, the biological nature of the 
skin is complex compared with membranes, and furthermore there is extremely 
large inter- and intra-individual variability of skin samples. Artificial model 
membranes can be used as simple and reproducible alternatives to study the 
effect of vehicles on the mechanisms of drug permeation, when seeking to 
understand the basic phenomenon of possible vehicle interaction with, and drug 
permeation through, human skin. The use of membrane models to screen 
transdermal formulations and assess their possible contribution to the overall 
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mechanisms of drug transport across human skin is well documented in the 
literature (Nakano & Patel, 1970; Twist & Zatz, 1988; Pellett et al., 1997; Cross 
et al., 2001; Yang et al., 2004; Chen et al., 2007; Dias et al., 2007a; Watkinson et 
al., 2009 a&b; Oliveira et al., 2010; Santos et al., 2011). 
 
With a view to investigating the release of model permeants, from an oil or oil 
blend, cellulose acetate nitrate membrane was used. In models using such a 
porous membrane, the permeants would be expected to partition from the oily 
vehicle into the receptor compartment through the buffer filled pores. Since this 
comprises a partitioning process the difference in the amount of drug released 
from the different blends is attributed to the difference in the activity coefficient 
(ɣ) of the drugs in the different vehicles, and the difference of the solubility and 
partitioning properties of the drug between the oil and buffer. However this 
outline of the diffusion process might be simplistic since it is possible: 1) that the 
oils (such as OA and IPM) might interact with the buffer filling the pores of the 
membrane, 2) the oil might displace some or all of the buffer bound to the pores, 
or 3) an interaction might occur between the membrane matrix and oily vehicle 
changing the pore size of the membrane. Since sink conditions were maintained 
throughout the experiment the partitioning process of the parabens did not reach 
equilibrium and the amount released continued to increase with time and would 
have been expected to be relatively unaffected by previous diffused compound. 
However in contrast to the parabens, CF release stopped after approximately 
three hours, and this was attributed to the high solubility of CF in the buffer 
compared with its low dissolution in the oily donor compartment, therefore the 
amount lost by release may not have been quickly restored from the particles 
suspended within the oil. 
 
In order to investigate any interaction between the oily vehicles and the 
membranes, diffusion studies were conducted through non-porous membranes 
employing saturated solution of the model permeants. The fluxes of a permeant 
from saturated solutions, despite the permeants displaying different solubilities, 
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are expected to be the same unless the vehicle interacts with the membrane. 
Different flux values were obtained for each of the permeants from the different 
vehicles, confirming that there might be some interaction of the different 
vehicles with the membrane. The use of IHD which has a branched structure was 
found to produce high penetrant flux values when compared with HD, which is 
its linear counterpart. These latter two oils were blended with IPM and LP in 
different ratios to study the effect of structure on the diffusion of model 
permeants through silicone membrane. In all formulations IHD blends yielded 
higher flux values compared with HD blends. In addition blends containing IPM 
yielded higher flux values. The flux of BP was increased as the ratio of IHD was 
increased when the latter was blended with any other oil. This relationship was 
found to be the same for MP and CF in IHD blends containing HD, LP and OA; 
whereas in contrast when IPM was blended with IHD, as the content of IHD 
decreased then the fluxes of MP and CF increased.  
 
Since all formulations had the same thermodynamic activity, the difference in the 
flux values might be attributed to the solvent being sorbed by the membrane 
leading to the properties of the latter being modified. Oil uptake by the 
membranes was determined gravimetrically; the oils being sorbed in different 
amounts into the different membranes. When blends of oils were applied it was 
hypothesised that preferential sorption of one of the oily components over the 
other might occur. If this were the case, then, the diffusion of a penetrant would 
depend on the nature of the membrane and the solvent within that membrane, 
therefore permeation might be affected by one vehicle more than the other. 
Furthermore, in some cases if one vehicle permeates the membrane more than 
the other, the thermodynamic activity of the drug in the donor compartment 
might be altered. Therefore silicone membrane was soaked in different oil blends 
and subsequently the sorbed oils were extracted and quantified by an appropriate 
gas chromatographic method. The results showed that in some cases the ratio of 
oils in the silicone membrane was not the same as the ratio in the original 
solution i.e. one vehicle was preferentially sorbed at the expense of the other. 
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However in other cases both oils were sorbed in the same ratio as in the original 
applied solution. The amount of oil sorbed into silicone from simulated Franz 
cell diffusion experiment, using different oil blends was also quantified, by 
assessing changes to the ratio of HD:IHD in the donor oil phase. The results of 
these experiments indicated that the oils (IHD and HD) were sorbed in different 
ratios during diffusion studies and hence would likely affect the partition and 
diffusion of model permeants through the modified membrane. The effect of oil 
sorbed to the membrane on the diffusion of a model permeant (MP) was also 
studied, by conducting a diffusion study of the permeant from buffer as a vehicle 
through silicone membrane soaked (i.e. pre-treated) with oils. The enhanced 
permeation of MP confirmed that the membrane had been modified by the oils. 
 
In order to investigate the parameters that might affect the uptake and diffusion 
process through synthetic membranes, and also the diffusion of the model 
permeants through human epidermis, multivariate analysis (QSPR and PCA) on 
the available data were performed. Previous studies (Flynn, 1990; Potts & Guy, 
1992; Wilschut et al., 1995; Pugh et al., 1996; Moss et al., 2002) have 
highlighted a range of permeant molecular properties that can be predictive of 
the extent of molecular transport across epidermal membranes. The current study 
has demonstrated the need to consider physicochemical properties of vehicle 
components, to understand vehicle uptake into the barrier membrane and 
consequent alteration of barrier properties. Therefore investigation of permeant 
flux requires an understanding of the physicochemical factors influencing 
interactions between vehicles, membranes (or vehicle-modified membranes) and 
permeants such as drug molecules. Multivariate statistics are statistical 
techniques that allow examination of the relationship between several variables 
simultaneously. Therefore it aids to obtain an overview of the relationship 
between different independent variables and a dependent variable. In this study 
the vehicle, permeant, membrane descriptors and interactions between different 
combinations of all three were analysed against different dependents. The results 
showed that the diffusion process was influenced by the drug, vehicle and 
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membrane descriptors. All factors which were identified as having an effect were 
found to be related to each other and should be considered when a formulation is 
designed. The interpretation of diffusion results involving the placing of weight 
on any one individual descriptor cannot provide an understanding of the uptake 
and diffusion behaviour. 
 
The solubility of the permeant in the vehicle and the size, branching and 
flexibility of the oil were identified as important descriptors that can contribute 
to the process of permeant diffusion through both the synthetic membranes and 
human epidermis. The branching and flexibility descriptors were also of 
importance when considering the vehicle uptake into membranes, permeability 
coefficient and lag time. These results indicate that the shape and flexibility 
should be taken into consideration either in formulation design or in choosing a 
vehicle for the formulations.   
 
The amount of solvent sorbed to the membrane affected the diffusion, 
permeability coefficient and lag time of permeants through the synthetic 
membranes. The diffusion, QSPR and PCA results confirmed the correlation 
between the diffusion and solvent uptake, therefore when the drug is intended to 
permeate the skin it may be advantageous to use a vehicle that is sorbed by the 
skin. On the other hand care should be taken when preparing topical and 
cosmetic formulations designed for localized function or use.  
 
The key descriptor related to the membrane was the distance between the Hansen 
solubility parameter values; this descriptor was important in determining the 
solvent uptake, diffusion, permeability coefficient and lag time. The smaller the 
value of the distance then the higher uptake and interaction between the vehicle 
and membrane, could predispose an enhancement in the diffusion of the 
permeant. However, since the diffusion and uptake is related to all descriptors, of 
the drug, vehicle and membrane, such a ‘distance rule’ was not obeyed in all 
vehicle-membrane interactions. 
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The QSPR of solvent uptake failed due to the limited data size, therefore a single 
equation could not describe the data. This was not the case with Log Kp and flux 
where an equation was found describing the available data. The data used in the 
QSPR were consistent since all experiments were made in the same laboratory 
under the same conditions. This would be expected to decrease the chances of 
the experimental errors in the QSPR data. The multivariate analysis technique 
could not be applied to the blends, since (as was proven by the solvent uptake 
experiments) there was preferential uptake of some oils from an applied blend 
and therefore the oil sorbed would modify the membrane in a non-linear way. 
 
Further studies to include a wider range of permeants and vehicles are needed to 
produce more data which would lead to a more robust modeling and QSPR. In 
addition, a wider range of membranes is needed in order to probe further a more 
robust correlation with that obtained using human epidermis diffusion. The drug 
and vehicle descriptors should be taken into consideration when preparing future 
formulations, in order to identify the most appropriate vehicle combination. 
Further studies should be carried out using topically relevant drugs such as 
steroids, incorporating the further use of synthetic membrane(s) and human 
stratum corneum. In due course it might then be possible to conduct in vivo trials 
employing the most promising formulations identified on the basis of these in 
vitro studies.  
 
In summary it is concluded that the novel approach of using multivariate analysis 
was found to be promising in understanding the interaction and diffusion 
behaviour of permeants from oily vehicles through synthetic membranes and 
human epidermis. The diffusion through synthetic membranes was found to be 
dependent upon the amount of oil sorbed by the membranes. Some of the oils 
that are currently widely used in cosmetics were found to enhance parabens 
permeation, which are currently used as preservatives in topical formulations. 
However, these preservatives have been reported to have a degree of associated 
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carcinogenicity (Darbre et al., 2004), if they permeate into the skin in sufficient 
quantities. In addition, should the vehicle contain a blend of oils in the 
formulation then these may be sorbed in different quantities to those present in 
the applied vehicle. Therefore some care should be exercised when developing 
blended products. Further PCA analysis is expected to improve the 
understanding of drug-vehicle-membrane interaction but clearly drug, vehicle 
and membrane descriptors have to be taken into account when modeling the 
permeability of membranes to drug and other xenobiotic molecules.   
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Appendix I: Definitions of molecular descriptors used in PCA analysis 
 
The molecular descriptors used in PCA analysis were determined using Molecular 
Operating Environment 2012, produced by Chemical Computing Group Inc., 
Montreal, Canada. and by HSPiP software version 4.0.04 
 
Table A1.1 Descriptions of PCA and QSPR descriptors 
 
Code Description 
Solvent uptake Amount of oil sorbed by membrane 
solubility Solubility of the permeants in the oil 
density Molecular mass density: Weight divided by vdw_vol (amu/Å3).  
Weight Molecular weight (including implicit hydrogens) in atomic 
mass units with atomic weights taken from (Lide.& Frederikse, 
1994). 
Mpoint Melting point 
δD The dispersive component of HSP 
δP The polar component of HSP 
δH The hydrogen bond component of HSP 
δT Hildebrand solubility parameter 
LogP(o/w) 
Log of the octanol/water partition coefficient (including 
implicit hydrogens). This property is calculated from a linear 
atom type model with r2 = 0.931, RMSE=0.393 on 1,827 
molecules.  
SlogP 
Log of the octanol/water partition coefficient (including 
implicit hydrogens). This property is an atomic contribution 
model that calculates LogP from the given structure; i.e., the 
correct protonation state (washed structures). Results may vary 
from the LogP(o/w) descriptor. The training set for SlogP was 
~7000 structures.  
ovality A measure of how the shape of a molecule approaches an oval shape 
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Mwt Molecular weight  
Mvol Molecular volume 
TPSA 
Polar surface area (Å2) calculated using group contributions to 
approximate the polar surface area from connection table 
information only. The parameterization is that of Ertlet al. 
[Ertl 2000].  
vdw_vol van der Waals volume (Å3) calculated using a connection table approximation.  
vdw_area Area of van der Waals surface (Å2) calculated using a connection table approximation.  
a_nH 
Number of hydrogen atoms (including implicit hydrogens). 
This is calculated as the sum of hi over all non-trivial atoms i 
plus the number of non-trivial hydrogen atoms. 
a_nC Number of carbon atoms: #{Zi | Zi = 6}. 
a_nO Number of oxygen atoms: #{Zi | Zi = 8}. 
b_1rotN Number of rotatable single bonds. Conjugated single bonds are not included (e.g., ester and peptide bonds).  
b_1rotR Fraction of rotatable single bonds: b_1rotN divided by b_heavy. 
b_ar Number of aromatic bonds. 
b_count Number of bonds (including implicit hydrogens). This is calculateds the sum of (di/2 + hi) over all non-trivial atoms i. 
b_double Number of double bonds. Aromatic bonds are not considered to be double bonds. 
b_rotN Number of rotatable bonds. A bond is rotatable if it has order 1, is not in a ring, and has at least two heavy neighbors.  
b_rotR Fraction of rotatable bonds: b_rotN divided by b_heavy. 
b_single Number of single bonds (including implicit hydrogens). Aromatic bonds are not considered to be single bonds. 
lip_acc The number of O and N atoms.  
lip_don The number of OH and NH atoms.  
opr_brigid The number of rigid bonds from [Oprea 2000].  
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A1.1 Descriptions of PCA and QSPR descriptors (continued) 
opr_nring The number of ring bonds from [Oprea 2000].  
opr_nrot The number of rotatable bonds from [Oprea 2000].  
chi0 
Atomic connectivity index (order 0) from [Hall 1991] and 
[Hall 1977]. This is calculated as the sum of 1/sqrt(di) over all 
heavy atoms i with di > 0. 
chi0_C Carbon connectivity index (order 0). This is calculated as the sum of 1/sqrt(di) over all carbon atoms i with di > 0. 
chi1 
Atomic connectivity index (order 1) from [Hall 1991] and 
[Hall 1977]. This is calculated as the sum of 1/sqrt(didj) over 
all bonds between heavy atoms i and j where i < j. 
chi1_C 
Carbon connectivity index (order 1). This is calculated as the 
sum of 1/sqrt(didj) over all bonds between carbon atoms i and 
j where i < j. 
chi0v 
Atomic valence connectivity index (order 0) from [Hall 1991] 
and [Hall 1977]. This is calculated as the sum of 1/sqrt(vi) 
over all heavy atoms i with vi > 0. 
chi0v_C Carbon valence connectivity index (order 0). This is calculated as the sum of 1/sqrt(vi) over all carbon atoms i with vi > 0. 
Kier1 First kappa shape index: (n-1)2 / m2 [Hall 1991].  
Kier2 Second kappa shape index: (n-1)2 / m2 [Hall 1991].  
Kier3 Third kappa shape index: (n-1) (n-3)2 / p32 for odd n, and (n-3) (n-2)2 / p32 for even n [Hall 1991].  
KierFlex Kier molecular flexibility index: (KierA1) (KierA2) / n [Hall 1991].  




Total hydrophobic van der Waals surface area. This is the sum 
of the vi such that |qi| is less than or equal to 0.2. The vi are 
calculated using a connection table approximation.  
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Fractional polar van der Waals surface area. This is the sum of 
the vi such that |qi| is greater than 0.2 divided by the total 





Fractional hydrophobic van der Waals surface area. This is the 
sum of the vi such that |qi| is less than or equal to 0.2 divided 
by the total surface area. The vi are calculated using a 




Total polar van der Waals surface area. This is the sum of the 
vi such that |qi| is greater than 0.2. The vi are calculated using 
a connection table approximation.  
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Appendix II: Correlation matrix for different independent and dependent variables 
 
Table A2.1 The final correlation matrix showing the descriptors that will be included in the flux through synthetic membranes 







































solubility 0.2249 1.0000 
normalized 
weight ratio 0.3000 -0.0396 1.0000 
normalized 
δPexp drug -0.2424 -0.4235 0.0000 1.0000 
normalized 
chi0 drug -0.0836 0.1633 0.0000 0.3599 1.0000 
normalized  
LogKo/w 
vehicle -0.4014 -0.3491 -0.1454 0.0000 0.0000 1.0000 
normalized 
lip_acc 
vehicle  0.0933 0.5315 -0.0166 0.0000 0.0000 -0.4530 1.0000 
normalized  
lip_don 
vehicle  -0.3294 0.0786 0.0805 0.0000 0.0000 0.0540 0.5774 1.0000 
normalized 
chi1_C 
vehicle  -0.2918 0.2131 -0.1073 0.0000 0.0000 0.3745 0.6453 0.7513 1.0000 
normalized  
δDexp 
membrane -0.2850 0.0000 -0.4129 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 1.0000 
normalized  
δHexp 
membrane -0.5968 0.0000 -0.1570 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.3653 1.0000 
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Table A2.2The final correlation matrix showing the descriptors that will be included in the solvent uptake into synthetic membranes 

























normalized weight ratio 1 
normalized  δDexp 
vehicle -0.2294124 1 
normalized  LogKo/w 
vehicle -0.1454454 0.551700643 1 
normalized  Molecular 
connectivity index 
vehicle -0.0881439 0.673488942 -0.15646 1 
normalized  opr_brigid 
vehicle 0.0805219 0.233380014 0.053972 0.583410084 1 
normalized chi0_C 
vehicle  0.2495684 -0.78383731 -0.79916 -0.08222289 0.28106091 1 
normalized  
δT/δHildebrand 
membrane -0.2988566 0 0 -6.3441E-18 1.26883E-17 -6.3413E-18 1 
normalized  δDexp 
membrane -0.4129002 0 0 3.17207E-18 1.90324E-17 -1.0324E-17 0.712492 1 
Appendices     265 












































Normalized Kp 1.00000 
normalized 
solubility -0.2265 1.00000 
normalized weight 








drug 0.2302 0.16333 0.0000 0.381 1.00000 
normalized  
Mpoint vehicle 0.2638 0.29319 
-
0.2154 0.000 0.00000 1.00000 
normalized  




vehicle -0.364 0.49074 -0.088 0.000 0.00000 0.78002 -0.15646 1.00000 
normalized  
opr_brigid vehicle -0.2382 0.07863 0.0805 0.000 0.00000 0.29858 0.05397 0.58341 1.00000 
normalized  chi0 
vehicle -0.2918 0.43227 0.1008 0.000 0.00000 0.15020 -0.66481 0.73389 0.65699 1.00000 
normalized  
δT/δHildebrand 
membrane -0.2842 0.00000 -0.298 0.000 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 1.00000 
normalized  δDexp 
membrane -0.1688 0.00000 
-
0.4129 0.000 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 0.71249 1.00000 
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solubility 0.09276 1.00000 
normalized 
weight ratio -0.00669 -0.03958 1.00000 
normalized  
δT/δHildebrand 
DRUG -0.04295 -0.51400 0.00000 1.00000 
normalized 
b_count drug  0.16191 0.33510 0.00000 -0.33597 1.00000 
normalized  
opr_brigid 
vehicle 0.20365 0.07863 0.08052 0.00000 0.00000 1.00000 
normalized  chi0 
vehicle 0.19884 0.43227 0.10089 0.00000 0.00000 0.65699 1.00000 
normalized chi1 
vehicle 0.24427 0.43689 -0.07788 0.00000 0.00000 0.68466 0.72437 1.00000 
normalized 
chi0v_C vehicle  -0.05107 0.00757 0.24258 0.00000 0.00000 0.00056 0.40795 -0.33386 1.00000 
normalized  
δT/δHildebrand 
membrane 0.62565 0.00000 -0.29886 0.00000 0.00000 0.00000 0.00000 0.00000 0.00000 1.00000 
normalized  
δDexp 
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